
<html lang="en"     class="pb-page"  data-request-id="11a4294a-b55c-4c96-a3f7-91a6f458ec27"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2010.53.issue-22;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm100971t;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="In Vivo Characterization of a Dual Adenosine A2A/A1 Receptor Antagonist in Animal Models of Parkinson’s Disease" /></meta><meta name="dc.Creator" content="Brian C.  Shook" /></meta><meta name="dc.Creator" content="Stefanie  Rassnick" /></meta><meta name="dc.Creator" content="Melville C.  Osborne" /></meta><meta name="dc.Creator" content="Scott  Davis" /></meta><meta name="dc.Creator" content="Lori  Westover" /></meta><meta name="dc.Creator" content="Jamie  Boulet" /></meta><meta name="dc.Creator" content="Daniel  Hall" /></meta><meta name="dc.Creator" content="Kenneth C.  Rupert" /></meta><meta name="dc.Creator" content="Geoffrey R.  Heintzelman" /></meta><meta name="dc.Creator" content="Kristin  Hansen" /></meta><meta name="dc.Creator" content="Devraj  Chakravarty" /></meta><meta name="dc.Creator" content="James L.  Bullington" /></meta><meta name="dc.Creator" content="Ronald  Russell" /></meta><meta name="dc.Creator" content="Shawn  Branum" /></meta><meta name="dc.Creator" content="Kenneth M.  Wells" /></meta><meta name="dc.Creator" content="Sandra  Damon" /></meta><meta name="dc.Creator" content="Scott  Youells" /></meta><meta name="dc.Creator" content="Xun  Li" /></meta><meta name="dc.Creator" content="Derek A.  Beauchamp" /></meta><meta name="dc.Creator" content="David  Palmer" /></meta><meta name="dc.Creator" content="Mayra  Reyes" /></meta><meta name="dc.Creator" content="Keith  Demarest" /></meta><meta name="dc.Creator" content="Yuting  Tang" /></meta><meta name="dc.Creator" content="Kenneth  Rhodes" /></meta><meta name="dc.Creator" content="Paul F.  Jackson" /></meta><meta name="dc.Description" content="The in vivo characterization of a dual adenosine A2A/A1 receptor antagonist in several animal models of Parkinson’s disease is described. Discovery and scale-up syntheses of compound 1 are describe..." /></meta><meta name="Description" content="The in vivo characterization of a dual adenosine A2A/A1 receptor antagonist in several animal models of Parkinson’s disease is described. Discovery and scale-up syntheses of compound 1 are describe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 25, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100971t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100971t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100971t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100971t" /></link>
        
    
    

<title>In Vivo Characterization of a Dual Adenosine A2A/A1 Receptor Antagonist in Animal Models of Parkinson’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100971t" /></meta><meta property="og:title" content="In Vivo Characterization of a Dual Adenosine A2A/A1 Receptor Antagonist in Animal Models of Parkinson’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0004.jpeg" /></meta><meta property="og:description" content="The in vivo characterization of a dual adenosine A2A/A1 receptor antagonist in several animal models of Parkinson’s disease is described. Discovery and scale-up syntheses of compound 1 are described in detail, highlighting optimization steps that increased the overall yield of 1 from 10.0% to 30.5%. Compound 1 is a potent A2A/A1 receptor antagonist in vitro (A2A Ki = 4.1 nM; A1 Ki = 17.0 nM) that has excellent activity, after oral administration, across a number of animal models of Parkinson’s disease including mouse and rat models of haloperidol-induced catalepsy, mouse model of reserpine-induced akinesia, rat 6-hydroxydopamine (6-OHDA) lesion model of drug-induced rotation, and MPTP-treated non-human primate model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100971t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100971t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100971t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100971t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100971t&amp;href=/doi/10.1021/jm100971t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 8104-8115</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm1009605" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm101010n" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">In Vivo Characterization of a Dual Adenosine A<sub>2A</sub>/A<sub>1</sub> Receptor Antagonist in Animal Models of Parkinson’s Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+C.++Shook">Brian C. Shook</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefanie++Rassnick">Stefanie Rassnick</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melville+C.++Osborne">Melville C. Osborne</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Davis">Scott Davis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lori++Westover">Lori Westover</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jamie++Boulet">Jamie Boulet</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Hall">Daniel Hall</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+C.++Rupert">Kenneth C. Rupert</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Geoffrey+R.++Heintzelman">Geoffrey R. Heintzelman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristin++Hansen">Kristin Hansen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Devraj++Chakravarty">Devraj Chakravarty</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+L.++Bullington">James L. Bullington</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald++Russell">Ronald Russell</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shawn++Branum">Shawn Branum</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+M.++Wells">Kenneth M. Wells</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Damon">Sandra Damon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Youells">Scott Youells</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xun++Li">Xun Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Derek+A.++Beauchamp">Derek A. Beauchamp</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Palmer">David Palmer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mayra++Reyes">Mayra Reyes</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith++Demarest">Keith Demarest</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuting++Tang">Yuting Tang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth++Rhodes">Kenneth Rhodes</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+F.++Jackson">Paul F. Jackson</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 215-628-7047. Fax: 215-540-4612. <a href="/cdn-cgi/l/email-protection#7b1908131414103b120f085511151155181416"><span class="__cf_email__" data-cfemail="7a1809121515113a130e095410141054191517">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100971t&amp;href=/doi/10.1021%2Fjm100971t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 8104–8115</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 25, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 July 2010</li><li><span class="item_label"><b>Published</b> online</span>25 October 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 November 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100971t" title="DOI URL">https://doi.org/10.1021/jm100971t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8104%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBrian%2BC.%2BShook%252C%2BStefanie%2BRassnick%252C%2BMelville%2BC.%2BOsborne%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D22%26contentID%3Djm100971t%26title%3DIn%2BVivo%2BCharacterization%2Bof%2Ba%2BDual%2BAdenosine%2BA2A%252FA1%2BReceptor%2BAntagonist%2Bin%2BAnimal%2BModels%2Bof%2BParkinson%25E2%2580%2599s%2BDisease%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8115%26publicationDate%3DNovember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100971t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2256</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">40</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100971t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;In Vivo Characterization of a Dual Adenosine A2A/A1 Receptor Antagonist in Animal Models of Parkinson’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;C. Shook&quot;},{&quot;first_name&quot;:&quot;Stefanie&quot;,&quot;last_name&quot;:&quot;Rassnick&quot;},{&quot;first_name&quot;:&quot;Melville&quot;,&quot;last_name&quot;:&quot;C. Osborne&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Davis&quot;},{&quot;first_name&quot;:&quot;Lori&quot;,&quot;last_name&quot;:&quot;Westover&quot;},{&quot;first_name&quot;:&quot;Jamie&quot;,&quot;last_name&quot;:&quot;Boulet&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Hall&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;C. Rupert&quot;},{&quot;first_name&quot;:&quot;Geoffrey&quot;,&quot;last_name&quot;:&quot;R. Heintzelman&quot;},{&quot;first_name&quot;:&quot;Kristin&quot;,&quot;last_name&quot;:&quot;Hansen&quot;},{&quot;first_name&quot;:&quot;Devraj&quot;,&quot;last_name&quot;:&quot;Chakravarty&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;L. Bullington&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;Russell&quot;},{&quot;first_name&quot;:&quot;Shawn&quot;,&quot;last_name&quot;:&quot;Branum&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;M. Wells&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Damon&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Youells&quot;},{&quot;first_name&quot;:&quot;Xun&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Derek&quot;,&quot;last_name&quot;:&quot;A. Beauchamp&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Palmer&quot;},{&quot;first_name&quot;:&quot;Mayra&quot;,&quot;last_name&quot;:&quot;Reyes&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;Demarest&quot;},{&quot;first_name&quot;:&quot;Yuting&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;Rhodes&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;F. Jackson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;8104-8115&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100971t&quot;},&quot;abstract&quot;:&quot;The in vivo characterization of a dual adenosine A2A/A1 receptor antagonist in several animal models of Parkinson’s disease is described. Discovery and scale-up syntheses of compound 1 are described in detail, highlighting optimization steps that increased the overall yield of 1 from 10.0% to 30.5%. Compound 1 is a potent A2A/A1 receptor antagonist in vitro (A2A Ki = 4.1 nM; A1 Ki = 17.0 nM) that has excellent activity, after oral administration, across a number of animal models of Parkinson’s disease including mouse and rat models of haloperidol-induced catalepsy, mouse model of reserpine-induced akinesia, rat 6-hydroxydopamine (6-OHDA) lesion model of drug-induced rotation, and MPTP-treated non-human primate model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100971t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100971t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100971t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100971t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100971t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100971t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100971t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100971t&amp;href=/doi/10.1021/jm100971t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100971t" /></input><a href="/doi/pdf/10.1021/jm100971t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100971t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100971t%26sid%3Dliteratum%253Aachs%26pmid%3D20973483%26genre%3Darticle%26aulast%3DShook%26date%3D2010%26atitle%3DIn%2BVivo%2BCharacterization%2Bof%2Ba%2BDual%2BAdenosine%2BA2A%252FA1%2BReceptor%2BAntagonist%2Bin%2BAnimal%2BModels%2Bof%2BParkinson%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D22%26spage%3D8104%26epage%3D8115%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jmcmar.2010.53.issue-22/production/jmcmar.2010.53.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The in vivo characterization of a dual adenosine A<sub>2A</sub>/A<sub>1</sub> receptor antagonist in several animal models of Parkinson’s disease is described. Discovery and scale-up syntheses of compound <b>1</b> are described in detail, highlighting optimization steps that increased the overall yield of <b>1</b> from 10.0% to 30.5%. Compound <b>1</b> is a potent A<sub>2A</sub>/A<sub>1</sub> receptor antagonist in vitro (A<sub>2A</sub><i>K</i><sub>i</sub> = 4.1 nM; A<sub>1</sub><i>K</i><sub>i</sub> = 17.0 nM) that has excellent activity, after oral administration, across a number of animal models of Parkinson’s disease including mouse and rat models of haloperidol-induced catalepsy, mouse model of reserpine-induced akinesia, rat 6-hydroxydopamine (6-OHDA) lesion model of drug-induced rotation, and MPTP-treated non-human primate model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Parkinson’s disease (PD<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: 6-OHDA, 6-hydroxydopamine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD, Parkinson’s disease; DA, dopamine; L-DOPA, levodopamine, MAO-B, monoamine oxidase type B; COMT, catchol <i>O</i>-methyltransferase; cAMP, cyclic adenosine monophosphate; PK, pharmacokinetics.</p></div> is a chronic, progressive neurological disease that affects ∼1% of the population over the age of 65.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It is characterized by progressive impairment in motor function that is often accompanied by disturbances in mood and cognitive function. Most of the motor impairments of PD are caused by a gradual loss of dopamine (DA) producing neurons in the ventral midbrain and concomitant loss of DA input to forebrain (striatal) motor structures.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> The loss of DA input to the neostriatum leads to dysregulation of striatal function and the classic motor symptoms of PD, such as resting tremor, muscular rigidity, and bradykinesia.</div><div class="NLM_p">Most of the treatments aim to restore dopamine signaling and thereby reduce the severity of the motor symptoms. Dopamine replacement therapy using L-DOPA, the precursor to dopamine, remains the gold-standard treatment for PD. Other approaches include inhibition of DA turnover using monoamine oxidase type B (MAO-B) inhibitors,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> catechol <i>O</i>-methyltransferase (COMT) inhibitors,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and inhibition of dopamine reuptake<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> or direct agonists<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> of postsynaptic dopamine receptors. Although the dopamine targeted therapies work well to address the PD related motor disturbances, they all produce undesirable side effects (dyskinesia, hallucinations, on−off effects) that become more severe and problematic with continued treatment. Also, the aforementioned therapies typically show reduced efficacy as motor functions deteriorate and the disease progresses. Moreover, these treatments do not alter disease progression and do not address the mood, postural instability, or cognitive disturbances that frequently accompany PD.</div><div class="NLM_p">As a result of the limitations of dopamine replacement agents, drug companies have sought non-dopamine based treatment for PD. One non-dopaminergic approach that has received considerable attention is modulation of adenosine receptors.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Adenosine is a neuromodulator that coordinates responses to dopamine and other neurotransmitters in areas of the brain that are responsible for motor function, learning and memory.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Adenosine comprises four distinct receptor subtypes designated A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub> belonging to the G-protein-coupled receptor superfamily.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Adenosine A<sub>1</sub> and A<sub>3</sub> receptors are coupled to inhibitory G proteins, while A<sub>2A</sub> and A<sub>2B</sub> receptors are coupled to stimulatory G proteins. On the basis of receptor autoradiography in rodents, the greatest densities of A<sub>2A</sub> receptors are found in the striatum<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> which closely matches the distribution in humans based on PET imaging.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">As described above, loss of dopamine input into the neostriatum is a hallmark of PD and underlies many of the cardinal motor symptoms of this disorder. In the striatum adenosine A<sub>2A</sub> receptors colocalize and physically associate with dopamine D<sub>2</sub> receptors.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> A<sub>2A</sub> and D<sub>2</sub> receptors have opposing effects on adenylate cyclase and cAMP production in cells such that activation of A<sub>2A</sub> receptors inhibits dopamine D<sub>2</sub> receptor signaling. Conversely, A<sub>2A</sub> receptor antagonists enhance D<sub>2</sub> dependent signaling as shown by induction of immediate early gene c-fos expression in the striatopallidal pathway<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and facilitate other D<sub>2</sub> mediated responses. Of importance to PD, pharmacological blockade of A<sub>2A</sub> receptors has shown dramatic beneficial effects in preclinical animal models of PD, showing potentiation of dopamine-mediated responses in dopamine depleted (6-hydroxydopamine treated) animals and dramatic relief of parkinsonian symptoms in MPTP-treated nonhuman primates.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> A<sub>2A</sub> antagonists facilitate dopamine receptor signaling and thereby normalize motor function in animal models of dopamine dysregulation. As a result of these findings, the adenosine A<sub>2A</sub> receptor has become a sought after target for treating PD. Blockade of A<sub>2A</sub> signaling by selective A<sub>2A</sub> receptor antagonists (e.g., <b>2</b> (KW-6002),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> istradefylline) was shown to be beneficial for not only enhancing the therapeutic effects of L-DOPA but also reducing dyskinesia from long-term L-DOPA treatment.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">The adenosine A<sub>1</sub> receptor is also expressed in the striatum. On the basis of anatomical and in vivo microdialysis studies, A<sub>1</sub> receptors appear to be localized presynaptically of dopamine axon terminals where they inhibit dopamine release.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> A<sub>1</sub> receptor antagonists facilitate dopamine release in the striatum and, like A<sub>2A</sub> receptors, potentiate dopamine mediated responses. Antagonism of both the A<sub>2A</sub> and A<sub>1</sub> would be synergistic; inhibition of the A<sub>1</sub> receptor will facilitate dopamine release, while inhibition of the A<sub>2A</sub> receptor will enhance postsynaptic responses to dopamine. Interestingly, the A<sub>1</sub> receptor is also concentrated in neocortical and limbic system structures that are important for cognitive function. Pharmacological inhibition of A<sub>1</sub> receptors enhances neurotransmitter release in the hippocampus<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and enhances performance in animal models of learning and memory.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p last">The major unmet medical needs of PD are improved symptomatic treatment without inducing adverse effects (primarily dyskinesia) associated with long-term L-DOPA or dopamine agonist therapy; opportunity to slow disease progression by protecting midbrain dopamine and other neurons from degeneration; treatment of disease comorbidities, including cognitive dysfunction, anxiety, and depression. On the basis of published preclinical and human clinical data, a dual A<sub>2A</sub>/A<sub>1</sub> receptor antagonist may address many of these unmet needs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We recently published a series of arylindenopyrimidines as dual A<sub>2A</sub>/A<sub>1</sub> receptor antagonists that reverse haloperidol induced catalepsy in mice when dosed orally.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The compounds typically showed very potent in vitro activity for both A<sub>2A</sub> and A<sub>1</sub> and had A<sub>1</sub>/A<sub>2A</sub> ratios ranging from ∼1 to 10. Compound <b>1</b> was identified as an ideal dual A<sub>2A</sub>/A<sub>1</sub> receptor antagonist having excellent functional in vitro (A<sub>2A</sub><i>K</i><sub>i</sub> = 4.1 nM; A<sub>1</sub><i>K</i><sub>i</sub> = 17.0 nM) and in vivo activity and showed excellent beneficial effects in several preclinical animal models of PD across a number of different species. We report herein the in vivo characterization of <b>1</b> in animal models of PD including mouse<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and rat<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> models of neuroleptic-induced catalepsy, mouse model of reserpine-induced akinesia,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> rat 6-hydroxydopamine (6-OHDA) lesion model of drug-induced rotation,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and MPTP-treated non-human primate model.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">The discovery synthesis of compound <b>1</b> started with the commercially available 6-methylindanone <b>3</b> which was deprotonated with NaHMDS and reacted with CS<sub>2</sub> followed by MeI to afford the dithioketenacetal <b>4</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compound <b>4</b> reacts with guanidine to form an intermediate aminopyrimidine, not shown or isolated, that is then oxidized to the corresponding ketone by passing air through the solution to give <b>5</b>.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The aminopyrimidine was protected using excess (Boc)<sub>2</sub>O and 4-dimethylaminopyridine (DMAP) to give <b>6</b>. Efforts to mono-Boc compound <b>5</b> were unsuccessful as the di-Boc compound was forming while starting material was present. Also, the reaction was very sluggish without the addition of DMAP. The phenyl substituent was installed via a modified Suzuki reaction under Liebeskind-type conditions using the methylthioether as the coupling partner to afford <b>7</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The Suzuki reaction proceeded smoothly with the di-Boc protected aminopyrimidine but could not be accomplished on the unprotected aminopyrimidine <b>5</b> under the same conditions. Compound <b>7</b> underwent benzyl bromination to afford the corresponding bromide <b>8</b>. Removal of the Boc groups with TFA followed by alkylation with pyrrolidine gave the desired target compound <b>1</b>. This synthesis was completed in a total of seven steps starting from <b>3</b> and had an overall yield of 10.0%. This route was sufficient enough to prepare gram quantities of <b>1</b>; however, a better, more robust route needed to be designed to prepare <b>1</b> in large quantities.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Discovery Synthesis of <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The optimized large scale synthesis of <b>1</b> started with the same commercially available 6-methylindanone <b>3</b> which was condensed with benzaldehyde to afford the benzylidene <b>9</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The benzylidene <b>9</b> was reacted with guanidine and upon aromatization was oxidized to the corresponding ketone <b>10</b> using air in a one-pot reaction as described above.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The aminopyrimidine was protected with (Boc)<sub>2</sub>O to give the intermediate <b>7</b> that underwent radical initiated benzyl bromination similar to the discovery synthesis, but 1,3-dibromo-5,5-dimethylhydantoin proved to be a more robust brominating agent than NBS. The formed benzyl bromide was displaced in situ by pyrrolidine to give the di-Boc protected <b>1</b>, which was directly subjected to excess HCl to remove the Boc protecting groups and afford compound <b>1</b> as the di-HCl salt. The three steps were performed sequentially, without purification, to deliver the desired <b>1</b> as the di-HCl salt in 75% yield. This optimized synthesis removed three isolation/purification steps overall but more importantly removed the Suzuki-type coupling which used 20 mol % of Pd(dppf)Cl<sub>2</sub> which was tedious to remove down to acceptable levels. More than 300 g of <b>1</b> were prepared via this sequence in an overall yield of 30.5%.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Optimized Large Scale Synthesis of <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pharmacokinetics (PK) of <b>1</b> was determined in mouse, rat, and monkey (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In general, the compound had good oral bioavailability in all species ranging from 39% to 100% (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Plasma levels of <b>1</b> were modest in all species but had excellent exposure in rat brain with a brain/plasma (<i>B</i>/<i>P</i>) of ∼3. The concentration of <b>1</b> found in rat brain (3552 nM) was 866-fold higher than the concentration needed to antagonize the A<sub>2A</sub> receptor (<i>K</i><sub>i</sub> = 4.1 nM) and 208-fold higher than the needed concentration for the A<sub>1</sub> receptor (<i>K</i><sub>i</sub> = 17.0 nM). The oral plasma half-life was relatively low in rodent but was moderate in monkey.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pharmacokinetic Data of Compound <b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">mouse (10 mg/kg, po)</th><th class="colsep0 rowsep0" align="center">rat (10 mg/kg, po)</th><th class="colsep0 rowsep0" align="center">monkey (10 mg/kg, po)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma <i>C</i><sub>max</sub> (nM)</td><td class="colsep0 rowsep0" align="left">655</td><td class="colsep0 rowsep0" align="left">1263</td><td class="colsep0 rowsep0" align="left">626</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain <i>C</i><sub>max</sub> (nM)</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">3552</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div></div><div class="NLM_p">In vivo efficacy of <b>1</b> was examined in a mouse model of neuroleptic-induced catalepsy.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Haloperidol, a neuroleptic medication that inhibits dopamine D<sub>2</sub> receptors,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> was used to induce catalepsy. In the rodent, catalepsy is characterized as a loss of voluntary motion where limbs uncharacteristically remain in placed positions, which mimics the muscular stiffness seen in PD patients. Efficacy in this model is defined as reversal of catalepsy, i.e., moving from the placed positions (refer to the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for a more detailed description of the mouse catalepsy model). This was the primary in vivo model that was used to evaluate compounds quickly by assessing oral and CNS activity. Also, the model typically required very little compound (5−10 mg), making it a robust tool with very fast turnaround. Compound <b>1</b> reversed haloperidol-induced catalepsy in mice in a dose-dependent fashion and had an ED<sub>50</sub> of 0.17 mg/kg, po, while the minimum effective dose was shown to be 1 mg/kg, po (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). L-DOPA was used as the positive control.</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reversal of neuroleptic-induced catalepsy in mice by compounds <b>1</b> and <b>2</b>. Left: Catalepsy was measured in haloperidol (1 mg/kg, sc) treated mice after oral administration of <b>1</b> (0.01, 0.10, 1.0, or 10.0 mg/kg, po). L-DOPA, the dopamine precursor and gold standard for treating PD, was used as the positive control for this model at 300 mg/kg, po. Right: Catalepsy was measured in haloperidol (1 mg/kg, sc) treated mice after oral administration of <b>2</b> (0.10, 1.0, 3.0, or 5.0 mg/kg, po). For both panels each value represents average (±SEM) time in cataleptic position of <i>n</i> = 9−11 mice per treatment group during a 60 s test session. Asterisks indicate significant differences compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As a point of reference, <b>2</b>, a selective A<sub>2A</sub> receptor antagonist, was also run in the model in the exact fashion described above. Compound <b>2</b> showed positive results in a number of preclinical models of PD<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and also showed positive clinical outcomes in PD patients.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The ED<sub>50</sub> of <b>2</b> for inhibiting haloperidol-induced catalepsy in mice was 0.14 mg/kg, po, and the minimum effective dose was shown to be 1 mg/kg, po (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The activity of <b>1</b> in the mouse catalepsy model was essentially the same as seen with the comparator <b>2</b>.</div><div class="NLM_p">Another study was performed using the same model of neuroleptic-induced catalepsy in mice to examine the duration of action of <b>1</b>. The results in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> show that haloperidol induced catalepsy at each measurement period and that <b>1</b> was effective in reversing haloperidol-induced catalepsy at all measurement periods. Positive results were also observed for the A<sub>2A</sub> receptor antagonist reference standard (<b>2</b>). These data suggest that in mice, the duration of action for in vivo efficacy of <b>1</b> is at least 4 h following oral administration at both 1 and 3 mg/kg. Extended measurement periods past 4 h were not examined nor were higher doses of compound <b>1</b>.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Duration of action of <b>1</b> in the mouse model of neuroleptic-induced catalepsy. Catalepsy time was measured in haloperidol (1 mg/kg, sc) treated mice after oral administration of <b>1</b> (0, 1, or 3 mg/kg), vehicle, or <b>2</b> (5 mg/kg). Catalepsy was measured repeatedly 15 min, 1 h, 2 h, and 4 h after oral dosing of the respective treatment groups. Each value represents average (±SEM) time in cataleptic position of <i>n</i> = 12 mice per treatment group during a 60 s test session. Asterisks indicate significant differences as compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In vivo efficacy of <b>1</b> was examined in a rat model of neuroleptic-induced catalepsy.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This model was carried out analogously to that described for mice except that the maximum duration for rat was 180 s compared to 60 s for mice. Results in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> show that <b>1</b> was effective in reversing the haloperidol-induced catalepsy having an ED<sub>50</sub> of 0.48 mg/kg, po, and a minimum effective dose of 1 mg/kg, po. As shown in mice, the reversal in rat was also dose-dependent.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0007.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Reversal of neuroleptic-induced catalepsy in rats by compound <b>1</b>. Time to descend from the bar was measured in haloperidol (1 mg/kg, sc) treated Sprague−Dawley rats after oral administration of <b>1</b> (0.01, 0.10, 1.0, 10.0, or 30.0 mg/kg), L-DOPA coadministered with carbidopa (200:50 mg/kg), or vehicle. Each value represents average (±SEM) time in cataleptic position of <i>n</i> = 10−16 rats per treatment group during a 180 s test session. Asterisks indicate significant differences compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A study was performed using the rat model of neuroleptic-induced catalepsy to examine the duration of action of <b>1</b>. The results in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> shows haloperidol induced catalepsy at each measurement period and that <b>1</b> was effective in reversing haloperidol-induced catalepsy at all measurement periods. Positive results were also observed for L-DOPA. These data suggest that in rats, the duration of action for in vivo efficacy of <b>1</b> is at least 4 h following oral administration.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0008.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Duration of action of <b>1</b> in the rat model of neuroleptic-induced catalepsy. Time to descend from the bar was measured in haloperidol (1 mg/kg, sc) treated rats after oral administration of <b>1</b> (0, 1, or 10 mg/kg) or L-DOPA (200 mg/kg) coadministered with benserazide (50 mg/kg). Catalepsy was measured repeatedly 15 min, 1 h, 2 h, and 4 h after oral dosing of the respective treatment groups. Each value represents average (±SEM) time in cataleptic position of <i>n</i> = 10 rats per treatment group during a 180 s test session. Asterisks indicate significant differences compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To evaluate the potential antiparkinsonian properties of <b>1</b>, locomotor activity was studied in a mouse model of reserpine-induced akinesia.<a onclick="showRef(event, 'ref23 ref32'); return false;" href="javascript:void(0);" class="ref ref23 ref32">(23, 32)</a> Reserpine is an alkaloid that depletes monoamine by inhibiting their vesicular uptake, resulting in a dramatic reduction of spontaneous locomotor activity (akinesia). Efficacy was defined as reversal of reserpine-induced akinesia and was quantified as total distance traveled (cm) (refer to the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for a more detailed description of the mouse reserpine model). Locomotion was studied 60 min after oral administration of <b>1</b> (0.10, 1.0, 10.0, or 30.0 mg/kg) or vehicle in mice that were pretreated with reserpine (0.6 mg/kg, sc) 18 h earlier. Reserpine produced a marked decrease in horizontal and vertical locomotor activity. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, reserpine-induced akinesia was reversed by <b>1</b> at 1, 10, and 30 mg/kg, po, and had a minimum effective dose of 1 mg/kg, po.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0009.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Reversal of resepine-induced akinesia in mice by compound <b>1</b>. Efficacy was defined as reversal of reserpine-induced akinesia and was quantified as total distance traveled (cm). Locomotion was studied 60 min after oral administration of <b>1</b> (0.10, 1.0, 10.0, or 30.0 mg/kg) or vehicle in mice that were pretreated with reserpine (0.6 mg/kg, sc) 18 h earlier. Each value represents the mean (±SEM) of the total distance traveled of <i>n</i> = 10−12 mice per treatment group during the 30 min measurement period in the behavioral test session. Asterisks indicate significant differences compared with the reserpine + vehicle control group (∗∗, <i>P</i> < 0.01; ∗∗∗, <i>P</i> < 0.001; Hochberg test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> was studied in the 6-OHDA-lesion model of drug-induced rotation in rats.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In this model, the neurotoxin 6-OHDA (12 μg) is microinjected unilaterally in the medial forebrain bundle to produce a targeted degeneration of midbrain dopamine neurons in the pars compacta of the substantia nigra. 6-OHDA-induced neurotoxicity causes a dramatic deficit in dopamine neurons that is accompanied by denervation-induced supersensitivity of postsynaptic dopamine receptors in the striatum of the lesioned side. An imbalance in dopamine activity between the two sides of the brain causes asymmetry in motor behavior that can be enhanced by drug treatment. For example, drugs that stimulate postsynaptic dopamine receptors produce an imbalance in dopamine signaling that favors the lesion side and induces rotation behavior (turning) toward the side opposite (contralateral to) the lesion side (refer to the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for a more detailed description of the 6-OHDA-lesion model).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">One rotation count was defined as one 360° turn. Results showed that on its own, <b>1</b> produced a low level of behavioral activity that was less than the activity evoked by L-DOPA (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). More importantly, a dose-dependent, synergistic effect is realized when L-DOPA is administered to animals that were dosed previously with the adenosine receptor antagonist <b>1</b> with the minimum effective dose being 1 mg/kg, po. These results suggest that there must be some dopamine on board for an adenosine antagonist to be effective in treating PD, as there is little effect of <b>1</b> alone on the behavior of animals having minimal amounts dopamine neurons. It is known that approximately 80% of dopamine neurons are depleted before any PD symptom (i.e., motor dysfunction) is apparent.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> It is therefore critical to identify PD patients at an earlier stage to maximize the benefit of adenosine receptor antagonists in treating PD. While this remains the ultimate challenge, significant efforts are being put forth to evaluate and treat PD patients to enhance quality of life.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0010.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>1</b> potentiates the effects of L-DOPA in the 6-OHDA-lesioned rat model of Parkinson’s disease. Six weeks after administration of 6-OHDA the behavioral test was started by dosing rats with L-DOPA (10 mg/kg, po coadministered with carbidopa (2.5 mg/k, sc)) alone or with each dose of <b>1</b> (0.1, 1.0, 3.0, and 10 mg/kg, po). The effects of <b>1</b> alone were also studied in this model. The rotational behavior was determined as each animal was tethered to a high-resolution optical sensor connected to an automated computerized system that quantifies circular motion. One rotation count was defined as one 360° turn. Each value represents the mean (±SEM) of total contralateral rotations of <i>n</i> = 16 rats per treatment group during the 2 h before and after L-DOPA administration. Asterisks indicate significant differences compared with the L-DOPA + vehicle control treatment group (∗, <i>P</i> < 0.05, Tukey’s test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The MPTP model in marmosets is perhaps the most predictive animal model of PD.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In this model, marmosets are administered a neurotoxin, MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), that gives the animals nonreversible symptoms of PD. They possess similar motor disabilities and muscular rigidity seen in Parkinson’s patients. The animals were administered <b>1</b> (0.3, 1.0, 10, and 50 mg/kg, po), L-DOPA as the positive control, or vehicle, and the Parkinson (motor) disability was scored. Doses of 10 and 50 mg/kg of <b>1</b> completely eliminated any motor disabilities in the marmosets for at least 6 h (the last time point scored), while a 1 mg/kg dose effectively eliminated the motor disabilities for ∼3 h (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). L-DOPA (12 mg/kg po) showed suppression of the motor disabilities for less than 3 h before seeing significant motor dysfunction in the animals (refer to the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for a more detailed description of the MPTP model).</div><div class="NLM_p">In this model the dyskinesias, involuntary movements, in the animals were also scored. It is clearly seen that animals dosed with L-DOPA immediately show marked dyskinesias, while animals dosed with <b>1</b>, at all doses, showed no undesirable side effects. The results of this model showed that <b>1</b> could be an effective, stand alone treatment for PD without the major unwanted side effects.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In the left panel the parkinsonian/motor disability was monitored and scored on MPTP-treated marmosets dosed with vehicle or L-DOPA (12 mg/kg, po) or with each dose of <b>1</b> (0.1, 1.0, 10, and 50 mg/kg, po) out to 6 h. In the right panel the dyskinesias were monitored and scored on MPTP-treated marmosets dosed with vehicle or L-DOPA (12 mg/kg, po) or with each dose of <b>1</b> (0.1, 1.0, 10, and 50 mg/kg, po) out to 4 h. A total of eight animals were used for each treatment group. Data derived from nonparametric data were analyzed with a nonparametric one-way repeated measures ANOVA (Friedman test) followed by Dunn’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, we have shown that an optimized dual A<sub>2A</sub>/A<sub>1</sub> receptor antagonist could be an effective treatment for PD. When administered orally, compound <b>1</b> was shown to have excellent efficacy across a number of animal models of PD including mouse and rat catalepsy, 6-OHDA lesion model in rats, and MPTP treated marmosets. Compound <b>1</b> was also able to demonstrate activity comparable to that seen with the comparator <b>2</b>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> General Information</h3><div class="NLM_p last">All proton and carbon nuclear magnetic resonance spectra were determined using a 400 MHz Bruker NMR with the appropriate internal standards. High resolution MS was performed on a JEOL Accutof JMS-T100 LC with a DART CE ionization source operating in the positive mode. Reagent grade chemicals and solvents were purchased from Aldrich, Oakwood, or TCI. All chromatographies were carried out on a CombiFlash system equipped with an automated fraction collector. All final compounds were purified to ≥95% purity as determined by Agilent 1100 series high performance liquid chromatography (HPLC) with UV detection at 254 nm using the following method: Supelcosil ABZ+PLUS, 3.3 cm × 2.1 cm, 11 min; 1.2 mL/min flow rate; 5−95% 0.1% TFA in CH<sub>3</sub>CN/0.1% TFA in H<sub>2</sub>O.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Small Scale (Discovery Synthesis) Preparation of <b>1</b></h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> 2-Amino-4-phenyl-8-(pyrrolidin-1-ylmethyl)-5<i>H</i>-indeno[1,2-<i>d</i>]pyrimidin-5-one (<b>1</b>)</h4><div class="NLM_p">Neat TFA (8 mL, 102.8 mmol) was added to a CH<sub>2</sub>Cl<sub>2</sub> solution (24 mL) of <b>7</b> (1.94 g, 3.4 mmol), and the mixture was stirred at room temperature. After 2 h the solution was concentrated in vacuo and saturated aqueous NaHCO<sub>3</sub> was added to the material. The resulting suspension was sonicated and the precipitate was collected by filtration and washed with water. The collected solid was dried under high vacuum to afford 1.1 g (90%) of 2-amino-8-(bromomethyl)-4-phenyl-5<i>H</i>-indeno[1,2-<i>d</i>]pyrimidin-5-one as a yellow solid that was used without further purification. <i>t</i><sub>R</sub> = 4.75 min. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.03−8.12 (m, 2H), 7.89 (d, <i>J</i> = 0.98 Hz, 1H), 7.72 (d, <i>J</i> = 7.58 Hz, 1H), 7.46−7.62 (m, 4H), 5.88 (br s, 2H), 4.56 (s, 2H) ppm. <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ 187.6, 176.1, 165.9, 164.5, 144.2, 140.6, 136.4, 135.2, 133.4, 131.4, 129.7, 128.1, 124.0, 122.0, 108.0, 32.1 ppm. HRMS, calcd for C<sub>18</sub>H<sub>12</sub>BrN<sub>3</sub>O 365.0164, found 366.0254 (M<sup>+</sup> + H).</div><div class="NLM_p last">Neat pyrrolidine (0.68 mL, 8.2 mmol) was added to a THF solution (20 mL) of 2-amino-8-(bromomethyl)-4-phenyl-5<i>H</i>-indeno[1,2-<i>d</i>]pyrimidin-5-one (1.5 g, 4.1 mmol), and the mixture was warmed to 40 °C. After 16 h the mixture was concentrated in vacuo, and the resulting material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (100 mL). The organic phase was washed with saturated aqueous NaHCO<sub>3</sub> and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified via column chromatography to afford 1.1 g of <b>1</b> as a yellow solid. This material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (60 mL) and added dropwise into 1 M HCl in ether (20 mL). The resulting yellow precipitate was collected by filtration and dried in vacuo to afford 1.2 g (75%) of <b>1</b> as the di-HCl salt. <i>t</i><sub>R</sub> = 3.07 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.26 (br s, 1H), 8.12 (br s, 1H), 8.04 (s, 1H), 7.98−8.03 (m, 2H), 7.92 (dd, <i>J</i> = 1.22, 7.58 Hz, 1H), 7.74 (d, <i>J</i> = 7.58 Hz, 1H), 7.48−7.60 (m, 3H), 5.41 (br s, 2H), 4.52 (d, <i>J</i> = 5.62 Hz, 2H), 3.39 (d, <i>J</i> = 5.14 Hz, 2H), 3.09 (dd, <i>J</i> = 7.34, 10.76 Hz, 2H), 1.98−2.11 (m, 2H), 1.82−1.97 (m, 2H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.6, 175.3, 164.6, 139.8, 137.6, 136.7, 135.3, 135.2, 130.9, 129.4, 127.6, 123.2, 123.2, 123.1, 110.9, 57.7, 52.6, 22.5 ppm. HRMS, calcd for C<sub>22</sub>H<sub>20</sub>N<sub>4</sub>O 356.1637, found 357.1681 (M<sup>+</sup> + H).</div></div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> 2-(Bis(methylthio)methylene)-6-methyl-2,3-dihydro-1<i>H</i>-inden-1-one (<b>4</b>)</h3><div class="NLM_p last">A 1.0 M THF solution of NaHMDS (106 mL, 105.5 mmol) was added to a −78 °C THF solution (200 mL) of 6-methylindanone (<b>3</b>) (7.0 g, 47.9 mmol). After 30 min at −78 °C neat CS<sub>2</sub> (7.2 mL, 119.8 mmol) was added quickly in one portion to the cloudy solution. The mixture turned red, and the solution became homogeneous. The mixture was allowed to warm slowly to −20 °C without removal of the cold bath (∼1.5 h). Then neat MeI (7.5 mL, 119.8 mmol) was added and the solution was allowed to warm to room temperature slowly overnight without removal of the cold bath. Water was added, and the layers were separated. The aqueous phase was extracted with EtOAc, and the combined organics were washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified via column chromatography to give 8.9 g of <b>4</b> as a yellow solid. <i>t</i><sub>R</sub> = 5.14 min. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.61 (s, 1H), 7.31−7.40 (m, 2H), 3.81 (s, 2H), 2.57 (s, 3H), 2.52 (s, 3H), 2.41 (s, 3H) ppm. <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ 189.3, 151.6, 144.5, 140.5, 137.3, 135.7, 134.9, 125.4, 124.0, 35.2, 21.2, 18.4, 17.9 ppm. HRMS, calcd for C<sub>13</sub>H<sub>14</sub>OS<sub>2</sub> 250.0486, found 251.0558 (M<sup>+</sup> + H).</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> 2-Amino-8-methyl-4-(methylthio)-5<i>H</i>-indeno[1,2-<i>d</i>]pyrimidin-5-one (<b>5</b>)</h3><div class="NLM_p last">Solid <b>4</b> (8.9 g, 35.6 mmol) was added to a three-neck flask containing a DMF solution (100 mL) of guanidine−HCl (10.2 g, 106.8 mmol) and K<sub>2</sub>CO<sub>3</sub> (14.8 g, 106.8 mmol), and the resulting mixture was heated to 100 °C while purging air into the reaction mixture. After 24 h the mixture was diluted with THF and EtOAc (200 mL each), and the mixture was washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and dry-packed onto silica gel. Column chromatography afforded 4.8 g (53%) of <b>5</b> as a yellow solid. <i>t</i><sub>R</sub> = 4.05 min. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.54−7.62 (m, 2H), 7.30 (d, <i>J</i> = 7.58 Hz, 1H), 5.56 (br s, 2H), 2.55 (s, 3H), 2.45 (s, 3H) ppm. <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ 188.7, 174.3, 169.0, 163.8, 144.7, 140.1, 134.2, 132.9, 123.3, 122.2, 22.0, 11.3 ppm. HRMS, calcd for C<sub>13</sub>H<sub>11</sub>N<sub>3</sub>OS 257.0623, found 258.0728 (M<sup>+</sup> + H).</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Bis-<i>tert</i>-butyl (8-Methyl-4-(methylthio)-5-oxo-5<i>H</i>-indeno[1,2-<i>d</i>]pyrimidin-2-yl)carbamate (<b>6</b>)</h3><div class="NLM_p last">Solid di-<i>tert</i>-butyl dicarbonate (12.2 g, 56.0 mmol) was added to a DMF solution (50 mL) of <b>5</b> (4.8 g, 18.7 mmol), 4-(dimethylamino)pyridine (228 mg, 1.8 mmol), and K<sub>2</sub>CO<sub>3</sub> (12.9 g, 56.0 mol). After 18 h at room temperature the reaction mixture was diluted with EtOAc (300 mL) and the mixture was washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified via column chromatography to afford 6.1 g (72%) of <b>6</b> as a light yellow solid. <i>t</i><sub>R</sub> = 6.78 min. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.58−7.68 (m, 2H), 7.34 (d, <i>J</i> = 7.58 Hz, 1H), 2.61 (s, 3H), 2.47 (s, 3H), 1.53 (s, 18H) ppm. <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ 189.2, 173.7, 168.4, 160.0, 150.3, 146.1, 140.4, 133.5, 133.1, 123.9, 123.1, 118.6, 83.8, 27.9, 22.1, 14.1 ppm. HRMS, calcd for C<sub>23</sub>H<sub>27</sub>N<sub>3</sub>O<sub>5</sub>S 457.1671, found 458.1776 (M<sup>+</sup> + H).</div></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Bis-<i>tert</i>-butyl (8-Methyl-5-oxo-4-phenyl-5<i>H</i>-indeno[1,2-<i>d</i>]pyrimidin-2-yl)carbamate (<b>7</b>)</h3><div class="NLM_p last">Solid Pd(dppf)Cl<sub>2</sub> (572 mg, 0.7 mmol) was added to a dioxane solution (60 mL) of <b>6</b> (1.6 g, 3.5 mmol), phenylboronic acid (854 mg, 7.0 mmol), and copper(I) thiophene-2-carboxylate (CuTC) (1.3 g, 7.0 mmol), and the resulting mixture was heated to 85 °C. After 20 h the mixture was diluted with EtOAc (100 mL) and filtered through medium porosity fritted funnel. The filtrate was washed 4 times with 10% aqueous NH<sub>4</sub>OH, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified via column chromatography to afford 1.25 g (74%) of <b>7</b> as a light yellow solid. <i>t</i><sub>R</sub> = 7.10 min. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.18−8.26 (m, 2H), 7.75 (s, 1H), 7.68 (d, <i>J</i> = 7.58 Hz, 1H), 7.47−7.60 (m, 3H), 7.39 (d, <i>J</i> = 7.58 Hz, 1H), 2.51 (s, 3H), 1.52 (s, 18H) ppm. <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>) δ 188.8, 176.4, 164.1, 160.7, 150.4, 146.6, 140.6, 134.5, 133.9, 133.1, 131.8, 130.3, 128.1, 124.2, 122.8, 118.7, 83.8, 27.9, 22.2 ppm. HRMS, calcd for C<sub>28</sub>H<sub>29</sub>N<sub>3</sub>O<sub>5</sub> 487.2107, found 488.2160 (M<sup>+</sup> + H).</div></div><div id="sec3_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Bis-<i>tert</i>-butyl (8-(Bromomethyl)-5-oxo-4-phenyl-5<i>H</i>-indeno[1,2-<i>d</i>]pyrimidin-2-yl)carbamate (<b>8</b>)</h3><div class="NLM_p last">Solid benzoyl peroxide (30 mg, 0.1 mmol) was added to a benzene solution (8 mL) of <b>6</b> (1.2 g, 2.5 mmol) and NBS (467 mg, 2.6 mmol), and the mixture was heated to reflux. After 16 h, the mixture was cooled to room temperature and diluted with EtOAc (50 mL). The mixture was washed with saturated aqueous NaHCO<sub>3</sub> and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified via column chromatography to afford 813 mg (57%) of <b>8</b> as a light yellow solid. An additional 342 mg (29%) of starting material <b>7</b> was also recovered. <i>t</i><sub>R</sub> = 7.21 min. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.17−8.28 (m, 2H), 7.96 (d, <i>J</i> = 0.98 Hz, 1H), 7.77 (d, <i>J</i> = 7.58 Hz, 1H), 7.47−7.65 (m, 4H), 4.56 (s, 2H), 1.54 (s, 18H) ppm. <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ 188.2, 175.8, 164.6, 160.9, 150.3, 145.4, 141.0, 135.1, 134.4, 133.9, 132.0, 130.3, 128.2, 124.7, 122.7, 118.4, 84.0, 31.8, 27.9 ppm. HRMS, calcd for C<sub>28</sub>H<sub>28</sub>BrN<sub>3</sub>O<sub>5</sub> 565.1212, found 566.1311 (M<sup>+</sup> + H).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Large Scale Preparation of <b>1</b></h3><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 2-Amino-4-phenyl-8-(pyrrolidin-1-ylmethyl)-5<i>H</i>-indeno[1,2-<i>d</i>]pyrimidin-5-one Dihydrochloride (<b>1</b>)</h4><div class="NLM_p">Solid 1,3-dibromo-5,5-dimethylhydantoin (89.8 g, 0.3 mol) was added to a 5 L four-neck flask equipped with a thermocouple controller, overhead mechanical stirrer, and a N<sub>2</sub> inlet/outlet adapter containing a CH<sub>3</sub>CN solution of <b>7</b> (150 g, 0.3 mol) and benzoyl peroxide (4.5 g, 0.02 mol), and the mixture was refluxed. After 1 h at reflux the reaction mixture was cooled to room temperature, stored under nitrogen, and used directly in the next step without further purification.</div><div class="NLM_p">Neat pyrrolidine (51 mL, 0.6 mol) was added to the same 5 L flask and stirred at room temperature. After 2 h, the reaction was complete, stored under nitrogen, and used directly in the next step without further purification.</div><div class="NLM_p last">A 5 M HCl solution in isopropyl alcohol (309 mL, 1.54 mol) was added to the same 5 L flask and stirred at room temperature. After 1 h the precipitate was collected by filtration, rinsed with CH<sub>2</sub>Cl<sub>2</sub> (2 × 100 mL), and dried in vacuo at 60 °C for 18 h to afford 99.2 g (75%) of <b>1</b> as a di-HCl salt which was a yellow solid.</div></div></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Bis<i>-tert</i>-butyl (8-Methy-5-oxo-4-phenyl-5<i>H</i>-indeno[1,2-<i>d</i>]pyrimidin-2-yl)carbamate (<b>7</b>)</h3><div class="NLM_p last">Solid di-<i>tert</i>-butyl dicarbonate (470 g, 2.1 mol) was added to a 12 L four-neck flask equipped with a thermocouple controller, overhead mechanical stirrer, and a N<sub>2</sub> inlet/outlet adapter containing a DMF solution of <b>10</b> (200 g, 0.7 mol), 4-(dimethylamino)pyridine (8.5 g, 0.07 mol), and K<sub>2</sub>CO<sub>3</sub> (289 g, 2.1 mol). After 18 h at room temperature the reaction mixture was diluted with water and the resulting slurry was stirred for 2 h. The slurry was filtered, washed with water, and the collected solid was dried in vacuo to afford 314 g of crude <b>7</b>. The product <b>7</b> was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (1.5 L) and passed through silica gel (3 kg), eluting with CH<sub>2</sub>Cl<sub>2</sub> (20 L). The collected filtrate was concentrated to afford 279 g (70%) of the title compound <b>7</b> as a white solid.</div></div><div id="sec3_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Benzylidene-6-methylindan-1-one (<b>9</b>)</h3><div class="NLM_p last">An aqueous solution (200 mL) of NaOH (65.7 g, 1.6 mol) was added to a 3 L three-neck flask equipped with an overhead mechanical stirrer charged with an EtOH solution (1.4 L) of 6-methylindan-1-one (<b>3</b>) (200 g, 1.4 mol) and benzaldehyde (153 mL, 1.5 mol). A white precipitate formed after the addition of NaOH was completed. The slurry became very thick, and stirring became difficult. So additional EtOH (1 L) was added. After 3 h the slurry was filtered, washed with cold EtOH and the collected precipitate was dried in vacuo to afford 321.0 g (100%) of the title compound <b>9</b> white solid. <i>t</i><sub>R</sub> = 5.57 min. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.61−7.74 (m, 4H), 7.36−7.50 (m, 5H), 4.01 (s, 2H), 2.44 (s, 3H) ppm. <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ 194.4, 147.0, 138.2, 137.6, 135.9, 135.5, 135.3, 133.7, 130.7, 130.7 129.6, 128.9, 128.9, 125.9, 124.5, 32.1, 21.2 ppm. HRMS, calcd for C<sub>17</sub>H<sub>14</sub>O 234.1045, found 235.1134 (M<sup>+</sup> + H).</div></div><div id="sec3_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Amino-8-methyl-4-phenyl-5<i>H</i>-indeno[1,2-<i>d</i>]pyrimidin-5-one (<b>10</b>)</h3><div class="NLM_p last">Solid NaOH (187.8 g, 4.7 mol) was slowly added in four portions over 0.5 h to a 5 L four-neck flask equipped with a thermocouple controller, N<sub>2</sub> inlet/outlet adapter, and an overhead mechanical stirrer charged with an EtOH solution (2.7 L) of guanidine−HCl (453 g, 4.7 mol). After an additional 0.5 h, the slurry was filtered and the solid (NaCl) was washed with EtOH. The resulting filtrate, which contained the free base guanidine, was added in one portion to a 12 L four-neck flask equipped with a thermocouple controller, an overhead stirrer, and a condenser containing an EtOH suspension (1.1 L) of <b>9</b> (220 g, 0.94 mol). The heterogeneous solution was heated to 80 °C. After 30 min the reaction became homogeneous and was heated for an additional 18 h. The mixture was cooled to 0 °C, and the resulting precipitate was filtered. The collected solid was rinsed with cold EtOH and dried in vacuo to afford 185 g of a yellow solid that was carried on without further purification. The yellow solid (100 g) was added to a 5 L four-neck flask equipped with a thermocouple controller, overhead stirrer, and a N<sub>2</sub> inlet/outlet adapter. DMF (1.85 L) was added. The heterogeneous mixture was heated to 70 °C to form a homogeneous solution. Solid NaOH (43.6 g, 1.1 mol) was added, and the mixture was heated to 100 °C while air was purged into the reaction mixture. After 4 h the reaction mixture was cooled to room temperature, diluted with water and the resulting slurry was stirred. After 0.5 h the slurry was cooled to 0 °C and filtered. The collected solid was washed with water and dried in vacuo to afford 84.2 g (81%) of the title compound <b>10</b> as a red solid. <i>t</i><sub>R</sub> = 4.25 min. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.98−8.17 (m, 2H), 7.60−7.71 (m, 2H), 7.47−7.58 (m, 3H), 7.36 (d, <i>J</i> = 7.09 Hz, 1H), 5.77 (br s, 2H), 2.49 (s, 3H) ppm. <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ 188.4, 176.7, 165.5, 164.5, 145.3, 140.3, 135.5, 134.2, 133.4, 131.1, 129.7, 128.0, 123.6, 121.9, 113.6, 22.1 ppm. HRMS, calcd for C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O 287.1059, found 288.1118 (M<sup>+</sup> + H).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Pharmacokinetic Studies</h3><div class="NLM_p last">Compound <b>1</b> was administered to fasted Sprague−Dawley rats (male), BALB/c mice (male), and Cynomolus monkeys (male and female) by a single iv or oral administration. Compound <b>1</b> was formulated in 10% solutol for the iv injection. Compound <b>1</b> was formulated in 0.5% methylcellulose and dosed orally as a solution. The iv concentrations of <b>1</b> were 2 mg/kg for mice and rats and were 1 mg/kg for monkeys. The oral concentrations of <b>1</b> were 10 mg/kg for all species. Discrete blood samples collected from mice and rats were withdrawn from three to four animals per time point at selected intervals postdose via orbital sinus (rats) or cardiac (mice) puncture. Serial blood collections from monkeys were withdrawn by venipuncture. Plasma was obtained by centrifugation, processed by acetonitrile precipitation, and then analyzed by LC−MS/MS. The limit of quantitiation (LOQ) was 0.7−2 ng/mL. Noncompartmental analysis was performed on individual plasma concentrations using WinNonlin (version 4.0.4). For the tissue distribution studies a 10 mg/kg solution of <b>1</b> in 0.5% methylcellulose was administered orally to fasted Sprague−Dawley rats (male). At each time point four animlas were euthanized for collection of blood, plasma, and brain. Each tissue was weighed and homogenized in methanol. The methanolic extracts were evaporated and then reconstituted in mobile phase for analysis by LC−MS/MS. Blood and plasma was treated with acetonitrile and the supernatants analyzed for drug concentration by LC−MS/MS.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Mouse Catalepsy Study</h3><div class="NLM_p">Haloperidol, a neuroleptic medication that inhibits dopamine D<sub>2</sub> receptors, was used to induce catalepsy. In the rodent, catalepsy is characterized as a loss of voluntary motion where limbs uncharacteristically remain in placed positions. Catalepsy was measured in haloperidol (1 mg/kg, sc) treated mice (fasted, male BALB/c mice) after oral administration of <b>1</b> (0.01, 0.10, 1.0, or 10.0 mg/kg, po), L-DOPA (300 mg/kg, coadministered with carbidopa (75 mg/kg)), or vehicle. Animals were randomly assigned to treatment groups, and behavioral testing was performed blind to treatment. Control mice received the respective sc and po vehicles. Haloperidol was dissolved in 0.3% tartaric acid in 0.9% saline. L-DOPA was diluted in 0.5% methylcellulose and dosed as a suspension. Compound <b>1</b> was diluted in 0.5% methylcellulose and dosed as a solution. Compound <b>1</b> was administered orally 30 min after haloperidol. Behavioral testing was conducted 1 h after dosing of <b>1</b>. The behavioral test trial (maximum duration of 60 s) began by placing the forepaws of fasted, male BALB/c mice (18−23 g) on a horizontal bar elevated 3.5 cm above the bench. The cataleptic state was regarded as over and the trial ended when the animal came off the bar by either placing its forepaws on the bench or climbing onto the bar with all of its limbs. Each value represents average (±SEM) time in cataleptic position of <i>n</i> = 9−11 mice per treatment group during a 60 s test session. Asterisks indicate significant differences compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</div><div class="NLM_p last">A separate study was performed using the same model of neuroleptic-induced catalepsy to examine the duration of action of <b>1</b> in mice. Catalepsy time was measured in haloperidol (1 mg/kg, sc) treated mice (fasted, male BALB/c mice) after oral administration of <b>1</b> (0, 1, or 3 mg/kg), <b>2</b> (5 mg/kg), or vehicle. Compounds <b>1</b> and <b>2</b> were diluted in 0.5% methylcellulose. Catalepsy was measured repeatedly 15 min, 1 h, 2 h, and 4 h after oral dosing of the respective groups. Each value represents average (±SEM) time in cataleptic position of <i>n</i> = 12 mice per treatment group during a 60 s test session. Asterisks indicate significant differences compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Rat Catalepsy Study</h3><div class="NLM_p">Haloperidol, a neuroleptic medication that inhibits dopamine D<sub>2</sub> receptors, was used to induce catalepsy. In the rodent, catalepsy is characterized as a loss of voluntary motion where limbs remain in placed positions. Time to descend from the bar was measured in haloperidol (1 mg/kg, sc) treated male Sprague−Dawley rats (fasted, 189−280 g) after oral administration of <b>1</b> (0.01, 0.10, 1.0, 10.0, or 30.0 mg/kg), L-DOPA coadministered with carbidopa (200:50 mg/kg), or vehicle. Animals were randomly assigned to treatment groups, and behavioral testing was performed blind to treatment. Control mice received the respective sc and po vehicles. Haloperidol was dissolved in 0.3% tartaric acid in 0.9% saline. L-DOPA/carbidopa were diluted in 0.5% methylcellulose and dosed as a suspension. Compound <b>1</b> was diluted in 0.5% methylcellulose and dosed as a solution. Compound <b>1</b> was administered orally 30 min after haloperidol. The behavioral test trial (maximum duration of 180 s) began by placing the forepaws of male Sprague−Dawley rats on a horizontal bar elevated 3.5 cm above the bench. The cataleptic state was regarded as over and the trial ended when the animal came off the bar by either placing its forepaws on the bench or climbing onto the bar with all of its limbs. Each value represents average (±SEM) time in cataleptic position of <i>n</i> = 10−16 rats per treatment group during a 180 s test session. Asterisks indicate significant differences compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</div><div class="NLM_p last">A separate study was performed using the same model of neuroleptic-induced catalepsy to examine the duration of action of <b>1</b> in rats. Catalepsy time was measured in haloperidol (1 mg/kg, sc) treated rats (fasted, male Sprague−Dawley rats) after oral administration of <b>1</b> (0, 1, or 10 mg/kg), L-DOPA coadministered with benserazide (200:50 mg/kg), or vehicle. L-DOPA was diluted in 0.5% methylcellulose and dosed as a suspension. Benserazide was diluted in saline and dosed as a solution. Compound <b>1</b> was diluted in 0.5% methylcellulose and dosed as a solution. Catalepsy was measured repeatedly 15 min, 1 h, 2 h, and 4 h after oral dosing of the respective groups. Each value represents average (±SEM) time in cataleptic position of <i>n</i> = 10 rats per treatment group during a 180 s test session. Asterisks indicate significant differences as compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Reserpine Induced Akinesia Study</h3><div class="NLM_p last">Reserpine is an alkaloid that depletes monoamines by inhibiting their vesicular uptake, resulting in a dramatic reduction of spontaneous locomotor activity (akinesia). Efficacy is defined as reversal of reserpine-induced akinesia. Locomotion was studied in open field activity boxes (L, 17.5 in.; W, 17.5 in.; H, 12 in.), each containing 20 equally spaced pairs of horizontal infrared photocell beams along one axis. Activity was measured automatically by a PC running the activity analysis software. One activity count corresponded to the consecutive interruption of two infrared beams placed 2.5 cm apart and 2 cm above the cage floor, and total distance traveled was quantified in cm. Locomotion was studied 60 min after oral administration of compound <b>1</b> (0.1, 1.0, 10, and 30 mg/kg, po) or vehicle in mice that were pretreated with reserpine (0.6 mg/kg, sc) 18 h earlier. Mice used were fasted, male CF-1 weighing 25−31 g at the start of the study. Animals were randomly assigned to treatment groups. Control mice received the respective sc and po vehicles. Reserpine was diluted in 0.5% acetic acid in distilled water and dosed sc. Compound <b>1</b> was diluted in 0.5% methylcellulose and dosed as a solution. Reserpine produced a marked decrease in horizontal and vertical locomotor activity. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, reserpine-induced akinesia was reversed by <b>1</b> at 1, 10, and 30 mg/kg, po. Each value represents the mean (±SEM) of the total distance traveled of <i>n</i> = 10−12 mice per treatment group during the 30 min measurement period in the behavioral test session. Asterisks indicate significant differences compared with the reserpine + vehicle control group (∗∗, <i>P</i> < 0.01; ∗∗∗, <i>P</i> < 0.001; Hochberg test of multiple comparisons).</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Rat 6-OHDA Lesion Model of Drug-Induced Rotation</h3><div class="NLM_p last">The neurotoxin 6-OHDA (12 μg) is microinjected unilaterally in the medial forebrain bundle to produce a targeted degeneration of midbrain dopamine neurons in the pars compacta of the substantia nigra. Fasted, male Sprague−Dawley rats weighing 225−250 g at the time of surgery were used in this study. 6-OHDA-induced neurotoxicity is relatively selective for monoaminergic neurons because dopamine and noradrenergic transporters preferentially take it up. 6-OHDA accumulates in the cytosol of neurons and generates reactive oxygen species, which then inhibit mitochondrial respiratory enzymes leading to metabolic deficits and dopamine cell death. Degeneration of dopaminergic neurons in the injected side of the brain is accompanied by denervation-induced supersensitivity of postsynaptic dopamine receptors in the striatum of the lesioned side. An imbalance in dopamine activity between the two sides of the brain causes asymmetry in motor behavior that can be enhanced by drug treatment. For example, drugs that stimulate postsynaptic dopamine receptors produce an imbalance in dopamine signaling that favors the lesion side and induces rotation behavior (turning) toward the side opposite (contralateral to) the lesion side. Three weeks after administration of 6-OHDA, rats were challenged with drugs acting on the dopaminergic system and studied in a behavioral test chamber. Each animal was tethered to high-resolution optical sensor connected to an automated computerized system that quantifies circular motion. One rotation count was defined as one 360° turn. To test the effects of neuronal loss on drug responsiveness, motor asymmetry was examined in a screening test with subcutaneous administration of a postsynaptic dopamine agonist, apomorphine (0.05 mg/kg, sc). This test was repeated 1 week later and then followed 2 weeks later with a behavioral test to L-DOPA (10 mg/kg, po) coadministered with carbidopa (2.5 mg/kg, po). Animals showing an average response of at least 125 contralateral rotations in 1 h after apomorphine were included in further studies. Sixteen animals selected equidistant from the median L-DOPA response were used to test the effects of compound <b>1</b> on rotational behavior. To exclude a priming effect of L-DOPA, L-DOPA (10 mg/kg, po, coadministered with carbidopa (2.5 mg/kg, po)) was administered alone or with each dose of <b>1</b> (0.1, 1.0, 3.0, and 10.0 mg/kg, po) to all animals on separate testing days in a randomized order, with each rat serving as its own control. The effects of <b>1</b> alone were also studied in the model. This within-subjects repeated measure design was carried out with at least two nondrug days elapsing between drug testing sessions. Control rats received the respective po vehicles. Compound <b>1</b> was diluted in 0.5% methylcellulose and dosed as a solution. L-DOPA and carbidopa were diluted in 0.5% methylcellulose and coadministered as suspensions. Each behavioral test session began with a 30 min interval of acclimation in the test chamber, followed by administration of <b>1</b> or vehicle and measurement of behavior for 120 min. Thereafter, the behavioral effects of L-DOPA (coadministered with carbidopa) or vehicle were measured for 120 min. Each value represents the mean (±SEM) of total contralateral rotations of <i>n</i> = 16 rats per treatment group during the 2 h before and after L-DOPA administration. Asterisks indicate significant differences compared with the L-DOPA + vehicle control treatment group (∗, <i>P</i> < 0.05, Tukey’s test of multiple comparisons).</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> MPTP-Marmosets</h3><div class="NLM_p">Marmosets (<i>Callithrix jacchus)</i> were rendered parkinsonian by subcutaneous injection of 2 mg/kg MPTP for 5 consecutive days. The marmosets were allowed to recover for a minimum of 10 weeks until their parkinsonism became stable. Stable dyskinesia was established by repeated L-DOPA therapy (12 mg/kg b.i.d. for 4 weeks). These animals have received other experimental treatments for Parkinson’s disease, but a minimum period 2 weeks washout was allowed before commencing the study. There were eight marmosets available per treatment group for this study. All drugs were administered in the animal’s home cage. The animals were immediately transferred to an observation cage (60 cm × 55 cm × 75 cm, with the perch 25 cm from floor of cage) for behavioral assessment. Parkinsonian disability was measured after oral administration of <b>1</b> (0.1, 1.0, 10.0, or 50.0 mg/kg), L-DOPA, or vehicle. Compound <b>1</b> was diluted in 0.5% methylcellulose and dosed as a solution. L-DOPA was suspended in 0.5% methylcellulose. Data derived from nonparametric data were analyzed with a nonparametric one-way repeated measures ANOVA (Friedman test) followed by Dunn’s multiple comparison test.</div><div class="NLM_p">A battery of behavioral tests was performed:</div><div class="NLM_p">(1) activity, a quantitative assessment using computer-based activity monitors, was obtained every 5 min for the duration of the experiment.</div><div class="NLM_p">(2) parkinsonian disability, nonparametric measures based on the following scales.</div><table class="listgroup" border="0" width="95%"><tr class="li1"><td valign="top">(a)</td><td colspan="5" valign="top" class="paragraph"><p class="last">range of movement score: 0 = no movement; 1 = movement of head on the floor of the cage; 2 = movement of limbs, but no locomotion, on the floor of the cage; 3 = movement of head or trunk on wall of cage or perch; 4 = movement of limbs, but no locomotion, on wall of cage or perch; 5 = walking around floor of cage or eating from hopper on floor; 6 = hopping on floor of cage; 7 = climbing onto wall of cage or perch; 8 = climbing up and down the walls of the cage or along perch; 9 = running, jumping, climbing between cage walls, perch, roof, using limbs through a wide range of motion and activity. The score given is the maximum achieved in each 10 min observation period.</p></td></tr><tr class="li1"><td valign="top">(b)</td><td colspan="5" valign="top" class="paragraph"><p class="last">bradykinesia score: 0 = normal speed and initiation of movement; 1 = mild slowing of movement; 2 = moderate slowing, difficulty initiating and maintaining movement, marked freezing; 3 = akinetic, unable to move, with prolonged freezing episodes. The score given is representative of behavior over the observation period.</p></td></tr><tr class="li1"><td valign="top">(c)</td><td colspan="5" valign="top" class="paragraph"><p class="last">postural abnormality score: 0 = normal, upright, holds head up, normal balance; 1 = abnormal, crouched, face down, may lose balance. The score given is representative of behavior over the observation period.</p></td></tr><tr class="li1"><td valign="top">(d)</td><td colspan="5" valign="top" class="paragraph"><p class="last">parkinsonian disability score: a combination of the mobility, bradykinesia and posture scores according to the formula [18 − (range of movement × 2) + (bradykinesia × 3) + (posture × 9)] to give a global parkinsonian disability rating.</p></td></tr></table><div class="NLM_p">(3) dyskinesiam nonparametric measures based on the following scale.</div><ul class="NLM_list-list_type-"><li><p class="inline">dyskinesia score: 0 = absent; 1 = mild, fleeting, present less than 30% of the observation period; 2 = moderate, not interfering with normal activity, present more than 30% of the observation period; 3 = marked, at times interfering with normal activity, present less than 70% of the observation period; 4 = severe, continuous, replacing normal activity, present more than 70% of the observation period.</p></li></ul><div class="NLM_p last">Behavior was assessed for 6 h after drug administration. Behavioral test 1 (activity) was assessed every 5 min for 6 h after drug administration. Behavioral tests 2 and 3 (parkinsonian disability and dyskinesia, respectively) were assessed for 10 min every 30 min over the course of 6 h, by post hoc analysis of video recordings by an observer blinded to the treatment. The score given/achieved in each 10 min time period was presented as defined above.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian C. Shook</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f694859e99999db69f8285d89c989cd895999b"><span class="__cf_email__" data-cfemail="e381908b8c8c88a38a9790cd898d89cd808c8e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefanie Rassnick</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melville C. Osborne</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Davis</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lori Westover</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jamie Boulet</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Hall</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth C. Rupert</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Geoffrey R. Heintzelman</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristin Hansen</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Devraj Chakravarty</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James L. Bullington</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald Russell</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shawn Branum</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth M. Wells</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Damon</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Youells</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xun Li</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Derek A. Beauchamp</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Palmer</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mayra Reyes</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith Demarest</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuting Tang</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth Rhodes</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul F. Jackson</span> - <span class="hlFld-Affiliation affiliation">Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Welsh and McKean Roads, P.O. Box 776, Spring House, Pennsylvania 19477, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm100971t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank to Motac Neuroscience for evaluating compound <b>1</b> in MPTP-treated marmosets.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lozano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostrovsky, J. O.</span><span> </span><span class="NLM_article-title">New developments in understanding the etiology of Parkinson’s disease and in its treatment</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=783-790&author=A.+M.+Lozanoauthor=A.+E.+Langauthor=W.+D.+Hutchisonauthor=J.+O.+Dostrovsky&title=New+developments+in+understanding+the+etiology+of+Parkinson%E2%80%99s+disease+and+in+its+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLozano%26aufirst%3DA.%2BM.%26aulast%3DLang%26aufirst%3DA.%2BE.%26aulast%3DHutchison%26aufirst%3DW.%2BD.%26aulast%3DDostrovsky%26aufirst%3DJ.%2BO.%26atitle%3DNew%2520developments%2520in%2520understanding%2520the%2520etiology%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520in%2520its%2520treatment%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D1998%26volume%3D8%26spage%3D783%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Fink, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivkees, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterfreund, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reppert, S. M.</span><span> </span><span class="NLM_article-title">Molecular cloning of the rat A<sub>2</sub> adenosine receptor: selective co-expression with D<sub>2</sub> dopamine receptors in rat striatum</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2F0169-328X%2892%2990173-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=1279342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVelt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1992&pages=186-195&author=J.+S.+Finkauthor=D.+R.+Weaverauthor=S.+A.+Rivkeesauthor=R.+A.+Peterfreundauthor=A.+E.+Pollackauthor=E.+M.+Adlerauthor=S.+M.+Reppert&title=Molecular+cloning+of+the+rat+A2+adenosine+receptor%3A+selective+co-expression+with+D2+dopamine+receptors+in+rat+striatum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum</span></div><div class="casAuthors">Fink, J. Stephen; Weaver, David R.; Rivkees, Scott A.; Peterfreund, Robert A.; Pollack, Alexia E.; Adler, Elizabeth M.; Reppert, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-95</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    </div><div class="casAbstract">A cDNA fragment homologous to other G protein-coupled receptors was isolated from rat brain using the PCR method and demonstrated to be abundantly expressed in striatum.  Using this fragment as a probe, a 2.1 kb full-length cDNA was isolated from a rat striatal cDNA library.  This cDNA encodes a protein of 410 amino acids and is highly homologous to previously isolated adenosine receptor cDNA.  Expression of this cDNA in COS cells revealed high affinity (Kd = 38.6 nM) and saturable binding of the A2 adenosine receptor-selective ligand [3H]CGS 21680.  Agonist displacement profile of [3H]CGS 21680 binding was consistent with an adenosine receptor of the A2 subtype (NECA > (R)-PIA > CPA > (S)-PIA).  In situ hybridization demonstrated that rat A2 adenosine receptor mRNA was co-expressed in the same striatal neurons as D2 dopamine receptor mRNA, and never co-expressed with striatal D1 dopamine receptor mRNA.  Several lines of evidence have previously suggested that dopamine-induced changes in motor behavior can be modulated by adenosine analogs acting at the A2 subtype of adenosine receptor in the forebrain.  The co-expression of D2 dopamine and A2 adenosine receptors in a subset of striatal cells provides an anatomical basis for dopaminergic-adenosinergic interactions on motor behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Daq1pagx8bVg90H21EOLACvtfcHk0lhQlgQOI7kkHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVelt7o%253D&md5=c625968121ce9599d80d0d7cad3e1b56</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0169-328X%2892%2990173-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-328X%252892%252990173-9%26sid%3Dliteratum%253Aachs%26aulast%3DFink%26aufirst%3DJ.%2BS.%26aulast%3DWeaver%26aufirst%3DD.%2BR.%26aulast%3DRivkees%26aufirst%3DS.%2BA.%26aulast%3DPeterfreund%26aufirst%3DR.%2BA.%26aulast%3DPollack%26aufirst%3DA.%2BE.%26aulast%3DAdler%26aufirst%3DE.%2BM.%26aulast%3DReppert%26aufirst%3DS.%2BM.%26atitle%3DMolecular%2520cloning%2520of%2520the%2520rat%2520A2%2520adenosine%2520receptor%253A%2520selective%2520co-expression%2520with%2520D2%2520dopamine%2520receptors%2520in%2520rat%2520striatum%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D1992%26volume%3D14%26spage%3D186%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Schiffmann, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderhaeghen, J. J.</span><span> </span><span class="NLM_article-title">Distribution of adenosine A<sub>2</sub>receptor mRNA in the human brain</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=1991&pages=177-181&author=S.+N.+Schiffmannauthor=F.+Lipertauthor=G.+Vassartauthor=J.+J.+Vanderhaeghen&title=Distribution+of+adenosine+A2receptor+mRNA+in+the+human+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchiffmann%26aufirst%3DS.%2BN.%26aulast%3DLipert%26aufirst%3DF.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DVanderhaeghen%26aufirst%3DJ.%2BJ.%26atitle%3DDistribution%2520of%2520adenosine%2520A2receptor%2520mRNA%2520in%2520the%2520human%2520brain%26jtitle%3DNeurosci.%2520Lett.%26date%3D1991%26volume%3D130%26spage%3D177%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">MAO-B inhibitors in Parkinson’s disease</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=8420207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK3sXktF2lurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1993&pages=666-671&author=C.+W.+Olanow&title=MAO-B+inhibitors+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">MAO-B inhibitors in Parkinson's disease</span></div><div class="casAuthors">Olanow, C. Warren</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Parkinson's Disease</span>),
    <span class="NLM_cas:pages">666-71</span>CODEN:
                <span class="NLM_cas:coden">ADNRA3</span>;
        ISSN:<span class="NLM_cas:issn">0091-3952</span>.
    </div><div class="casAbstract">A review with 46 ref.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQFDRpN_SkdrVg90H21EOLACvtfcHk0ljBoEykrWNLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktF2lurw%253D&md5=e90fcc306d9c58991fe71c94a48e5fba</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DMAO-B%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAdv.%2520Neurol.%26date%3D1993%26volume%3D60%26spage%3D666%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title">Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson’s disease</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">IV/37</span><span class="NLM_x">–</span> <span class="NLM_lpage">IV/48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2007&pages=IV%2F37-IV%2F48&author=A.+Gordinauthor=D.+J.+Brooks&title=Clinical+pharmacology+and+therapeutic+use+of+COMT+inhibition+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3DClinical%2520pharmacology%2520and%2520therapeutic%2520use%2520of%2520COMT%2520inhibition%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%26date%3D2007%26volume%3D254%26spage%3DIV%252F37%26epage%3DIV%252F48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocchi, F.</span><span> </span><span class="NLM_article-title">COMT inhibitors in Parkinson’s disease. Can they prevent and/or reverse levodopa-induced motor complications?</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">S72</span><span class="NLM_x">–</span> <span class="NLM_lpage">S81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2004&pages=S72-S81&author=C.+W.+Olanowauthor=F.+Stocchi&title=COMT+inhibitors+in+Parkinson%E2%80%99s+disease.+Can+they+prevent+and%2For+reverse+levodopa-induced+motor+complications%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DStocchi%26aufirst%3DF.%26atitle%3DCOMT%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease.%2520Can%2520they%2520prevent%2520and%252For%2520reverse%2520levodopa-induced%2520motor%2520complications%253F%26jtitle%3DNeurology%26date%3D2004%26volume%3D62%26spage%3DS72%26epage%3DS81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Antonini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clilia, R.</span><span> </span><span class="NLM_article-title">Behavioural adverse effects of dopaminergic treatments in Parkinson’s disease: incidence, neurobiological basis, management and prevention</span> <span class="citation_source-journal">Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=475-488&author=A.+Antoniniauthor=R.+Clilia&title=Behavioural+adverse+effects+of+dopaminergic+treatments+in+Parkinson%E2%80%99s+disease%3A+incidence%2C+neurobiological+basis%2C+management+and+prevention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAntonini%26aufirst%3DA.%26aulast%3DClilia%26aufirst%3DR.%26atitle%3DBehavioural%2520adverse%2520effects%2520of%2520dopaminergic%2520treatments%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520incidence%252C%2520neurobiological%2520basis%252C%2520management%2520and%2520prevention%26jtitle%3DDrug%2520Safety%26date%3D2009%26volume%3D32%26spage%3D475%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hansard, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetham, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1124%2Fjpet.102.039743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=12438514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD38Xptlamt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=952-958&author=M.+J.+Hansardauthor=L.+A.+Smithauthor=M.+J.+Jacksonauthor=S.+C.+Cheethamauthor=P.+Jenner&title=Dopamine%2C+but+not+norepinephrine+or+serotonin%2C+reuptake+inhibition+reverses+motor+deficits+in+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine-treated+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates</span></div><div class="casAuthors">Hansard, Matthew J.; Smith, Lance A.; Jackson, Michael J.; Cheetham, Sharon C.; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">952-958</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Monoamine reuptake inhibitors that do not discriminate between the transporters for dopamine (DA), norepinephrine (NE), or 5-hydroxytryptamine (5-HT, serotonin) can reverse locomotor deficits and motor disability in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosets.  DA reuptake inhibition is presumed to be primarily responsible, but the role played by inhibition of NE and 5-HT reuptake is unknown.  This work evaluated the efficacy of a range of monoamine reuptake inhibitors either alone or in combination in MPTP-treated common marmosets to det. the actions required for effective antiparkinsonian activity.  Monoamine reuptake inhibitors not discriminating between the DA, NE, and 5-HT transporters [1-[1-(3,4-dichlororphenyl)cyclobutyl]-2-(3-diaminethylaminopropylthio)ethanone monocitrate (BTS 74 398) and nomifensine] reversed locomotor deficits and motor disability in MPTP-treated marmosets but bupropion was without effect.  The selective DA reuptake inhibitor 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride (GBR 12909) also reversed these motor deficits.  The relative efficacy of the compds. (BTS 74 398 > GBR 12909 > nomifensine » bupropion) paralleled their previously detd. potency in inhibiting DA uptake in vitro and in vivo.  In contrast, the selective NE reuptake inhibitor nisoxetine and the 5-HT reuptake inhibitor sertraline administered alone failed to improve motor function and tended to worsen the deficits.  Coadministration of nisoxetine attenuated the improvement in motor deficits produced by GBR 12909.  Coadministration of sertraline also abolished the reversal of motor deficits produced by GBR 12909.  Coadministration of both sertraline and nisoxetine similarly abolished the improvement of motor deficits produced by GBR 12909.  Mols. possessing potent DA reuptake inhibitory activity may be useful in the treatment of the motor symptoms of Parkinson's disease.  In contrast, there seems to be no role for NE or 5-HT reuptake inhibitors, and they may impair antiparkinsonian activity mediated through dopaminergic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprkAiG5hgKS7Vg90H21EOLACvtfcHk0ljBoEykrWNLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xptlamt7g%253D&md5=f5b88eadd0c931fe318d49b4701b8760</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039743%26sid%3Dliteratum%253Aachs%26aulast%3DHansard%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DCheetham%26aufirst%3DS.%2BC.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DDopamine%252C%2520but%2520not%2520norepinephrine%2520or%2520serotonin%252C%2520reuptake%2520inhibition%2520reverses%2520motor%2520deficits%2520in%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine-treated%2520primates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D952%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Antonini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolosa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poewe, W. H.</span><span> </span><span class="NLM_article-title">A reassessment of risks and benefits of dopamine agonists in Parkinson’s disease</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2FS1474-4422%2809%2970225-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=19709931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Kitr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=929-937&author=A.+Antoniniauthor=E.+Tolosaauthor=Y.+Mizunoauthor=M.+Yamamotoauthor=W.+H.+Poewe&title=A+reassessment+of+risks+and+benefits+of+dopamine+agonists+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">A reassessment of risks and benefits of dopamine agonists in Parkinson's disease</span></div><div class="casAuthors">Antonini, Angelo; Tolosa, Eduardo; Mizuno, Yoshikuni; Yamamoto, Mitsutoshi; Poewe, Werner H.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">929-937</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurologists have several choices of drugs that have been shown to be effective for the treatment of the symptoms of Parkinson's disease.  Among the first options are the dopamine agonists, which are commonly used both as an early monotherapy and as an adjunct therapy to levodopa.  However, before starting any treatment, the overall benefit-to-risk ratio to individual patients must be considered.  For the dopamine agonists, the available evidence on their symptomatic efficacy, effect on long-term levodopa-related motor complications, putative effect on progression of disease, and adverse event profile must be taken into account.  Recently, the occurrence of adverse events such as leg edema, daytime somnolence, impulse control disorders, and fibrosis have increasingly been recognized.  The risks of these potentially serious adverse events must therefore be taken into account and treatment decisions should be based on considerations of risks vs. benefits for individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Rc8SOX7hMrVg90H21EOLACvtfcHk0ljx0NvaNpP4Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Kitr7I&md5=3126e343054967641c318000aab5d2fe</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970225-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970225-X%26sid%3Dliteratum%253Aachs%26aulast%3DAntonini%26aufirst%3DA.%26aulast%3DTolosa%26aufirst%3DE.%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DPoewe%26aufirst%3DW.%2BH.%26atitle%3DA%2520reassessment%2520of%2520risks%2520and%2520benefits%2520of%2520dopamine%2520agonists%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%2520Neurol.%26date%3D2009%26volume%3D8%26spage%3D929%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Dopamine agonists in Parkinson’s disease</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1586%2F14737175.8.4.671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=18416667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFSht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=671-677&author=M.+Yamamotoauthor=A.+H.+V.+Schapira&title=Dopamine+agonists+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine agonists in Parkinson's disease</span></div><div class="casAuthors">Yamamoto, Mitsutoshi; Schapira, Anthony H. V.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">671-677</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Dopamine agonists are established as effective drugs for the symptomatic treatment of Parkinson's disease (PD) throughout its course.  As monotherapy, they produce effective control of motor symptoms and combine this with a low risk for motor complications.  As an adjunct to levodopa, they improve motor control and limit the need for levodopa in those patients in whom this may be considered relevant.  The non-ergot dopamine agonists in particular have a good safety profile, although as with other agonists, sedation, and cognitive and behavioral problems may be limiting in some patients.  Pramipexole has shown benefit in improving depressive symptoms in PD.  Ropinirole and pramipexole have both demonstrated a redn. in the rate of loss of nigrostriatal innervation as detd. by imaging in PD patients, when compared with levodopa.  Thus, dopamine agonists contribute to several dimensions of the management of PD and have become an integral part of the disease treatment algorithm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxVM_IekUXprVg90H21EOLACvtfcHk0ljx0NvaNpP4Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFSht70%253D&md5=9a145ab9c49de374322fb02fe543d4ad</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1586%2F14737175.8.4.671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.8.4.671%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DDopamine%2520agonists%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2008%26volume%3D8%26spage%3D671%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredduzzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span> </span><span class="NLM_article-title">Potent and selective adenosine A<sub>2A</sub> antagonists 1,2,4-triazolo[1,5-<i>c</i>]pyrimidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=967-971&author=B.+R.+Neustadtauthor=H.+Liuauthor=J.+Haoauthor=W.+J.+Greenleeauthor=A.+W.+Stamfordauthor=C.+Fosterauthor=L.+Arikauthor=J.+Lachowiczauthor=H.+Zhangauthor=R.+Bertorelliauthor=S.+Fredduzziauthor=G.+Vartyauthor=M.+Cohen-Williamsauthor=K.+Ng&title=Potent+and+selective+adenosine+A2A+antagonists+1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DLachowicz%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DFredduzzi%26aufirst%3DS.%26aulast%3DVarty%26aufirst%3DG.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DNg%26aufirst%3DK.%26atitle%3DPotent%2520and%2520selective%2520adenosine%2520A2A%2520antagonists%25201%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D967%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">Identification of novel, water soluble, 2-amino-<i>N</i>-pyrimin-4-ylacetamides as A<sub>2A</sub> receptor antagonists with in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070623o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=400-406&author=D.+H.+Sleeauthor=X.+Zhangauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+K.+rueterauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=T.+Joswigauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+P.+Williamsauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.+L.+Diazauthor=J.+Wenauthor=Z.+O%E2%80%99Brienauthor=J.+Saunders&title=Identification+of+novel%2C+water+soluble%2C+2-amino-N-pyrimin-4-ylacetamides+as+A2A+receptor+antagonists+with+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm070623o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070623o%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3Drueter%26aufirst%3DJ.%2BK.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520novel%252C%2520water%2520soluble%252C%25202-amino-N-pyrimin-4-ylacetamides%2520as%2520A2A%2520receptor%2520antagonists%2520with%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D400%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Shao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brescia, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokosz, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuinness, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1399-1402&author=Y.+Shaoauthor=A.+G.+Coleauthor=M.+R.+Bresciaauthor=L.+Y.+Qinauthor=J.+Duoauthor=T.+M.+Staufferauthor=L.+L.+Rokoszauthor=B.+F.+McGuinnessauthor=I.+Henderson&title=Synthesis+and+SAR+studies+of+trisubstituted+purinones+as+potent+and+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DY.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DBrescia%26aufirst%3DM.%2BR.%26aulast%3DQin%26aufirst%3DL.%2BY.%26aulast%3DDuo%26aufirst%3DJ.%26aulast%3DStauffer%26aufirst%3DT.%2BM.%26aulast%3DRokosz%26aufirst%3DL.%2BL.%26aulast%3DMcGuinness%26aufirst%3DB.%2BF.%26aulast%3DHenderson%26aufirst%3DI.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520trisubstituted%2520purinones%2520as%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1399%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smits, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phadke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span> </span><span class="NLM_article-title">Piperazine derivatives of 1,2,4-triazolo[1,5-<i>a</i>][1,3,5]triazine as potent and selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4291</span><span class="NLM_x">–</span> <span class="NLM_lpage">4299</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0498405" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4291-4299&author=C.+B.+Vuauthor=B.+Pengauthor=G.+Kumaravelauthor=G.+Smitsauthor=X.+Jinauthor=D.+Phadkeauthor=T.+Engberauthor=C.+Huangauthor=J.+Reillyauthor=S.+Tamauthor=D.+Grantauthor=G.+Hetuauthor=L.+Chenauthor=J.+Zhangauthor=R.+C.+Petter&title=Piperazine+derivatives+of+1%2C2%2C4-triazolo%5B1%2C5-a%5D%5B1%2C3%2C5%5Dtriazine+as+potent+and+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1021%2Fjm0498405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0498405%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DSmits%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DPhadke%26aufirst%3DD.%26aulast%3DEngber%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DGrant%26aufirst%3DD.%26aulast%3DHetu%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26atitle%3DPiperazine%2520derivatives%2520of%25201%252C2%252C4-triazolo%255B1%252C5-a%255D%255B1%252C3%252C5%255Dtriazine%2520as%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4291%26epage%3D4299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span> </span><span class="NLM_article-title">Adenosine in the central nervous system: release mechanisms and extracellular concentrations</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1046%2Fj.1471-4159.2001.00607.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=11701750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlSht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2001&pages=463-484&author=S.+Latiniauthor=F.+Pedata&title=Adenosine+in+the+central+nervous+system%3A+release+mechanisms+and+extracellular+concentrations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine in the central nervous system: release mechanisms and extracellular concentrations</span></div><div class="casAuthors">Latini, Serena; Pedata, Felicita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">463-484</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Adenosine has several functions within the CNS that involve an inhibitory tone of neurotransmission and neuroprotective actions in pathol. conditions.  The understanding of adenosine prodn. and release in the brain is therefore of fundamental importance and has been extensively studied.  Conflicting results are often obtained regarding the cellular source of adenosine, the stimulus that induces release and the mechanism for release, in relation to different exptl. approaches used to study adenosine prodn. and release.  A neuronal origin of adenosine has been demonstrated through electrophysiol. approaches showing that neurons can release significant quantities of adenosine, sufficient to activate adenosine receptors and to modulate synaptic functions.  Specific actions of adenosine are mediated by different receptor subtypes (A1, A2A, A2B and A3), which are activated by various ranges of adenosine concns.  Another important issue is the measurement of adenosine concns. in the extracellular fluid under different conditions in order to know the degree of receptor stimulation and understand adenosine central actions.  For this purpose, several exptl. approaches have been used both in vivo and in vitro, which provide an estn. of basal adenosine levels in the range of 50-200 nM.  The purpose of this review is to describe pathways of adenosine prodn. and metab., and to summarize characteristics of adenosine release in the brain in response to different stimuli.  Finally, studies performed to evaluate adenosine concns. under physiol. and hypoxic/ischemic conditions will be described to evaluate the degree of adenosine receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD81oBeM405rVg90H21EOLACvtfcHk0lhDMiFJfotBeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlSht7Y%253D&md5=c9636f206b3dbf0e3e2aa1c9ac9bb9fc</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2001.00607.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2001.00607.x%26sid%3Dliteratum%253Aachs%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DPedata%26aufirst%3DF.%26atitle%3DAdenosine%2520in%2520the%2520central%2520nervous%2520system%253A%2520release%2520mechanisms%2520and%2520extracellular%2520concentrations%26jtitle%3DJ.%2520Neurochem.%26date%3D2001%26volume%3D79%26spage%3D463%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dunwiddie, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masino, S. A.</span><span> </span><span class="NLM_article-title">The role and regulation of adenosine in the central nervous system</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1146%2Fannurev.neuro.24.1.31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=11283304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Siu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=31-55&author=T.+V.+Dunwiddieauthor=S.+A.+Masino&title=The+role+and+regulation+of+adenosine+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">The role and regulation of adenosine in the central nervous system</span></div><div class="casAuthors">Dunwiddie, Thomas V.; Masino, Susan A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-55</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 166 refs.  Adenosine is a modulator that has a pervasive and generally inhibitory effect on neuronal activity.  Tonic activation of adenosine receptors by adenosine that is normally present in the extracellular space in brain tissue leads to inhibitory effects that appear to be mediated by both adenosine A1 and A2A receptors.  Relief from this tonic inhibition by receptor antagonists such as caffeine accounts for the excitatory actions of these agents.  Characterization of the effects of adenosine receptor agonists and antagonists has led to numerous hypotheses concerning the role of this nucleoside.  Previous work has established a role for adenosine in a diverse array of neural phenomena, which include regulation of sleep and the level of arousal, neuroprotection, regulation of seizure susceptibility, locomotor effects, analgesia, mediation of the effects of ethanol, and chronic drug use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0o-Qitx0a6LVg90H21EOLACvtfcHk0lhDMiFJfotBeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Siu7c%253D&md5=b9e0a3a4bc0c6cc23cc0ab9728d4b410</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.24.1.31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.24.1.31%26sid%3Dliteratum%253Aachs%26aulast%3DDunwiddie%26aufirst%3DT.%2BV.%26aulast%3DMasino%26aufirst%3DS.%2BA.%26atitle%3DThe%2520role%2520and%2520regulation%2520of%2520adenosine%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D24%26spage%3D31%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Stiles, G. L.</span><span> </span><span class="NLM_article-title">Adenosine receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">6451</span><span class="NLM_x">–</span> <span class="NLM_lpage">6454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=6451-6454&author=G.+L.+Stiles&title=Adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStiles%26aufirst%3DG.%2BL.%26atitle%3DAdenosine%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D6451%26epage%3D6454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rosin, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robeva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyenet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">Immunohistochemical localization of adenosine A<sub>2A</sub> receptors in rat central nervous system</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1002%2F%28SICI%291096-9861%2819981116%29401%3A2%3C163%3A%3AAID-CNE2%3E3.0.CO%3B2-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=9822147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK1cXntlanu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1998&pages=163-186&author=D.+L.+Rosinauthor=A.+Robevaauthor=R.+L.+Woodardauthor=P.+G.+Guyenetauthor=J.+Linden&title=Immunohistochemical+localization+of+adenosine+A2A+receptors+in+rat+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system</span></div><div class="casAuthors">Rosin, Diane L.; Robeva, Anna; Woodard, Robin L.; Guyenet, Patrice G.; Linden, Joel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-186</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The A2A adenosine receptor (A2A-AR) transcript and radioligand binding sites have a distinct distribution in rat brain, restricted primarily to the striatum, nucleus accumbens, and olfactory tubercles.  The authors describe here the use of purified recombinant human A2A-ARs to generate a monoclonal antibody that has been used to better resolve the distribution of A2A-ARs in rat brain.  The antibody can detect 1 ng of purified recombinant receptor by Western blotting and is potent (EC50 = 0.62 μg/mL) and highly selective for the A12A-AR subtype.  By Western blotting, the apparent mol. mass of recombinant and rat striatal receptors shifts upon deglycosylation from 43-48 to 42 kilodaltons.  Analyses of chimeric A1/A2A-ARs and synthesis of a blocking peptide pinpointed the epitope (SQPLPGER) of the antibody to the center of the third intracellular loop of the receptor.  Incubation of rat striatal membranes with antibody reduces receptor coupling to G-proteins.  In rat brain, dense A2A-AR-like immunoreactivity that is eliminated by the blocking peptide was found in the neuropil of the striatum, nucleus accumbens (rostral pole, core, and shell), cell bridges of the striatum, olfactory tubercles, and areas of extended amygdala with somewhat lighter labeling in the globus pallidus and nucleus of the solitary tract.  Light perikaryal labeling was found in other areas of the brain, including the cortex, hippocampus, thalamus, cerebellum, and portions of the hindbrain.  The obsd. distribution of A2A-AR immunoreactivity throughout the neuraxis is consistent with the receptors' role in modulating dopaminergic neurotransmission and central control of cardiovascular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNFUvkZHeam7Vg90H21EOLACvtfcHk0lgWeRe1cc-5Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntlanu7Y%253D&md5=297b00a8d21c3430128983539209aa65</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-9861%2819981116%29401%3A2%3C163%3A%3AAID-CNE2%3E3.0.CO%3B2-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-9861%252819981116%2529401%253A2%253C163%253A%253AAID-CNE2%253E3.0.CO%253B2-D%26sid%3Dliteratum%253Aachs%26aulast%3DRosin%26aufirst%3DD.%2BL.%26aulast%3DRobeva%26aufirst%3DA.%26aulast%3DWoodard%26aufirst%3DR.%2BL.%26aulast%3DGuyenet%26aufirst%3DP.%2BG.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DImmunohistochemical%2520localization%2520of%2520adenosine%2520A2A%2520receptors%2520in%2520rat%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D1998%26volume%3D401%26spage%3D163%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenningsson, P.</span><span> </span><span class="NLM_article-title">Striatal adenosine A<sub>2A</sub> receptors-where are they? What do they do? Comments</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=46-47&author=B.+B.+Fredholmauthor=P.+Svenningsson&title=Striatal+adenosine+A2A+receptors-where+are+they%3F+What+do+they+do%3F+Comments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DSvenningsson%26aufirst%3DP.%26atitle%3DStriatal%2520adenosine%2520A2A%2520receptors-where%2520are%2520they%253F%2520What%2520do%2520they%2520do%253F%2520Comments%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26spage%3D46%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K.</span><span> </span><span class="NLM_article-title">First visualization of adenosine A<sub>2A</sub> receptors in the human brain by positron emission tomography with [<sup>11</sup>C]TMSX</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=133-136&author=K.+Ishiwataauthor=M.+Mishinaauthor=Y.+Kimuraauthor=K.+Odaauthor=T.+Sasakiauthor=K.+Ishii&title=First+visualization+of+adenosine+A2A+receptors+in+the+human+brain+by+positron+emission+tomography+with+%5B11C%5DTMSX"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DMishina%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DOda%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DK.%26atitle%3DFirst%2520visualization%2520of%2520adenosine%2520A2A%2520receptors%2520in%2520the%2520human%2520brain%2520by%2520positron%2520emission%2520tomography%2520with%2520%255B11C%255DTMSX%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D133%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Svenningsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedvall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1997&pages=322-335&author=P.+Svenningssonauthor=H.+Hallauthor=G.+Sedvallauthor=B.+B.+Fredholm&title=Distribution+of+adenosine+receptors+in+the+postmortem+human+brain%3A+an+extended+autoradiographic+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DHall%26aufirst%3DH.%26aulast%3DSedvall%26aufirst%3DG.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DDistribution%2520of%2520adenosine%2520receptors%2520in%2520the%2520postmortem%2520human%2520brain%253A%2520an%2520extended%2520autoradiographic%2520study%26jtitle%3DSynapse%26date%3D1997%26volume%3D27%26spage%3D322%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Pollack, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, J. S.</span><span> </span><span class="NLM_article-title">Adenosine antagonists potentiate D2 dopamine dependent activation of Fos in the striatopallidal pathway</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1995&pages=721-728&author=A.+E.+Pollackauthor=J.+S.+Fink&title=Adenosine+antagonists+potentiate+D2+dopamine+dependent+activation+of+Fos+in+the+striatopallidal+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPollack%26aufirst%3DA.%2BE.%26aulast%3DFink%26aufirst%3DJ.%2BS.%26atitle%3DAdenosine%2520antagonists%2520potentiate%2520D2%2520dopamine%2520dependent%2520activation%2520of%2520Fos%2520in%2520the%2520striatopallidal%2520pathway%26jtitle%3DNeuroscience%26date%3D1995%26volume%3D68%26spage%3D721%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonsalla, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzchild, M. A.</span><span> </span><span class="NLM_article-title">Neuroprotection by caffeine and A<sub>2A</sub> adenosine receptor inactivation in a model of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">RC143/1</span><span class="NLM_x">–</span> <span class="NLM_lpage">RC143/6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=RC143%2F1-RC143%2F6&author=J.+F.+Chenauthor=K.+Xuauthor=J.+P.+Petzerauthor=R.+Staalauthor=Y.+H.+Xuauthor=M.+Beilsteinauthor=P.+K.+Sonsallaauthor=K.+Castagnoliauthor=N.+Castagnoliauthor=M.+A.+Schwarzchild&title=Neuroprotection+by+caffeine+and+A2A+adenosine+receptor+inactivation+in+a+model+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DStaal%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DY.%2BH.%26aulast%3DBeilstein%26aufirst%3DM.%26aulast%3DSonsalla%26aufirst%3DP.%2BK.%26aulast%3DCastagnoli%26aufirst%3DK.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DSchwarzchild%26aufirst%3DM.%2BA.%26atitle%3DNeuroprotection%2520by%2520caffeine%2520and%2520A2A%2520adenosine%2520receptor%2520inactivation%2520in%2520a%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3DRC143%252F1%26epage%3DRC143%252F6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grondin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahar, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregoire, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span> </span><span class="NLM_article-title">Antiparkinsonian effect of a new adenosine A<sub>2A</sub> receptor antagonist in MPTP-treated monkeys</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=1673-1677&author=R.+Grondinauthor=P.+J.+Bedardauthor=A.+J.+Taharauthor=L.+Gregoireauthor=A.+Moriauthor=H.+Kase&title=Antiparkinsonian+effect+of+a+new+adenosine+A2A+receptor+antagonist+in+MPTP-treated+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrondin%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DP.%2BJ.%26aulast%3DTahar%26aufirst%3DA.%2BJ.%26aulast%3DGregoire%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DKase%26aufirst%3DH.%26atitle%3DAntiparkinsonian%2520effect%2520of%2520a%2520new%2520adenosine%2520A2A%2520receptor%2520antagonist%2520in%2520MPTP-treated%2520monkeys%26jtitle%3DNeurology%26date%3D1999%26volume%3D52%26spage%3D1673%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Impagnatiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredduzzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzchild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span> </span><span class="NLM_article-title">Dual actions of A<sub>2A</sub> adenosine receptor antagonists on motor dysfunction and neurodegenerative processes</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2001&pages=379-386&author=E.+Onginiauthor=A.+Monopoliauthor=F.+Impagnatielloauthor=S.+Fredduzziauthor=M.+Schwarzchildauthor=J.+F.+Chen&title=Dual+actions+of+A2A+adenosine+receptor+antagonists+on+motor+dysfunction+and+neurodegenerative+processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DImpagnatiello%26aufirst%3DF.%26aulast%3DFredduzzi%26aufirst%3DS.%26aulast%3DSchwarzchild%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26atitle%3DDual%2520actions%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%2520on%2520motor%2520dysfunction%2520and%2520neurodegenerative%2520processes%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2001%26volume%3D52%26spage%3D379%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span> </span><span class="NLM_article-title">Neuroprotection by adenosine A<sub>2A</sub> receptor blockade in experimental models of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1046%2Fj.0022-3042.2001.00694.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=11902116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD38XptV2jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=262-270&author=K.+Ikedaauthor=M.+Kurokawaauthor=S.+Aoyamaauthor=Y.+Kuwana&title=Neuroprotection+by+adenosine+A2A+receptor+blockade+in+experimental+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease</span></div><div class="casAuthors">Ikeda, Ken; Kurokawa, Masako; Aoyama, Shiro; Kuwana, Yoshihisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-270</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Adenosine A2A receptors are abundant in the caudate-putamen and involved in the motor control in several species.  In MPTP-treated monkeys, A2A receptor-blockade with an antagonist alleviates parkinsonian symptoms without provoking dyskinesia, suggesting this receptor may offer a new target for the antisymptomatic therapy of Parkinson's disease.  In the present study, a significant neuroprotective effect of A2A receptor antagonists is shown in exptl. models of Parkinson's disease.  Oral administration of A2A receptor antagonists protected against the loss of nigral dopaminergic neuronal cells induced by 6-hydroxydopamine in rats.  A2A antagonists also prevented the functional loss of dopaminergic nerve terminals in the striatum and the ensuing gliosis caused by MPTP in mice.  The neuroprotective property of A2A receptor antagonists may be exerted by altering the packaging of these neurotoxins into vesicles, thus reducing their effective intracellular concn.  We therefore conclude that the adenosine A2A receptor may provide a novel target for the long-term medication of Parkinson's disease, because blockade of this receptor exerts both acutely antisymptomatic and chronically neuroprotective activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb8toXJpqCzLVg90H21EOLACvtfcHk0likhLBygSm1oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptV2jsQ%253D%253D&md5=68ddb10b0be184393df31567d2acc7ca</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1046%2Fj.0022-3042.2001.00694.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0022-3042.2001.00694.x%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKurokawa%26aufirst%3DM.%26aulast%3DAoyama%26aufirst%3DS.%26aulast%3DKuwana%26aufirst%3DY.%26atitle%3DNeuroprotection%2520by%2520adenosine%2520A2A%2520receptor%2520blockade%2520in%2520experimental%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D80%26spage%3D262%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, R. K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1002%2Fana.410430415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=9546333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK1cXisFyisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=507-513&author=T.+Kandaauthor=M.+J.+Jacksonauthor=L.+A.+Smithauthor=R.+K.+B.+Pearceauthor=J.+Nakamuraauthor=H.+Kaseauthor=Y.+Kuwanaauthor=P.+Jenner&title=Adenosine+A2A+antagonist%3A+a+novel+antiparkinsonian+agent+that+does+not+provoke+dyskinesia+in+parkinsonian+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys</span></div><div class="casAuthors">Kanda, Tomoyuki; Jackson, Michael J.; Smith, Lance A.; Pearce, Ronald K. B.; Nakamura, Joji; Kase, Hiroshi; Kuwana, Yoshihisa; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">507-513</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">Treatment of Parkinson's disease with L-DOPA therapy leads to long-term complications, including loss of drug efficacy and the onset of dyskinesia.  Adenosine A2A receptors in the striatum are selectively localized to GABAergic output neurons of the striato-pallidal pathway and may avoid such problems.  The novel adenosine A2A receptor antagonist KW-6002 was examd. for antiparkinsonian activity in MPTP-treated primates.  Oral administration of KW-6002 reversed motor disability in MPTP-treated common marmosets in a dose-dependent manner.  However, KW-6002 only modestly increased overall locomotor activity and did not cause abnormal movement, such as stereotypy.  The ability of KW-6002 to reverse motor disability was maintained on repeated daily administration for 21 days, and no tolerance was obsd.  KW-6002 induced little or no dyskinesia in MPTP-treated primates previously primed to exhibit dyskinesia by prior exposure to L-DOPA.  Thus, selective adenosine A2A receptor antagonists represent a new class of antiparkinsonian agents that do not produce hyperactivity or induce dyskinesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouQ20y4EvPvLVg90H21EOLACvtfcHk0likhLBygSm1oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFyisbw%253D&md5=36af21fdde02b63c588e3ca03785dafe</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1002%2Fana.410430415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410430415%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DPearce%26aufirst%3DR.%2BK.%2BB.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DKase%26aufirst%3DH.%26aulast%3DKuwana%26aufirst%3DY.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DAdenosine%2520A2A%2520antagonist%253A%2520a%2520novel%2520antiparkinsonian%2520agent%2520that%2520does%2520not%2520provoke%2520dyskinesia%2520in%2520parkinsonian%2520monkeys%26jtitle%3DAnn.%2520Neurol.%26date%3D1998%26volume%3D43%26spage%3D507%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2FS0014-2999%2800%2900745-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=11090641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1ygsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=249-255&author=K.+Kogaauthor=M.+Kurokawaauthor=M.+Ochiauthor=J.+Nakamuraauthor=Y.+Kuwana&title=Adenosine+A2A+receptor+antagonists+KF17837+and+KW-6002+potentiate+rotation+induced+by+dopaminergic+drugs+in+hemi-Parkinsonian+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats</span></div><div class="casAuthors">Koga, K.; Kurokawa, M.; Ochi, M.; Nakamura, J.; Kuwana, Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-255</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The effects of novel adenosine A2A receptor antagonists KF17837 ((E)-1,3-dipropyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dihydro-1H-purine-2,6-dione) and KW-6002 ((E)-1,3-diethyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dihydro-1H-purine-2,6-dione), on rotational behavior induced by apomorphine or L-DOPA (l-3,4-dihydroxyphenylalanine) were investigated in rats with unilateral 6-hydroxydopamine lesions.  Both KF17837 and KW-6002 slightly induced rotational behavior per se.  However, KF17837 and KW-6002 significantly increased the total counts of turning induced by apomorphine at doses of 3 mg/kg, p.o. and 10 mg/kg, p.o., and at doses of 1 mg/kg, p.o. and higher, resp.  KF17837 and KW-6002 also potentiated the rotational behavior induced by L-DOPA at a dose of 3 mg/kg, p.o.  Furthermore, i.c.v. injection (10 μg/20 μl) of a selective adenosine A2 receptor agonist CGS 21680 {2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine} partially prevented the rotational behavior induced by apomorphine and this inhibition was reversed by KW-6002 (1 mg/kg, p.o.).  The increase in total counts of apomorphine-induced turning by the adenosine A2A receptor antagonists seems to be mainly attributable to prolongation of turning duration rather than enhancement of intensity.  These results suggest that these adenosine A2A receptor antagonists may be useful to ameliorate shortening in the duration of dopaminergic drug response in patients with advanced Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZbOArDCv31rVg90H21EOLACvtfcHk0likhLBygSm1oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1ygsb0%253D&md5=1763bbd6e38fbfc8bf3f9ab1b3f12374</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900745-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900745-7%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DK.%26aulast%3DKurokawa%26aufirst%3DM.%26aulast%3DOchi%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DKuwana%26aufirst%3DY.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonists%2520KF17837%2520and%2520KW-6002%2520potentiate%2520rotation%2520induced%2520by%2520dopaminergic%2520drugs%2520in%2520hemi-Parkinsonian%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D408%26spage%3D249%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Combined use of the adenosine A<sub>2A</sub> antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1006%2Fexnr.2000.7350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=10739638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVWqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2000&pages=321-327&author=T.+Kandaauthor=M.+J.+Jacksonauthor=L.+A.+Smithauthor=R.+K.+Pearceauthor=J.+Nakamuraauthor=H.+Kaseauthor=Y.+Kuwanaauthor=P.+Jenner&title=Combined+use+of+the+adenosine+A2A+antagonist+KW-6002+with+L-DOPA+or+with+selective+D1+or+D2+dopamine+agonists+increases+antiparkinsonian+activity+but+not+dyskinesia+in+MPTP-treated+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Combined Use of the Adenosine A2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys</span></div><div class="casAuthors">Kanda, Tomoyuki; Jackson, Michael J.; Smith, Lance A.; Pearce, Ronald K. B.; Nakamura, Joji; Kase, Hiroshi; Kuwana, Yoshihisa; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-327</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The novel selective adenosine A2A receptor antagonist KW-6002 improves motor disability in MPTP-treated parkinsonian marmosets without provoking dyskinesia.  In this study we have investigated whether KW-6002 in combination with l-DOPA or selective D1 or D2 dopamine receptor agonists enhances antiparkinsonian activity in MPTP-treated common marmosets.  Combination of KW-6002 with the selective dopamine D2 receptor agonist quinpirole or the D1 receptor agonist SKF80723 produced an additive improvement in motor disability.  Coadministration of KW-6002 with a low dose of l-DOPA also produced an additive improvement in motor disability, and increased locomotor activity.  The ability of KW-6002 to enhance antiparkinsonian activity was more marked with l-DOPA and quinpirole than with the D1 agonist.  However, despite producing an enhanced antiparkinsonian response KW-6002 did not exacerbate l-DOPA-induced dyskinesia in MPTP-treated common marmosets previously primed to exhibit dyskinesia by prior exposure to l-DOPA.  Selective adenosine A2A receptor antagonists, such as KW-6002, may be one means of reducing the dosage of l-DOPA used in treating Parkinson's disease and are potentially a novel approach to treating the illness both as monotherapy and in combination with dopaminergic drugs.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsA7cu-aJS8rVg90H21EOLACvtfcHk0lhHtkL1PZXokQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVWqsLY%253D&md5=28db343f66ae2a8179d7113246f39ae7</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1006%2Fexnr.2000.7350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexnr.2000.7350%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DPearce%26aufirst%3DR.%2BK.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DKase%26aufirst%3DH.%26aulast%3DKuwana%26aufirst%3DY.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DCombined%2520use%2520of%2520the%2520adenosine%2520A2A%2520antagonist%2520KW-6002%2520with%2520L-DOPA%2520or%2520with%2520selective%2520D1%2520or%2520D2%2520dopamine%2520agonists%2520increases%2520antiparkinsonian%2520activity%2520but%2520not%2520dyskinesia%2520in%2520MPTP-treated%2520monkeys%26jtitle%3DExp.%2520Neurol.%26date%3D2000%26volume%3D162%26spage%3D321%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hauser, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubble, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, D. D.</span><span> </span><span class="NLM_article-title">Randomized trial of adenosine A<sub>2A</sub> receptor antagonist istradefylline in advanced PD</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=297-303&author=R.+A.+Hauserauthor=J.+P.+Hubbleauthor=D.+D.+Truong&title=Randomized+trial+of+adenosine+A2A+receptor+antagonist+istradefylline+in+advanced+PD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DHubble%26aufirst%3DJ.%2BP.%26aulast%3DTruong%26aufirst%3DD.%2BD.%26atitle%3DRandomized%2520trial%2520of%2520adenosine%2520A2A%2520receptor%2520antagonist%2520istradefylline%2520in%2520advanced%2520PD%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D297%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bara-Jimenez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherzai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouradian, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonist treatment of Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=293-296&author=W.+Bara-Jimenezauthor=A.+Sherzaiauthor=T.+Dimitrovaauthor=A.+Favitauthor=F.+Bibbianiauthor=M.+Gillespieauthor=M.+J.+Morrisauthor=M.+M.+Mouradianauthor=T.+N.+Chase&title=Adenosine+A2A+receptor+antagonist+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBara-Jimenez%26aufirst%3DW.%26aulast%3DSherzai%26aufirst%3DA.%26aulast%3DDimitrova%26aufirst%3DT.%26aulast%3DFavit%26aufirst%3DA.%26aulast%3DBibbiani%26aufirst%3DF.%26aulast%3DGillespie%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonist%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D293%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ballarin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiriz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahy, N.</span><span> </span><span class="NLM_article-title">Effect of locally infused 2-cholroadenosine, an A<sub>1</sub> receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1995&pages=29-32&author=M.+Ballarinauthor=J.+Reirizauthor=S.+Ambrosioauthor=N.+Mahy&title=Effect+of+locally+infused+2-cholroadenosine%2C+an+A1+receptor+agonist%2C+on+spontaneous+and+evoked+dopamine+release+in+rat+neostriatum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallarin%26aufirst%3DM.%26aulast%3DReiriz%26aufirst%3DJ.%26aulast%3DAmbrosio%26aufirst%3DS.%26aulast%3DMahy%26aufirst%3DN.%26atitle%3DEffect%2520of%2520locally%2520infused%25202-cholroadenosine%252C%2520an%2520A1%2520receptor%2520agonist%252C%2520on%2520spontaneous%2520and%2520evoked%2520dopamine%2520release%2520in%2520rat%2520neostriatum%26jtitle%3DNeurosci.%2520Lett.%26date%3D1995%26volume%3D185%26spage%3D29%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moore, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, D.</span><span> </span><span class="NLM_article-title">Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses</span> <span class="citation_source-journal">Proc. Nat. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">14397</span><span class="NLM_x">–</span> <span class="NLM_lpage">14402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1073%2Fpnas.1835831100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=14608033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFGhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=14397-14402&author=K.+A.+Mooreauthor=R.+A.+Nicollauthor=D.+Schmitz&title=Adenosine+gates+synaptic+plasticity+at+hippocampal+mossy+fiber+synapses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses</span></div><div class="casAuthors">Moore, Kimberly A.; Nicoll, Roger A.; Schmitz, Dietmar</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">14397-14402</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The release properties of synapses in the central nervous system vary greatly, not only across anatomically distinct types of synapses but also among the same class of synapse.  This variation manifests itself in large part by differences in the probability of transmitter release, which affects such activity-dependent presynaptic forms of plasticity as paired-pulse facilitation and frequency facilitation.  This heterogeneity in presynaptic function reflects differences in the intrinsic properties of the synaptic terminal and the activation of presynaptic neurotransmitter receptors.  The unique presynaptic properties of the hippocampal mossy fiber synapse are largely imparted onto the synapse by the continuous local action of extracellular adenosine at presynaptic A1 adenosine receptors, which maintains a low basal probability of transmitter release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7O6W_5jGVTLVg90H21EOLACvtfcHk0lhHtkL1PZXokQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFGhs7w%253D&md5=4f873eae58d0090114a4e1c8854384b9</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1835831100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1835831100%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DK.%2BA.%26aulast%3DNicoll%26aufirst%3DR.%2BA.%26aulast%3DSchmitz%26aufirst%3DD.%26atitle%3DAdenosine%2520gates%2520synaptic%2520plasticity%2520at%2520hippocampal%2520mossy%2520fiber%2520synapses%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D14397%26epage%3D14402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rebola, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinheiro, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malva, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, R. A.</span><span> </span><span class="NLM_article-title">Subcellular localization of adenosine A<sub>1</sub> receptors in nerve terminal and synapses of the rat hippocampus</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">987</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2FS0006-8993%2803%2903247-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=14499945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1aqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=987&publication_year=2003&pages=49-58&author=N.+Rebolaauthor=P.+C.+Pinheiroauthor=C.+R.+Oliveiraauthor=J.+O.+Malvaauthor=R.+A.+Cunha&title=Subcellular+localization+of+adenosine+A1+receptors+in+nerve+terminal+and+synapses+of+the+rat+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Subcellular localization of adenosine A1 receptors in nerve terminals and synapses of the rat hippocampus</span></div><div class="casAuthors">Rebola, Nelson; Pinheiro, Paulo C.; Oliveira, Catarina R.; Malva, Joao O.; Cunha, Rodrigo A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">987</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-58</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Adenosine is a neuromodulator in the CNS that mainly acts through pre- and postsynaptic A1 receptors to inhibit the release of excitatory neurotransmitters and NMDA receptor function.  This might result from a highly localized distribution of A1 receptors in the active zone and postsynaptic d. of CNS synapses that we now investigated in the rat hippocampus.  The binding d. of the selective A1 receptor antagonist, [3H]1,3-dipropyl-8-cyclopentylxanthine ([3H]DPCPX), was enriched in membranes from Percoll-purified nerve terminals (Bmax=1839±52 fmol/mg protein) compared to total membranes from the hippocampus (Bmax=984±31 fmol/mg protein), the same occurring with A1 receptor immunoreactivity.  [3H]DPCPX binding occurred mainly to the plasma membrane rather than to intracellular sites, since the binding of the membrane permeable A1 receptor ligand [3H]DPCPX to intact hippocampal nerve terminals (Bmax=1901±192 fmol/mg protein) was markedly reduced (Bmax=321±30 fmol/mg protein) by the membrane impermeable adenosine receptor antagonist, 8-sulfophenyltheophilline (25 μM).  Further subcellular fractionation of hippocampal nerve terminals revealed that A1 receptor immunoreactivity was strategically located in the active zone of presynaptic nerve terminals, as expected to understand the efficiency of A1 receptors to depress neurotransmitter release.  A1 Receptors were also present in nerve terminals outside the active zone in accordance with the existence of a presynaptic A1 receptor reserve.  Finally, A1 receptor immunoreactivity was evident in the postsynaptic d. together with NMDA receptor subunits 1, 2A and 2B and with N-and P/Q-type calcium channel immunoreactivity, emphasizing the importance of A1 receptors in the control of dendritic integration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXNS9YJIv75rVg90H21EOLACvtfcHk0lhHtkL1PZXokQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1aqsr8%253D&md5=3400357993c99c6aa97d2def8af5b8ca</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2803%2903247-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252803%252903247-5%26sid%3Dliteratum%253Aachs%26aulast%3DRebola%26aufirst%3DN.%26aulast%3DPinheiro%26aufirst%3DP.%2BC.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26aulast%3DMalva%26aufirst%3DJ.%2BO.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26atitle%3DSubcellular%2520localization%2520of%2520adenosine%2520A1%2520receptors%2520in%2520nerve%2520terminal%2520and%2520synapses%2520of%2520the%2520rat%2520hippocampus%26jtitle%3DBrain%2520Res.%26date%3D2003%26volume%3D987%26spage%3D49%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Maemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noriko, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyoharu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoru, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsushi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinori, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitaro, M.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of FR194921, a new potent, selective, orally active antagonist for central adenosine A<sub>1</sub> receptors</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1254%2Fjphs.FP0040359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=15351792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFyjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=42-52&author=T.+Maemotoauthor=T.+Mihoauthor=M.+Takumaauthor=U.+Norikoauthor=M.+Hideakiauthor=H.+Katsuyaauthor=Y.+Takayukiauthor=S.+Kiyoharuauthor=K.+Satoruauthor=A.+Atsushiauthor=I.+Akinoriauthor=M.+Nobuyaauthor=M.+Seitaro&title=Pharmacological+characterization+of+FR194921%2C+a+new+potent%2C+selective%2C+orally+active+antagonist+for+central+adenosine+A1+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A1 receptors</span></div><div class="casAuthors">Maemoto, Takuya; Tada, Miho; Mihara, Takuma; Ueyama, Noriko; Matsuoka, Hideaki; Harada, Katsuya; Yamaji, Takayuki; Shirakawa, Kiyoharu; Kuroda, Satoru; Akahane, Atsushi; Iwashita, Akinori; Matsuoka, Nobuya; Mutoh, Seitaro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-52</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Adenosine A1 receptors in the brain are believed to play an important role in brain functioning.  We have discovered a novel adenosine A1 receptor antagonist, FR194921 (2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-3(2H)-pyridazinone), and characterized the pharmacol. activity in the present study.  FR194921 showed potent and selective affinity for the adenosine A1 receptor without affinity for A2A and A3 receptors and did not show any species differences in binding affinity profile among human, rat, and mouse.  Pharmacokinetic study in rats revealed that FR194921 was orally active and highly brain penetrable.  Oral administration of FR194921 dose-dependently ameliorated the hypolocomotion induced by the A1 receptor agonist N6-cyclopentyladenosine in rats, indicating this compd. exerts A1-antagonistic action in vivo.  In the passive avoidance test, scopolamine (1 mg/kg)-induced memory deficits were significantly ameliorated by FR194921 (0.32, 1 mg/kg).  In two animal models of anxiety, the social interaction test and elevated plus maze, FR194921 showed specific anxiolytic activity without significantly influencing general behavior.  In contrast, FR194921 did not show antidepressant activity even at a dose of 32 mg/kg in the rat forced swimming test.  These results indicate that the novel, potent, and selective adenosine A1 receptor antagonist FR194921 exerts both cognitive-enhancing and anxiolytic activity, suggesting the therapeutic potential of this compd. for dementia and anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpor8cuLg5xVrVg90H21EOLACvtfcHk0lggw9_b9WB4Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFyjs78%253D&md5=1828b4e7afe4c25a61aa0fa094f64c38</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FP0040359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FP0040359%26sid%3Dliteratum%253Aachs%26aulast%3DMaemoto%26aufirst%3DT.%26aulast%3DMiho%26aufirst%3DT.%26aulast%3DTakuma%26aufirst%3DM.%26aulast%3DNoriko%26aufirst%3DU.%26aulast%3DHideaki%26aufirst%3DM.%26aulast%3DKatsuya%26aufirst%3DH.%26aulast%3DTakayuki%26aufirst%3DY.%26aulast%3DKiyoharu%26aufirst%3DS.%26aulast%3DSatoru%26aufirst%3DK.%26aulast%3DAtsushi%26aufirst%3DA.%26aulast%3DAkinori%26aufirst%3DI.%26aulast%3DNobuya%26aufirst%3DM.%26aulast%3DSeitaro%26aufirst%3DM.%26atitle%3DPharmacological%2520characterization%2520of%2520FR194921%252C%2520a%2520new%2520potent%252C%2520selective%252C%2520orally%2520active%2520antagonist%2520for%2520central%2520adenosine%2520A1%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D96%26spage%3D42%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintzelman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullington, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osbourne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Methylene amine substituted arylindenopyrimidines as potent adenosine A<sub>2A</sub>/A<sub>1</sub> antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2864</span><span class="NLM_x">–</span> <span class="NLM_lpage">2867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2864-2867&author=B.+C.+Shookauthor=S.+Rassnickauthor=D.+Hallauthor=K.+C.+Rupertauthor=G.+R.+Heintzelmanauthor=K.+Hansenauthor=D.+Chakravartyauthor=J.+L.+Bullingtonauthor=R.+Scannevinauthor=B.+Magliaroauthor=L.+Westoverauthor=K.+Carrollauthor=L.+Lampronauthor=R.+Russellauthor=S.+Branumauthor=K.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=X.+Liauthor=M.+Osbourneauthor=K.+Demarestauthor=Y.+Tangauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Methylene+amine+substituted+arylindenopyrimidines+as+potent+adenosine+A2A%2FA1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHeintzelman%26aufirst%3DG.%2BR.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DBullington%26aufirst%3DJ.%2BL.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DMagliaro%26aufirst%3DB.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DOsbourne%26aufirst%3DM.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DMethylene%2520amine%2520substituted%2520arylindenopyrimidines%2520as%2520potent%2520adenosine%2520A2A%252FA1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2864%26epage%3D2867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbay, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alford, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintzelman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullington, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Optimization of arylindenopyrimidines as potent adenosine A<sub>2A</sub>/A<sub>1</sub> antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2868</span><span class="NLM_x">–</span> <span class="NLM_lpage">2871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2868-2871&author=B.+C.+Shookauthor=S.+Rassnickauthor=D.+Chakravartyauthor=N.+Wallaceauthor=M.+Aultauthor=J.+Crookeauthor=J.+K.+Barbayauthor=A.+Wangauthor=K.+Leonardauthor=M.+T.+Powellauthor=V.+Alfordauthor=D.+Hallauthor=K.+C.+Rupertauthor=G.+R.+Heintzelmanauthor=K.+Hansenauthor=J.+L.+Bullingtonauthor=R.+Scannevinauthor=K.+Carrollauthor=L.+Lampronauthor=L.+Westoverauthor=R.+Russellauthor=S.+Branumauthor=K.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=D.+Beauchampauthor=X.+Liauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Optimization+of+arylindenopyrimidines+as+potent+adenosine+A2A%2FA1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DWallace%26aufirst%3DN.%26aulast%3DAult%26aufirst%3DM.%26aulast%3DCrooke%26aufirst%3DJ.%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DPowell%26aufirst%3DM.%2BT.%26aulast%3DAlford%26aufirst%3DV.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHeintzelman%26aufirst%3DG.%2BR.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DBullington%26aufirst%3DJ.%2BL.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DBeauchamp%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DOptimization%2520of%2520arylindenopyrimidines%2520as%2520potent%2520adenosine%2520A2A%252FA1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2868%26epage%3D2871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Zarrindast, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modabber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabetkasai, M.</span><span> </span><span class="NLM_article-title">Influence on different adenosine receptor subtypes on catalepsy in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1993&pages=257-261&author=M.+R.+Zarrindastauthor=M.+Modabberauthor=M.+Sabetkasai&title=Influence+on+different+adenosine+receptor+subtypes+on+catalepsy+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZarrindast%26aufirst%3DM.%2BR.%26aulast%3DModabber%26aufirst%3DM.%26aulast%3DSabetkasai%26aufirst%3DM.%26atitle%3DInfluence%2520on%2520different%2520adenosine%2520receptor%2520subtypes%2520on%2520catalepsy%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D1993%26volume%3D113%26spage%3D257%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Mandhane, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopde, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2</sub> receptors modulate haloperidol-induced catalepsy in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x"> (</span><span class="NLM_issue">2/3</span><span class="NLM_x">) </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2FS0014-2999%2897%2983039-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=9218695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK2sXjsVKgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=1997&pages=135-141&issue=2%2F3&author=S.+N.+Mandhaneauthor=C.+T.+Chopdeauthor=A.+K.+Ghosh&title=Adenosine+A2+receptors+modulate+haloperidol-induced+catalepsy+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats</span></div><div class="casAuthors">Mandhane, Sanjay N.; Chopde, Chandrabhan T.; Ghosh, Anuradha K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">135-141</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effect of adenosine A1 and A2 receptor agonists and antagonists was investigated on haloperidol-induced catalepsy in rats.  Pretreatment (i.p.) with the non-selective adenosine receptor antagonist, theophylline, or the selective adenosine A2 receptor antagonist, 3,7-dimethyl-1-propargylxanthine (DMPX), significantly reversed haloperidol-induced catalepsy, whereas the selective adenosine A1 receptor antagonists, 8-phenyltheophylline and 8-cyclopentyl-1,3-dipropylxanthine produced no effect.  Similar administration of the adenosine A2 receptor agonists, 5'-(N-cyclopropyl)carboxamidoadenosine and 5'-N-ethylcarboxamidoadenosine (NECA), and the mixed agonists with predominantly A1 site of action, N6-(2-phenylisopropyl)adenosine or 2-chloroadenosine, potentiated haloperidol-induced catalepsy.  Higher doses of the adenosine agonists produced catalepsy when given alone.  However, N6-cyclopentyladenosine, a highly selective adenosine A1 receptor agonist, was ineffective in these respects.  The per se cataleptic effect of adenosine agonists was blocked by DMPX and the centrally acting anticholinergic agent, scopolamine.  Scopolamine also attenuated the potentiation of haloperidol-induced catalepsy by adenosine agonists.  Further, i.c.v. administration of NECA and DMPX produced a similar effect as that produced after their systemic administration.  These findings demonstrate the differential influence of adenosine A1 and A2 receptors on haloperidol-induced catalepsy and support the hypothesis that the functional interaction between adenosine and dopamine mechanisms might occur through adenosine A2 receptors at the level of cholinergic neurons.  The results suggest that adenosine A2, but not A1, receptor antagonists may be of potential use in the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_yuXIH62xu7Vg90H21EOLACvtfcHk0lj_8wtuuh7UNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsVKgt70%253D&md5=369d9508f13df6a3a9e3ce41bf83fa13</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2983039-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252983039-7%26sid%3Dliteratum%253Aachs%26aulast%3DMandhane%26aufirst%3DS.%2BN.%26aulast%3DChopde%26aufirst%3DC.%2BT.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26atitle%3DAdenosine%2520A2%2520receptors%2520modulate%2520haloperidol-induced%2520catalepsy%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D328%26issue%3D2%252F3%26spage%3D135%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Cooper, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C. D.</span><span> </span><span class="NLM_article-title">L-Dopa esters as potential prodrugs: behavioral activity in experimental models of Parkinson’s disease</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1111%2Fj.2042-7158.1987.tb03441.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=2888854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaL2sXmtFWnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1987&pages=627-635&author=D.+R.+Cooperauthor=C.+Marrelauthor=H.+van+de+Waterbeemdauthor=B.+Testaauthor=P.+Jennerauthor=C.+D.+Marsden&title=L-Dopa+esters+as+potential+prodrugs%3A+behavioral+activity+in+experimental+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">L-Dopa esters as potential prodrugs:  behavioral activity in experimental models of Parkinson's disease</span></div><div class="casAuthors">Cooper, D. R.; Marrel, C.; Van de Waterbeemd, H.; Testa, B.; Jenner, P.; Marsden, C. D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-35</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">The behavioral activity of 13 ester prodrugs of L-dopa (I; R = Me, Et, Pr, CH2CH(OH)Me, CHMeCH2OMe, cyclohexyl, tetrahydropyranylmethyl, CH2Ph, substituted benzyl, phenylethyl, phenoxyethyl, substituted phenylethyl) was evaluated on 2 exptl. animal models of Parkinson's disease; reverse of reserpine-induced akinesia in mice and induction of circling behavior in rats with 6-hydroxydopamine lesion of the medial forebrain bundle.  In general, I did not have markedly greater activity or a more sustained effect than L-dopa itself and thus would be unlikely to offer major therapeutic advantages on intermittent oral dosage.  However, their various physiochem. properties may make them more suitable i.v. or s.c. infusions.  Structure-activity relations are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx_hPJDd522bVg90H21EOLACvtfcHk0lj_8wtuuh7UNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmtFWnt7k%253D&md5=06e8a60094d1a7d55c4017a2ff462cd3</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1987.tb03441.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1987.tb03441.x%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DD.%2BR.%26aulast%3DMarrel%26aufirst%3DC.%26aulast%3Dvan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DMarsden%26aufirst%3DC.%2BD.%26atitle%3DL-Dopa%2520esters%2520as%2520potential%2520prodrugs%253A%2520behavioral%2520activity%2520in%2520experimental%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1987%26volume%3D39%26spage%3D627%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ungerstedt, U.</span><span> </span><span class="NLM_article-title">6-Hydroxydopamine-induced generation of central monoamine neurons</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2F0014-2999%2868%2990164-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=5718510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaF1MXns1eisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1968&pages=107-110&author=U.+Ungerstedt&title=6-Hydroxydopamine-induced+generation+of+central+monoamine+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">6-Hydroxydopamine-induced degeneration of central monoamine neurons</span></div><div class="casAuthors">Ungerstedt, Urban</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-10</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">6-Hydroxydopamine (I) (2 or 8 μg.) injected into the nucleus caudatus putamen, the zona compacta of the substantia nigra, and the area dorsolateral to the nucleus interpedunclaris of rats caused degeneration of dopamine and noradrenaline cell bodies, axons, and terminals in the vicinity of the injection site.  The degeneration of the nigroneostriatal dopamine neuron system occurring after I injections into the substantia nigra produced marked motor disturbances.  Intracerebral administration of I may be used as a tool for anatomical and functional studies on central monoamine neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI9wsRougpvrVg90H21EOLACvtfcHk0lj_8wtuuh7UNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXns1eisw%253D%253D&md5=57298843164b07af35ca21b4624826c4</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2868%2990164-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252868%252990164-7%26sid%3Dliteratum%253Aachs%26aulast%3DUngerstedt%26aufirst%3DU.%26atitle%3D6-Hydroxydopamine-induced%2520generation%2520of%2520central%2520monoamine%2520neurons%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1968%26volume%3D5%26spage%3D107%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ungerstedt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbuthnott, G. W.</span><span> </span><span class="NLM_article-title">Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2F0006-8993%2870%2990187-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=5494536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A280%3ADyaE3M%252Fotl2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1970&pages=485-493&author=U.+Ungerstedtauthor=G.+W.+Arbuthnott&title=Quantitative+recording+of+rotational+behavior+in+rats+after+6-hydroxy-dopamine+lesions+of+the+nigrostriatal+dopamine+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system</span></div><div class="casAuthors">Ungerstedt U; Arbuthnott G W</div><div class="citationInfo"><span class="NLM_cas:title">Brain research</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">485-93</span>
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxWjpxbmSViUg6wdEZmT2rfW6udTcc2eZ9QNIN3ueLS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3M%252Fotl2msA%253D%253D&md5=e31a2eee4f4fff68329c0ab8a8a62788</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2870%2990187-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252870%252990187-3%26sid%3Dliteratum%253Aachs%26aulast%3DUngerstedt%26aufirst%3DU.%26aulast%3DArbuthnott%26aufirst%3DG.%2BW.%26atitle%3DQuantitative%2520recording%2520of%2520rotational%2520behavior%2520in%2520rats%2520after%25206-hydroxy-dopamine%2520lesions%2520of%2520the%2520nigrostriatal%2520dopamine%2520system%26jtitle%3DBrain%2520Res.%26date%3D1970%26volume%3D24%26spage%3D485%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Luthman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredriksson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstroem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, T.</span><span> </span><span class="NLM_article-title">Selective lesion of central dopamine or moradenaline neuron systems in the neonatal rat: motor behavior and monoamine alteration at adult stage</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1989&pages=267-277&author=J.+Luthmanauthor=A.+Fredrikssonauthor=E.+Sundstroemauthor=G.+Jonssonauthor=T.+Archer&title=Selective+lesion+of+central+dopamine+or+moradenaline+neuron+systems+in+the+neonatal+rat%3A+motor+behavior+and+monoamine+alteration+at+adult+stage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuthman%26aufirst%3DJ.%26aulast%3DFredriksson%26aufirst%3DA.%26aulast%3DSundstroem%26aufirst%3DE.%26aulast%3DJonsson%26aufirst%3DG.%26aulast%3DArcher%26aufirst%3DT.%26atitle%3DSelective%2520lesion%2520of%2520central%2520dopamine%2520or%2520moradenaline%2520neuron%2520systems%2520in%2520the%2520neonatal%2520rat%253A%2520motor%2520behavior%2520and%2520monoamine%2520alteration%2520at%2520adult%2520stage%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1989%26volume%3D33%26spage%3D267%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bankiewicz, K. S.</span><span> </span><span class="NLM_article-title">MPTP-induced parkinsonism in nonhuman primates</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2FB978-0-12-185263-4.50018-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK38XisFejt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1991&pages=168-182&author=K.+S.+Bankiewicz&title=MPTP-induced+parkinsonism+in+nonhuman+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">MPTP-induced parkinsonism in nonhuman primates</span></div><div class="casAuthors">Bankiewicz, Krzysztof S.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">Lesions Transplant.</span>),
    <span class="NLM_cas:pages">168-82</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review with 45 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx3yh0hBeYerVg90H21EOLACvtfcHk0li5Et3egSaHbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XisFejt7s%253D&md5=d3848e6d09f0015f716ca9cdca6933ea</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-185263-4.50018-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-185263-4.50018-2%26sid%3Dliteratum%253Aachs%26aulast%3DBankiewicz%26aufirst%3DK.%2BS.%26atitle%3DMPTP-induced%2520parkinsonism%2520in%2520nonhuman%2520primates%26jtitle%3DMethods%2520Neurosci.%26date%3D1991%26volume%3D7%26spage%3D168%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jakowec, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzinger, G. M.</span><span> </span><span class="NLM_article-title">1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced lesion model of Parkinson’s disease, with emphasis on mice and nonhuman primates</span> <span class="citation_source-journal">Comp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=15575363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVejsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=497-513&author=M.+W.+Jakowecauthor=G.+M.+Petzinger&title=1-Methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine-induced+lesion+model+of+Parkinson%E2%80%99s+disease%2C+with+emphasis+on+mice+and+nonhuman+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of Parkinson's disease, with emphasis on mice and nonhuman primates</span></div><div class="casAuthors">Jakowec, Michael W.; Petzinger, Giselle M.</div><div class="citationInfo"><span class="NLM_cas:title">Comparative Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-513</span>CODEN:
                <span class="NLM_cas:coden">COMEFT</span>;
        ISSN:<span class="NLM_cas:issn">1532-0820</span>.
    
            (<span class="NLM_cas:orgname">American Association for Laboratory Animal Science</span>)
        </div><div class="casAbstract">A review.  Animal models play a crit. role in our understanding of the cause of human diseases and provide an opportunity to evaluate new therapeutic treatments.  The usefulness of an animal model is dependent, in part, on how closely it resembles neurochem., neuropathol., and behavioral features of the human condition.  Other considerations that may enhance the value of a model include expense, availability, reproducibility, animal morbidity and mortality, and investigator experience.  Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by slow movements, tremor, and walking impairment due to loss of midbrain nigrostriatal neurons and depletion of striatal dopamine.  In the PD research field, a no. of neurotoxic, pharmacol., and transgenic animal models are available for research studies.  We will focus on the advantages and disadvantages of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned mouse and nonhuman primate models of PD.  Our goal is to guide researchers in the appropriateness of the MPTP models in their studies by balancing understanding of the models, objectives of the study, and health and safety of the animals.  In addn., the tech. use and safe handling of MPTP are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1AbpYksctuLVg90H21EOLACvtfcHk0li5Et3egSaHbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVejsrrE&md5=268362f3d9a889531b0d888f0c86a96f</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakowec%26aufirst%3DM.%2BW.%26aulast%3DPetzinger%26aufirst%3DG.%2BM.%26atitle%3D1-Methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine-induced%2520lesion%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%252C%2520with%2520emphasis%2520on%2520mice%2520and%2520nonhuman%2520primates%26jtitle%3DComp.%2520Med.%26date%3D2004%26volume%3D54%26spage%3D497%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Campos-Romo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojeda-Flores, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Briseno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Ruiz, J.</span><span> </span><span class="NLM_article-title">Quantitative evaluation of MPTP-treated nonhuman parkinsonian primates in the hallway task</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2Fj.jneumeth.2008.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=19022292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2009&pages=361-368&author=A.+Campos-Romoauthor=R.+Ojeda-Floresauthor=P.+Moreno-Brisenoauthor=J.+Fernandez-Ruiz&title=Quantitative+evaluation+of+MPTP-treated+nonhuman+parkinsonian+primates+in+the+hallway+task"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative evaluation of MPTP-treated nonhuman parkinsonian primates in the HALLWAY task</span></div><div class="casAuthors">Campos-Romo, Aurelio; Ojeda-Flores, Rafael; Moreno-Briseno, Pablo; Fernandez-Ruiz, Juan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">361-368</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is a progressive neurodegenerative disorder.  An exptl. model of this disease is produced in nonhuman primates by the administration of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).  In this work, we put forward a new quant. evaluation method that uses video recordings to measure the displacement, gate, gross and fine motor performance of freely moving subjects.  Four Vervet monkeys (Cercopithecus aethiops) were trained in a behavioral observation hallway while being recorded with digital video cameras from four different angles.  After MPTP intoxication the animals were tested without any drug and after 30 and 90 min of Levodopa/Carbidopa administration.  Using a personal computer the following behaviors were measured and evaluated from the video recordings: displacement time across the hallway, reaching time towards rewards, ingestion time, no. of attempts to obtain rewards, no. of rewards obtained, and level of the highest shelf reached for rewards.  Our results show that there was an overall behavioral deterioration after MPTP administration and an overall improvement after Levodopa/Carbidopa treatment.  This demonstrates that the HALLWAY task is a sensitive and objective method that allows detailed behavioral evaluation of freely moving monkeys in the MPTP Parkinson's disease model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruYimo678roLVg90H21EOLACvtfcHk0lgFJp33jrqEpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFeisQ%253D%253D&md5=e824a38d96e1e6d37bac316822174a89</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2008.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2008.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DCampos-Romo%26aufirst%3DA.%26aulast%3DOjeda-Flores%26aufirst%3DR.%26aulast%3DMoreno-Briseno%26aufirst%3DP.%26aulast%3DFernandez-Ruiz%26aufirst%3DJ.%26atitle%3DQuantitative%2520evaluation%2520of%2520MPTP-treated%2520nonhuman%2520parkinsonian%2520primates%2520in%2520the%2520hallway%2520task%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2009%26volume%3D177%26spage%3D361%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Kraus, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sy, J. O.</span><span> </span><span class="NLM_article-title">A synthetic approach to rocaglamide via reductive cyclization of δ-keto nitriles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00262a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=77-83&author=G.+A.+Krausauthor=J.+O.+Sy&title=A+synthetic+approach+to+rocaglamide+via+reductive+cyclization+of+%CE%B4-keto+nitriles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo00262a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00262a022%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DG.%2BA.%26aulast%3DSy%26aufirst%3DJ.%2BO.%26atitle%3DA%2520synthetic%2520approach%2520to%2520rocaglamide%2520via%2520reductive%2520cyclization%2520of%2520%25CE%25B4-keto%2520nitriles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1989%26volume%3D54%26spage%3D77%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Heintzelman, G. R.; Bullington, J. L.; Rupert, K. C.</span><span> </span><span class="NLM_article-title">Preparation of Arylindenopyridines and Arylindenopyrimidines and Their Use as Adenosine A<sub>2a</sub> Receptor Antagonists</span>. PCT Int. Appl. WO 2005042500,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=G.+R.+Heintzelman&author=J.+L.+Bullington&author=K.+C.+Rupert&title=Preparation+of+Arylindenopyridines+and+Arylindenopyrimidines+and+Their+Use+as+Adenosine+A2a+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHeintzelman%26aufirst%3DG.%2BR.%26atitle%3DPreparation%2520of%2520Arylindenopyridines%2520and%2520Arylindenopyrimidines%2520and%2520Their%2520Use%2520as%2520Adenosine%2520A2a%2520Receptor%2520Antagonists%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebeskind, L. S.</span><span> </span><span class="NLM_article-title">Copper-mediated, palladium-catalyzed coupling of thiol ester with aliphatic organoboron reagents</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3554</span><span class="NLM_x">–</span> <span class="NLM_lpage">3557</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo049964p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=3554-3557&author=Y.+Yuauthor=L.+S.+Liebeskind&title=Copper-mediated%2C+palladium-catalyzed+coupling+of+thiol+ester+with+aliphatic+organoboron+reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1021%2Fjo049964p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049964p%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DLiebeskind%26aufirst%3DL.%2BS.%26atitle%3DCopper-mediated%252C%2520palladium-catalyzed%2520coupling%2520of%2520thiol%2520ester%2520with%2520aliphatic%2520organoboron%2520reagents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D3554%26epage%3D3557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kusturin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebeskind, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sample, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srogl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, W. L.</span><span> </span><span class="NLM_article-title">Switchable catalysis: modular synthesis of functionalized pyrimidones via selective sulfide and halide cross-coupling chemistry</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4349</span><span class="NLM_x">–</span> <span class="NLM_lpage">4352</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol035649y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=4349-4352&author=C.+Kusturinauthor=L.+S.+Liebeskindauthor=H.+Rahmanauthor=K.+Sampleauthor=B.+Schweitzerauthor=J.+Sroglauthor=W.+L.+Neumann&title=Switchable+catalysis%3A+modular+synthesis+of+functionalized+pyrimidones+via+selective+sulfide+and+halide+cross-coupling+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1021%2Fol035649y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol035649y%26sid%3Dliteratum%253Aachs%26aulast%3DKusturin%26aufirst%3DC.%26aulast%3DLiebeskind%26aufirst%3DL.%2BS.%26aulast%3DRahman%26aufirst%3DH.%26aulast%3DSample%26aufirst%3DK.%26aulast%3DSchweitzer%26aufirst%3DB.%26aulast%3DSrogl%26aufirst%3DJ.%26aulast%3DNeumann%26aufirst%3DW.%2BL.%26atitle%3DSwitchable%2520catalysis%253A%2520modular%2520synthesis%2520of%2520functionalized%2520pyrimidones%2520via%2520selective%2520sulfide%2520and%2520halide%2520cross-coupling%2520chemistry%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D4349%26epage%3D4352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Liebeskind, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srogl, J.</span><span> </span><span class="NLM_article-title">Heteroaromatic thioether−boronic acid cross-coupling under neutral reaction conditions</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0200091" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=979-981&author=L.+S.+Liebeskindauthor=J.+Srogl&title=Heteroaromatic+thioether%E2%88%92boronic+acid+cross-coupling+under+neutral+reaction+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1021%2Fol0200091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0200091%26sid%3Dliteratum%253Aachs%26aulast%3DLiebeskind%26aufirst%3DL.%2BS.%26aulast%3DSrogl%26aufirst%3DJ.%26atitle%3DHeteroaromatic%2520thioether%25E2%2588%2592boronic%2520acid%2520cross-coupling%2520under%2520neutral%2520reaction%2520conditions%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D979%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Hyttel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span> </span><span class="NLM_article-title">Recptor-binding profiles of neuroleptics</span> <span class="citation_source-journal">Psychopharmacol. Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1007%2F978-3-642-70140-5_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=2860665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaL2MXlvVyrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1985&pages=9-18&author=J.+Hyttelauthor=J.+J.+Larsenauthor=A.+V.+Christensenauthor=J.+Arnt&title=Recptor-binding+profiles+of+neuroleptics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor-binding profiles of neuroleptics</span></div><div class="casAuthors">Hyttel, J.; Larsen, J. J.; Christensen, A. V.; Arnt, J.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology, Supplementum</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">Dyskinesia</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">PSSUE5</span>;
        ISSN:<span class="NLM_cas:issn">0179-8456</span>.
    </div><div class="casAbstract">A review with 33 refs. of the dopaminergic receptor binding blockade by neuroleptics in relation to antipsychotic activity and side-effects of neuroleptics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBA2EApKaKZ7Vg90H21EOLACvtfcHk0lgFJp33jrqEpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlvVyrurk%253D&md5=fb425b1ed020812fdd72f602a9e398e4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-70140-5_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-70140-5_2%26sid%3Dliteratum%253Aachs%26aulast%3DHyttel%26aufirst%3DJ.%26aulast%3DLarsen%26aufirst%3DJ.%2BJ.%26aulast%3DChristensen%26aufirst%3DA.%2BV.%26aulast%3DArnt%26aufirst%3DJ.%26atitle%3DRecptor-binding%2520profiles%2520of%2520neuroleptics%26jtitle%3DPsychopharmacol.%2520Suppl.%26date%3D1985%26volume%3D2%26spage%3D9%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptors modify motor function in MPTP-treated common marmosets</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2857</span><span class="NLM_x">–</span> <span class="NLM_lpage">2860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=2857-2860&author=T.+Kandaauthor=T.+Tashiroauthor=Y.+Kuwanaauthor=P.+Jenner&title=Adenosine+A2A+receptors+modify+motor+function+in+MPTP-treated+common+marmosets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DT.%26aulast%3DTashiro%26aufirst%3DT.%26aulast%3DKuwana%26aufirst%3DY.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DAdenosine%2520A2A%2520receptors%2520modify%2520motor%2520function%2520in%2520MPTP-treated%2520common%2520marmosets%26jtitle%3DNeuroReport%26date%3D1998%26volume%3D9%26spage%3D2857%26epage%3D2860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grondin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadj, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregoire, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span> </span><span class="NLM_article-title">Antiparkinsonian effect of a new selective adenosine A<sub>2A</sub> receptor antagonist in MPTP-treated monkeys</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=1673-1677&author=R.+Grondinauthor=P.+J.+Bedardauthor=T.+A.+Hadjauthor=L.+Gregoireauthor=A.+Moriauthor=H.+Kase&title=Antiparkinsonian+effect+of+a+new+selective+adenosine+A2A+receptor+antagonist+in+MPTP-treated+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrondin%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DP.%2BJ.%26aulast%3DHadj%26aufirst%3DT.%2BA.%26aulast%3DGregoire%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DKase%26aufirst%3DH.%26atitle%3DAntiparkinsonian%2520effect%2520of%2520a%2520new%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonist%2520in%2520MPTP-treated%2520monkeys%26jtitle%3DNeurology%26date%3D1999%26volume%3D52%26spage%3D1673%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bara-Jimenez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherzai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouradian, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonist treatment of Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=293-296&author=W.+Bara-Jimenezauthor=A.+Sherzaiauthor=T.+Dimitrovaauthor=A.+Favitauthor=F.+Bibbianiauthor=M.+Gillespieauthor=M.+J.+Morrisauthor=M.+M.+Mouradianauthor=T.+N.+Chase&title=Adenosine+A2A+receptor+antagonist+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBara-Jimenez%26aufirst%3DW.%26aulast%3DSherzai%26aufirst%3DA.%26aulast%3DDimitrova%26aufirst%3DT.%26aulast%3DFavit%26aufirst%3DA.%26aulast%3DBibbiani%26aufirst%3DF.%26aulast%3DGillespie%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonist%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D293%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hauser, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubble, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, D. D.</span><span> </span><span class="NLM_article-title">Randomized trial of the adenosine A<sub>2A</sub> receptor antagonist istradefylline in advanced PD</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=297-303&author=R.+A.+Hauserauthor=J.+P.+Hubbleauthor=D.+D.+Truong&title=Randomized+trial+of+the+adenosine+A2A+receptor+antagonist+istradefylline+in+advanced+PD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DHubble%26aufirst%3DJ.%2BP.%26aulast%3DTruong%26aufirst%3DD.%2BD.%26atitle%3DRandomized%2520trial%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520antagonist%2520istradefylline%2520in%2520advanced%2520PD%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D297%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marsden, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolphin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvoisin, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarsy, D.</span><span> </span><span class="NLM_article-title">Role of noradrenaline in levodopa reversal of reserpine akinesia</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2F0006-8993%2874%2990643-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaE2MXlsVA%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1974&pages=521-525&author=C.+D.+Marsdenauthor=A.+Dolphinauthor=R.+C.+Duvoisinauthor=P.+Jennerauthor=D.+Tarsy&title=Role+of+noradrenaline+in+levodopa+reversal+of+reserpine+akinesia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of noradrenaline in levodopa reversal of reserpine akinesia</span></div><div class="casAuthors">Marsden, C. D.; Dolphin, A.; Duvoisin, R. C.; Jenner, P.; Tarsy, D.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">521-5</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Pretreatment of reserpinized rats with 25 mg FLA-63/kg, a dopamine β-hydroxylase inhibitor, or with 20 mg phenoxybenzamine/kg, a noradrenaline (I) [51-41-2] receptor blocker, decreased the levodopa [59-92-7] (500 mg/kg) reversal of akinesia induced by reserpine [50-55-5].  Some spontaneous activity did occur after levodopa administration in animals pretreated with FLA-63 or phenoxybenzamine but this activity was unlike that of reserpinized animals treated with levodopa alone.  Other compds. which blocked both central dopamine [51-61-6] and I receptors in the brain also decreased the levodopa effect, whereas pimozide, which primarily blocks only dopamine receptors, had no effect on the response to levodopa.  Thus, levodopa reversal of reserpine akinesia may require the formation of  I as well as dopamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQMLyHwjYI7rVg90H21EOLACvtfcHk0lhjVLdkN81_yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXlsVA%253D&md5=68b938889d6e3945f83bbcaa2539642c</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2874%2990643-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252874%252990643-X%26sid%3Dliteratum%253Aachs%26aulast%3DMarsden%26aufirst%3DC.%2BD.%26aulast%3DDolphin%26aufirst%3DA.%26aulast%3DDuvoisin%26aufirst%3DR.%2BC.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DTarsy%26aufirst%3DD.%26atitle%3DRole%2520of%2520noradrenaline%2520in%2520levodopa%2520reversal%2520of%2520reserpine%2520akinesia%26jtitle%3DBrain%2520Res.%26date%3D1974%26volume%3D17%26spage%3D521%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Starr, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, B. S.</span><span> </span><span class="NLM_article-title">Comparison of the effects NMDA and AMPA antagonist on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1994&pages=495-504&author=M.+S.+Starrauthor=B.+S.+Starr&title=Comparison+of+the+effects+NMDA+and+AMPA+antagonist+on+the+locomotor+activity+induced+by+selective+D1+and+D2+dopamine+agonists+in+reserpine-treated+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStarr%26aufirst%3DM.%2BS.%26aulast%3DStarr%26aufirst%3DB.%2BS.%26atitle%3DComparison%2520of%2520the%2520effects%2520NMDA%2520and%2520AMPA%2520antagonist%2520on%2520the%2520locomotor%2520activity%2520induced%2520by%2520selective%2520D1%2520and%2520D2%2520dopamine%2520agonists%2520in%2520reserpine-treated%2520mice%26jtitle%3DPsychopharmacology%26date%3D1994%26volume%3D114%26spage%3D495%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Robinson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. B.</span><span> </span><span class="NLM_article-title">The rotational behavior model: asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2F0006-8993%2883%2991129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=6405975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaL3sXitV2rtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1983&pages=127-131&author=T.+E.+Robinsonauthor=J.+B.+Becker&title=The+rotational+behavior+model%3A+asymmetry+in+the+effects+of+unilateral+6-OHDA+lesions+of+the+substantia+nigra+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The rotational behavior model:  asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats</span></div><div class="casAuthors">Robinson, Terry E.; Becker, Jill B.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-31</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The d-amphetamine  [51-64-9]-induced rotational behavior of rats with dopamine  [51-61-6] depletion in the dominant striatum was in the opposite direction of that obsd. in rats with damage to the nondominant striatum.  Thus, when using the 6-hydroxydopamine (6-OHDA) lesion rotation model, the intrinsic asymmetry in the nigrostriatal dopaminergic system should be taken into consideration with respect to the side of lesion placement, since different results may be obtained depending on the side of the lesion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG7YxiJKMBTbVg90H21EOLACvtfcHk0lhjVLdkN81_yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitV2rtbg%253D&md5=b90687387f1f528f0b5ed09e84084344</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2883%2991129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252883%252991129-0%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DT.%2BE.%26aulast%3DBecker%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520rotational%2520behavior%2520model%253A%2520asymmetry%2520in%2520the%2520effects%2520of%2520unilateral%25206-OHDA%2520lesions%2520of%2520the%2520substantia%2520nigra%2520in%2520rats%26jtitle%3DBrain%2520Res.%26date%3D1983%26volume%3D264%26spage%3D127%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Damier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graybiel, A. M.</span><span> </span><span class="NLM_article-title">The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1437</span><span class="NLM_x">–</span> <span class="NLM_lpage">1448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1999&pages=1437-1448&author=P.+Damierauthor=E.+C.+Hirschauthor=Y.+Agidauthor=A.+M.+Graybiel&title=The+substantia+nigra+of+the+human+brain.+II.+Patterns+of+loss+of+dopamine-containing+neurons+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDamier%26aufirst%3DP.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DAgid%26aufirst%3DY.%26aulast%3DGraybiel%26aufirst%3DA.%2BM.%26atitle%3DThe%2520substantia%2520nigra%2520of%2520the%2520human%2520brain.%2520II.%2520Patterns%2520of%2520loss%2520of%2520dopamine-containing%2520neurons%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D1999%26volume%3D122%26spage%3D1437%26epage%3D1448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b','cit8c','cit8d'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c','cit14d'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b','cit16c'],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b','cit24c'],'ref25':['cit25a','cit25b','cit25c'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b','cit28c'],'ref29':['cit29'],'ref30':['cit30a','cit30b'],'ref31':['cit31a','cit31b'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 40 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John R.  Atack</span>, <span class="hlFld-ContribAuthor ">Brian C.  Shook</span>, <span class="hlFld-ContribAuthor ">Stefanie  Rassnick</span>, <span class="hlFld-ContribAuthor ">Paul F.  Jackson</span>, <span class="hlFld-ContribAuthor ">Kenneth  Rhodes</span>, <span class="hlFld-ContribAuthor ">Wilhelmus H.  Drinkenburg</span>, <span class="hlFld-ContribAuthor ">Abdallah  Ahnaou</span>, <span class="hlFld-ContribAuthor ">Paula  te Riele</span>, <span class="hlFld-ContribAuthor ">Xavier  Langlois</span>, <span class="hlFld-ContribAuthor ">Brian  Hrupka</span>, <span class="hlFld-ContribAuthor ">Patrick  De Haes</span>, <span class="hlFld-ContribAuthor ">Herman  Hendrickx</span>, <span class="hlFld-ContribAuthor ">Nancy  Aerts</span>, <span class="hlFld-ContribAuthor ">Koen  Hens</span>, <span class="hlFld-ContribAuthor ">Annemie  Wellens</span>, <span class="hlFld-ContribAuthor ">Jef  Vermeire</span>, and <span class="hlFld-ContribAuthor ">Anton A. H. P.  Megens</span>  . </span><span class="cited-content_cbyCitation_article-title">JNJ-40255293, a Novel Adenosine A2A/A1 Antagonist with Efficacy in Preclinical Models of Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2014,</strong> <em>5 </em>
                                    (10)
                                     , 1005-1019. <a href="https://doi.org/10.1021/cn5001606" title="DOI URL">https://doi.org/10.1021/cn5001606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn5001606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn5001606%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DJNJ-40255293%25252C%252Ba%252BNovel%252BAdenosine%252BA2A%25252FA1%252BAntagonist%252Bwith%252BEfficacy%252Bin%252BPreclinical%252BModels%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DAtack%26aufirst%3DJohn%2BR.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D27072014%26date%3D08092014%26date%3D24092014%26date%3D15102014%26date%3D09092014%26volume%3D5%26issue%3D10%26spage%3D1005%26epage%3D1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  de Lera Ruiz</span>, <span class="hlFld-ContribAuthor ">Yeon-Hee  Lim</span>, and <span class="hlFld-ContribAuthor ">Junying  Zheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Adenosine A2A Receptor as a Drug Discovery Target. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (9)
                                     , 3623-3650. <a href="https://doi.org/10.1021/jm4011669" title="DOI URL">https://doi.org/10.1021/jm4011669</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4011669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4011669%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdenosine%252BA2A%252BReceptor%252Bas%252Ba%252BDrug%252BDiscovery%252BTarget%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DManuel%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D31072013%26date%3D15112013%26date%3D08052014%26date%3D28102013%26volume%3D57%26issue%3D9%26spage%3D3623%26epage%3D3650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian C.  Shook</span>, <span class="hlFld-ContribAuthor ">Stefanie  Rassnick</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Wallace</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Crooke</span>, <span class="hlFld-ContribAuthor ">Mark  Ault</span>, <span class="hlFld-ContribAuthor ">Devraj  Chakravarty</span>, <span class="hlFld-ContribAuthor ">J. Kent  Barbay</span>, <span class="hlFld-ContribAuthor ">Aihua  Wang</span>, <span class="hlFld-ContribAuthor ">Mark T.  Powell</span>, <span class="hlFld-ContribAuthor ">Kristi  Leonard</span>, <span class="hlFld-ContribAuthor ">Vernon  Alford</span>, <span class="hlFld-ContribAuthor ">Robert H.  Scannevin</span>, <span class="hlFld-ContribAuthor ">Karen  Carroll</span>, <span class="hlFld-ContribAuthor ">Lisa  Lampron</span>, <span class="hlFld-ContribAuthor ">Lori  Westover</span>, <span class="hlFld-ContribAuthor ">Heng-Keang  Lim</span>, <span class="hlFld-ContribAuthor ">Ronald  Russell</span>, <span class="hlFld-ContribAuthor ">Shawn  Branum</span>, <span class="hlFld-ContribAuthor ">Kenneth M.  Wells</span>, <span class="hlFld-ContribAuthor ">Sandra  Damon</span>, <span class="hlFld-ContribAuthor ">Scott  Youells</span>, <span class="hlFld-ContribAuthor ">Xun  Li</span>, <span class="hlFld-ContribAuthor ">Derek A.  Beauchamp</span>, <span class="hlFld-ContribAuthor ">Kenneth  Rhodes</span>, and <span class="hlFld-ContribAuthor ">Paul F.  Jackson</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Characterization of Optimized Adenosine A2A/A1 Receptor Antagonists for the Treatment of Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (3)
                                     , 1402-1417. <a href="https://doi.org/10.1021/jm201640m" title="DOI URL">https://doi.org/10.1021/jm201640m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201640m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201640m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BCharacterization%252Bof%252BOptimized%252BAdenosine%252BA2A%25252FA1%252BReceptor%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%252527s%252BDisease%26aulast%3DShook%26aufirst%3DBrian%2BC.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D02122011%26date%3D26012012%26date%3D09022012%26date%3D12012012%26volume%3D55%26issue%3D3%26spage%3D1402%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian C.  Shook</span> and <span class="hlFld-ContribAuthor ">Paul F.  Jackson</span>  . </span><span class="cited-content_cbyCitation_article-title">Adenosine A2A Receptor Antagonists and Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2011,</strong> <em>2 </em>
                                    (10)
                                     , 555-567. <a href="https://doi.org/10.1021/cn2000537" title="DOI URL">https://doi.org/10.1021/cn2000537</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn2000537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn2000537%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DAdenosine%252BA2A%252BReceptor%252BAntagonists%252Band%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DShook%26aufirst%3DBrian%2BC.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D07062011%26date%3D21062011%26date%3D05072011%26date%3D19102011%26date%3D21062011%26volume%3D2%26issue%3D10%26spage%3D555%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabelle  Waku</span>, <span class="hlFld-ContribAuthor ">Mylena S.  Magalhães</span>, <span class="hlFld-ContribAuthor ">Camila O.  Alves</span>, <span class="hlFld-ContribAuthor ">Amanda R.  de Oliveira</span>. </span><span class="cited-content_cbyCitation_article-title">Haloperidol‐induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Neuroscience</span><span> <strong>2021,</strong> <em>53 </em>
                                    (11)
                                     , 3743-3767. <a href="https://doi.org/10.1111/ejn.15222" title="DOI URL">https://doi.org/10.1111/ejn.15222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/ejn.15222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fejn.15222%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Neuroscience%26atitle%3DHaloperidol%2525E2%252580%252590induced%252Bcatalepsy%252Bas%252Ban%252Banimal%252Bmodel%252Bfor%252Bparkinsonism%25253A%252BA%252Bsystematic%252Breview%252Bof%252Bexperimental%252Bstudies%26aulast%3DWaku%26aufirst%3DIsabelle%26date%3D2021%26date%3D2021%26volume%3D53%26issue%3D11%26spage%3D3743%26epage%3D3767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dandong  Hu</span>, <span class="hlFld-ContribAuthor ">Yujuan  Cui</span>, <span class="hlFld-ContribAuthor ">Ji  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Nervonic acid amends motor disorder in a mouse model of Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Translational Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 237-246. <a href="https://doi.org/10.1515/tnsci-2020-0171" title="DOI URL">https://doi.org/10.1515/tnsci-2020-0171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/tnsci-2020-0171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Ftnsci-2020-0171%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Neuroscience%26atitle%3DNervonic%252Bacid%252Bamends%252Bmotor%252Bdisorder%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DHu%26aufirst%3DDandong%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1%26spage%3D237%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mukuo  Wang</span>, <span class="hlFld-ContribAuthor ">Shujing  Hou</span>, <span class="hlFld-ContribAuthor ">Yu  Wei</span>, <span class="hlFld-ContribAuthor ">Dongmei  Li</span>, <span class="hlFld-ContribAuthor ">Jianping  Lin</span>, . </span><span class="cited-content_cbyCitation_article-title">Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking. </span><span class="cited-content_cbyCitation_journal-name">PLOS Computational Biology</span><span> <strong>2021,</strong> <em>17 </em>
                                    (3)
                                     , e1008821. <a href="https://doi.org/10.1371/journal.pcbi.1008821" title="DOI URL">https://doi.org/10.1371/journal.pcbi.1008821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pcbi.1008821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pcbi.1008821%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Computational%2520Biology%26atitle%3DDiscovery%252Bof%252Bnovel%252Bdual%252Badenosine%252BA1%25252FA2A%252Breceptor%252Bantagonists%252Busing%252Bdeep%252Blearning%25252C%252Bpharmacophore%252Bmodeling%252Band%252Bmolecular%252Bdocking%26aulast%3DWang%26aufirst%3DMukuo%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D3%26spage%3De1008821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navjot  Kaur</span>, <span class="hlFld-ContribAuthor ">Pratibha  Singh</span>, <span class="hlFld-ContribAuthor ">Pawandeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Ajar Nath  Yadav</span>, <span class="hlFld-ContribAuthor ">Karan  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">One‐pot multicomponent synthesis and antimicrobial evaluation of novel tricyclic indenopyrimidine‐2‐amines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (10)
                                     , 3622-3631. <a href="https://doi.org/10.1002/jhet.4081" title="DOI URL">https://doi.org/10.1002/jhet.4081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4081%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DOne%2525E2%252580%252590pot%252Bmulticomponent%252Bsynthesis%252Band%252Bantimicrobial%252Bevaluation%252Bof%252Bnovel%252Btricyclic%252Bindenopyrimidine%2525E2%252580%2525902%2525E2%252580%252590amines%26aulast%3DKaur%26aufirst%3DNavjot%26date%3D2020%26date%3D2020%26volume%3D57%26issue%3D10%26spage%3D3622%26epage%3D3631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navjot  Kaur</span>, <span class="hlFld-ContribAuthor ">Anil  Kumar</span>, <span class="hlFld-ContribAuthor ">Karan  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel Indenopyrimidine Sulfonamides from Indenopyrimidine-2-Amines via S–N Bond Formation. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2020,</strong> <em>124 </em>, 1-14. <a href="https://doi.org/10.1080/10406638.2020.1809470" title="DOI URL">https://doi.org/10.1080/10406638.2020.1809470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2020.1809470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2020.1809470%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DSynthesis%252Bof%252BNovel%252BIndenopyrimidine%252BSulfonamides%252Bfrom%252BIndenopyrimidine-2-Amines%252Bvia%252BS%2525E2%252580%252593N%252BBond%252BFormation%26aulast%3DKaur%26aufirst%3DNavjot%26date%3D2020%26date%3D2020%26volume%3D124%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Kasabova-Angelova</span>, <span class="hlFld-ContribAuthor ">Diana  Tzankova</span>, <span class="hlFld-ContribAuthor ">Javor  Mitkov</span>, <span class="hlFld-ContribAuthor ">Maya  Georgieva</span>, <span class="hlFld-ContribAuthor ">Virginia  Tzankova</span>, <span class="hlFld-ContribAuthor ">Alexander  Zlatkov</span>, <span class="hlFld-ContribAuthor ">Magdalena  Kondeva-Burdina</span>. </span><span class="cited-content_cbyCitation_article-title">Xanthine Derivatives as Agents Affecting Non-dopaminergic Neuroprotection in Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (12)
                                     , 2021-2036. <a href="https://doi.org/10.2174/0929867325666180821153316" title="DOI URL">https://doi.org/10.2174/0929867325666180821153316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180821153316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180821153316%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DXanthine%252BDerivatives%252Bas%252BAgents%252BAffecting%252BNon-dopaminergic%252BNeuroprotection%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DKasabova-Angelova%26aufirst%3DAlexandra%26date%3D2020%26volume%3D27%26issue%3D12%26spage%3D2021%26epage%3D2036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helena D.  Janse van Rensburg</span>, <span class="hlFld-ContribAuthor ">Lesetja J.  Legoabe</span>, <span class="hlFld-ContribAuthor ">Gisella  Terre'Blanche</span>, <span class="hlFld-ContribAuthor ">Janine  Aucamp</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of methoxy substituted 2-benzoyl-1-benzofuran derivatives as lead compounds for the development adenosine A1 and/or A2A receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103459. <a href="https://doi.org/10.1016/j.bioorg.2019.103459" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103459%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bmethoxy%252Bsubstituted%252B2-benzoyl-1-benzofuran%252Bderivatives%252Bas%252Blead%252Bcompounds%252Bfor%252Bthe%252Bdevelopment%252Badenosine%252BA1%252Band%25252For%252BA2A%252Breceptor%252Bantagonists%26aulast%3DJanse%2Bvan%2BRensburg%26aufirst%3DHelena%2BD.%26date%3D2020%26volume%3D94%26spage%3D103459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aliaa  Abdelrahman</span>, <span class="hlFld-ContribAuthor ">Swapnil G.  Yerande</span>, <span class="hlFld-ContribAuthor ">Vigneshwaran  Namasivayam</span>, <span class="hlFld-ContribAuthor ">Tim A.  Klapschinski</span>, <span class="hlFld-ContribAuthor ">Mohamad Wessam  Alnouri</span>, <span class="hlFld-ContribAuthor ">Ali  El-Tayeb</span>, <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted 4-phenylthiazoles: Development of potent and selective A1, A3 and dual A1/A3 adenosine receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111879. <a href="https://doi.org/10.1016/j.ejmech.2019.111879" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111879</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111879%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSubstituted%252B4-phenylthiazoles%25253A%252BDevelopment%252Bof%252Bpotent%252Band%252Bselective%252BA1%25252C%252BA3%252Band%252Bdual%252BA1%25252FA3%252Badenosine%252Breceptor%252Bantagonists%26aulast%3DAbdelrahman%26aufirst%3DAliaa%26date%3D2020%26volume%3D186%26spage%3D111879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Celorrio</span>, <span class="hlFld-ContribAuthor ">Estefanía  Rojo-Bustamante</span>, <span class="hlFld-ContribAuthor ">Diana  Fernández-Suárez</span>, <span class="hlFld-ContribAuthor ">Elena  Sáez</span>, <span class="hlFld-ContribAuthor ">Ander  Estella-Hermoso de Mendoza</span>, <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>, <span class="hlFld-ContribAuthor ">María J.  Ramírez</span>, <span class="hlFld-ContribAuthor ">Julen  Oyarzábal</span>, <span class="hlFld-ContribAuthor ">Rafael  Franco</span>, <span class="hlFld-ContribAuthor ">María S.  Aymerich</span>. </span><span class="cited-content_cbyCitation_article-title">GPR55: A therapeutic target for Parkinson's disease?. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2017,</strong> <em>125 </em>, 319-332. <a href="https://doi.org/10.1016/j.neuropharm.2017.08.017" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.08.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.08.017%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DGPR55%25253A%252BA%252Btherapeutic%252Btarget%252Bfor%252BParkinson%252527s%252Bdisease%25253F%26aulast%3DCelorrio%26aufirst%3DMarta%26date%3D2017%26volume%3D125%26spage%3D319%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young-Hyun  Kim</span>, <span class="hlFld-ContribAuthor ">Sang-Je  Park</span>, <span class="hlFld-ContribAuthor ">Se-Hee  Choe</span>, <span class="hlFld-ContribAuthor ">Ja-Rang  Lee</span>, <span class="hlFld-ContribAuthor ">Hyeon-Mu  Cho</span>, <span class="hlFld-ContribAuthor ">Sun-Uk  Kim</span>, <span class="hlFld-ContribAuthor ">Ji-Su  Kim</span>, <span class="hlFld-ContribAuthor ">Bo-Woong  Sim</span>, <span class="hlFld-ContribAuthor ">Bong-Seok  Song</span>, <span class="hlFld-ContribAuthor ">Youngjeon  Lee</span>, <span class="hlFld-ContribAuthor ">Yeung Bae  Jin</span>, <span class="hlFld-ContribAuthor ">Jung-Joo  Hong</span>, <span class="hlFld-ContribAuthor ">Kang-Jin  Jeong</span>, <span class="hlFld-ContribAuthor ">Philyong  Kang</span>, <span class="hlFld-ContribAuthor ">Seung-Ho  Baek</span>, <span class="hlFld-ContribAuthor ">Sang-Rae  Lee</span>, <span class="hlFld-ContribAuthor ">Jae-Won  Huh</span>, <span class="hlFld-ContribAuthor ">Kyu-Tae  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and characterization of the tyrosinase gene ( TYR ) and its transcript variants ( TYR_1 and TYR_2 ) in the crab-eating macaque ( Macaca fascicularis ). </span><span class="cited-content_cbyCitation_journal-name">Gene</span><span> <strong>2017,</strong> <em>630 </em>, 21-27. <a href="https://doi.org/10.1016/j.gene.2017.07.047" title="DOI URL">https://doi.org/10.1016/j.gene.2017.07.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gene.2017.07.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gene.2017.07.047%26sid%3Dliteratum%253Aachs%26jtitle%3DGene%26atitle%3DIdentification%252Band%252Bcharacterization%252Bof%252Bthe%252Btyrosinase%252Bgene%252B%252528%252BTYR%252B%252529%252Band%252Bits%252Btranscript%252Bvariants%252B%252528%252BTYR_1%252Band%252BTYR_2%252B%252529%252Bin%252Bthe%252Bcrab-eating%252Bmacaque%252B%252528%252BMacaca%252Bfascicularis%252B%252529%26aulast%3DKim%26aufirst%3DYoung-Hyun%26date%3D2017%26volume%3D630%26spage%3D21%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan-Juan  Du</span>, <span class="hlFld-ContribAuthor ">Sheng-Di  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Current Nondopaminergic Therapeutic Options for Motor Symptoms of Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name">Chinese Medical Journal</span><span> <strong>2017,</strong> <em>130 </em>
                                    (15)
                                     , 1856-1866. <a href="https://doi.org/10.4103/0366-6999.211555" title="DOI URL">https://doi.org/10.4103/0366-6999.211555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/0366-6999.211555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2F0366-6999.211555%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Medical%2520Journal%26atitle%3DCurrent%252BNondopaminergic%252BTherapeutic%252BOptions%252Bfor%252BMotor%252BSymptoms%252Bof%252BParkinson%252527s%252BDisease%26aulast%3DDu%26aufirst%3DJuan-Juan%26date%3D2017%26volume%3D130%26issue%3D15%26spage%3D1856%26epage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joachim C.  Burbiel</span>, <span class="hlFld-ContribAuthor ">Wadih  Ghattas</span>, <span class="hlFld-ContribAuthor ">Petra  Küppers</span>, <span class="hlFld-ContribAuthor ">Meryem  Köse</span>, <span class="hlFld-ContribAuthor ">Svenja  Lacher</span>, <span class="hlFld-ContribAuthor ">Anna-Maria  Herzner</span>, <span class="hlFld-ContribAuthor ">Rajan Subramanian  Kombu</span>, <span class="hlFld-ContribAuthor ">Raghuram Rao  Akkinepally</span>, <span class="hlFld-ContribAuthor ">Jörg  Hockemeyer</span>, <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">2-Amino[1,2,4]triazolo[1,5
              -c
              ]quinazolines and Derived Novel Heterocycles: Syntheses and Structure-Activity Relationships of Potent Adenosine Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (20)
                                     , 2272-2286. <a href="https://doi.org/10.1002/cmdc.201600255" title="DOI URL">https://doi.org/10.1002/cmdc.201600255</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600255%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3D2-Amino%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5%252B-c%252B%25255Dquinazolines%252Band%252BDerived%252BNovel%252BHeterocycles%25253A%252BSyntheses%252Band%252BStructure-Activity%252BRelationships%252Bof%252BPotent%252BAdenosine%252BReceptor%252BAntagonists%26aulast%3DBurbiel%26aufirst%3DJoachim%2BC.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D20%26spage%3D2272%26epage%3D2286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lien-Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Tsung-Chih  Chen</span>, <span class="hlFld-ContribAuthor ">Shiag-Jiun  Chen</span>, <span class="hlFld-ContribAuthor ">Chun-Liang  Chen</span>, <span class="hlFld-ContribAuthor ">Chia-Chung  Lee</span>, <span class="hlFld-ContribAuthor ">Shih-Hsiung  Wu</span>, <span class="hlFld-ContribAuthor ">Yun  Yen</span>, <span class="hlFld-ContribAuthor ">Hsu-Shan  Huang</span>, <span class="hlFld-ContribAuthor ">Jing-Jer  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a new class of
              WNT1
              inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (42)
                                     , 67986-68001. <a href="https://doi.org/10.18632/oncotarget.6622" title="DOI URL">https://doi.org/10.18632/oncotarget.6622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.6622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.6622%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DIdentification%252Bof%252Ba%252Bnew%252Bclass%252Bof%252BWNT1%252Binhibitor%25253A%252BCancer%252Bcells%252Bmigration%25252C%252BG-quadruplex%252Bstabilization%252Band%252Btarget%252Bvalidation%26aulast%3DChang%26aufirst%3DLien-Cheng%26date%3D2016%26date%3D2015%26volume%3D7%26issue%3D42%26spage%3D67986%26epage%3D68001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Celorrio</span>, <span class="hlFld-ContribAuthor ">Diana  Fernández-Suárez</span>, <span class="hlFld-ContribAuthor ">Estefanía  Rojo-Bustamante</span>, <span class="hlFld-ContribAuthor ">Víctor  Echeverry-Alzate</span>, <span class="hlFld-ContribAuthor ">María J.  Ramírez</span>, <span class="hlFld-ContribAuthor ">Cecilia J.  Hillard</span>, <span class="hlFld-ContribAuthor ">José A.  López-Moreno</span>, <span class="hlFld-ContribAuthor ">Rafael  Maldonado</span>, <span class="hlFld-ContribAuthor ">Julen  Oyarzábal</span>, <span class="hlFld-ContribAuthor ">Rafael  Franco</span>, <span class="hlFld-ContribAuthor ">María S.  Aymerich</span>. </span><span class="cited-content_cbyCitation_article-title">Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Brain, Behavior, and Immunity</span><span> <strong>2016,</strong> <em>57 </em>, 94-105. <a href="https://doi.org/10.1016/j.bbi.2016.06.010" title="DOI URL">https://doi.org/10.1016/j.bbi.2016.06.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbi.2016.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbi.2016.06.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%252C%2520Behavior%252C%2520and%2520Immunity%26atitle%3DFatty%252Bacid%252Bamide%252Bhydrolase%252Binhibition%252Bfor%252Bthe%252Bsymptomatic%252Brelief%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DCelorrio%26aufirst%3DMarta%26date%3D2016%26volume%3D57%26spage%3D94%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Xue</span>, <span class="hlFld-ContribAuthor ">Yu-Ting  Yang</span>, <span class="hlFld-ContribAuthor ">Hong-Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-Fang  Chen</span>, <span class="hlFld-ContribAuthor ">An-Qi  Chen</span>, <span class="hlFld-ContribAuthor ">Qing  Sheng</span>, <span class="hlFld-ContribAuthor ">Xin-Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Hua  Chen</span>, <span class="hlFld-ContribAuthor ">Hong-Xia  Liu</span>, <span class="hlFld-ContribAuthor ">Ya-Yan  Pang</span>, <span class="hlFld-ContribAuthor ">Lei  Chen</span>, . </span><span class="cited-content_cbyCitation_article-title">Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Neuroscience</span><span> <strong>2016,</strong> <em>44 </em>
                                    (5)
                                     , 2247-2257. <a href="https://doi.org/10.1111/ejn.13323" title="DOI URL">https://doi.org/10.1111/ejn.13323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/ejn.13323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fejn.13323%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Neuroscience%26atitle%3DOrexin-A%252Bincreases%252Bthe%252Bactivity%252Bof%252Bglobus%252Bpallidus%252Bneurons%252Bin%252Bboth%252Bnormal%252Band%252Bparkinsonian%252Brats%26aulast%3DXue%26aufirst%3DYan%26date%3D2016%26date%3D2016%26volume%3D44%26issue%3D5%26spage%3D2247%26epage%3D2257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarel J.  Robinson</span>, <span class="hlFld-ContribAuthor ">Jacobus P.  Petzer</span>, <span class="hlFld-ContribAuthor ">Amanda L.  Rousseau</span>, <span class="hlFld-ContribAuthor ">Gisella  Terre’Blanche</span>, <span class="hlFld-ContribAuthor ">Anél  Petzer</span>, <span class="hlFld-ContribAuthor ">Anna C.U.  Lourens</span>. </span><span class="cited-content_cbyCitation_article-title">Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 734-738. <a href="https://doi.org/10.1016/j.bmcl.2016.01.004" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCarbamate%252Bsubstituted%252B2-amino-4%25252C6-diphenylpyrimidines%252Bas%252Badenosine%252Breceptor%252Bantagonists%26aulast%3DRobinson%26aufirst%3DSarel%2BJ.%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D734%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nada  Marquise</span>, <span class="hlFld-ContribAuthor ">Floris  Chevallier</span>, <span class="hlFld-ContribAuthor ">Ekhlas  Nassar</span>, <span class="hlFld-ContribAuthor ">Michel  Frédérich</span>, <span class="hlFld-ContribAuthor ">Allison  Ledoux</span>, <span class="hlFld-ContribAuthor ">Yury S.  Halauko</span>, <span class="hlFld-ContribAuthor ">Oleg A.  Ivashkevich</span>, <span class="hlFld-ContribAuthor ">Vadim E.  Matulis</span>, <span class="hlFld-ContribAuthor ">Thierry  Roisnel</span>, <span class="hlFld-ContribAuthor ">Vincent  Dorcet</span>, <span class="hlFld-ContribAuthor ">Florence  Mongin</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted azafluorenones: access from dihalogeno diaryl ketones by palladium-catalyzed auto-tandem processes and evaluation of their antibacterial, antifungal, antimalarial and antiproliferative activities. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (6)
                                     , 825-836. <a href="https://doi.org/10.1016/j.tet.2015.12.050" title="DOI URL">https://doi.org/10.1016/j.tet.2015.12.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.12.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.12.050%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSubstituted%252Bazafluorenones%25253A%252Baccess%252Bfrom%252Bdihalogeno%252Bdiaryl%252Bketones%252Bby%252Bpalladium-catalyzed%252Bauto-tandem%252Bprocesses%252Band%252Bevaluation%252Bof%252Btheir%252Bantibacterial%25252C%252Bantifungal%25252C%252Bantimalarial%252Band%252Bantiproliferative%252Bactivities%26aulast%3DMarquise%26aufirst%3DNada%26date%3D2016%26volume%3D72%26issue%3D6%26spage%3D825%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarel J.  Robinson</span>, <span class="hlFld-ContribAuthor ">Jacobus P.  Petzer</span>, <span class="hlFld-ContribAuthor ">Gisella  Terre’Blanche</span>, <span class="hlFld-ContribAuthor ">Anél  Petzer</span>, <span class="hlFld-ContribAuthor ">Mietha M.  van der Walt</span>, <span class="hlFld-ContribAuthor ">Jacobus J.  Bergh</span>, <span class="hlFld-ContribAuthor ">Anna C.U.  Lourens</span>. </span><span class="cited-content_cbyCitation_article-title">2-Aminopyrimidines as dual adenosine A1/A2A antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>104 </em>, 177-188. <a href="https://doi.org/10.1016/j.ejmech.2015.09.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.09.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.09.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Aminopyrimidines%252Bas%252Bdual%252Badenosine%252BA1%25252FA2A%252Bantagonists%26aulast%3DRobinson%26aufirst%3DSarel%2BJ.%26date%3D2015%26volume%3D104%26spage%3D177%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Delia  Preti</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Allan R.  Moorman</span>, <span class="hlFld-ContribAuthor ">Pier Andrea  Borea</span>, <span class="hlFld-ContribAuthor ">Katia  Varani</span>. </span><span class="cited-content_cbyCitation_article-title">History and Perspectives of A
              2A
              Adenosine Receptor Antagonists as Potential Therapeutic Agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2015,</strong> <em>35 </em>
                                    (4)
                                     , 790-848. <a href="https://doi.org/10.1002/med.21344" title="DOI URL">https://doi.org/10.1002/med.21344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21344%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DHistory%252Band%252BPerspectives%252Bof%252BA%252B2A%252BAdenosine%252BReceptor%252BAntagonists%252Bas%252BPotential%252BTherapeutic%252BAgents%26aulast%3DPreti%26aufirst%3DDelia%26date%3D2015%26date%3D2015%26volume%3D35%26issue%3D4%26spage%3D790%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anderson H.F.F.  Leão</span>, <span class="hlFld-ContribAuthor ">Aldair J.  Sarmento-Silva</span>, <span class="hlFld-ContribAuthor ">José R.  Santos</span>, <span class="hlFld-ContribAuthor ">Alessandra M.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Regina H.  Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model. </span><span class="cited-content_cbyCitation_journal-name">Brain Pathology</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 377-390. <a href="https://doi.org/10.1111/bpa.12253" title="DOI URL">https://doi.org/10.1111/bpa.12253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bpa.12253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbpa.12253%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Pathology%26atitle%3DMolecular%25252C%252BNeurochemical%25252C%252Band%252BBehavioral%252BHallmarks%252Bof%252BReserpine%252Bas%252Ba%252BModel%252Bfor%252BParkinson%252527s%252BDisease%25253A%252BNew%252BPerspectives%252Bto%252Ba%252BLong-Standing%252BModel%26aulast%3DLe%25C3%25A3o%26aufirst%3DAnderson%2BH.F.F.%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D377%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frank T  Zindo</span>, <span class="hlFld-ContribAuthor ">Jacques  Joubert</span>, <span class="hlFld-ContribAuthor ">Sarel F  Malan</span>. </span><span class="cited-content_cbyCitation_article-title">Propargylamine as functional moiety in the design of multifunctional drugs for neurodegenerative disorders: MAO inhibition and beyond. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (5)
                                     , 609-629. <a href="https://doi.org/10.4155/fmc.15.12" title="DOI URL">https://doi.org/10.4155/fmc.15.12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.15.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.15.12%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DPropargylamine%252Bas%252Bfunctional%252Bmoiety%252Bin%252Bthe%252Bdesign%252Bof%252Bmultifunctional%252Bdrugs%252Bfor%252Bneurodegenerative%252Bdisorders%25253A%252BMAO%252Binhibition%252Band%252Bbeyond%26aulast%3DZindo%26aufirst%3DFrank%2BT%26date%3D2015%26volume%3D7%26issue%3D5%26spage%3D609%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annalisa  Pinna</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine A2A Receptor Antagonists as Drugs for Symptomatic Control of Parkinson’s Disease in Preclinical Studies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 127-148. <a href="https://doi.org/10.1007/978-3-319-20273-0_7" title="DOI URL">https://doi.org/10.1007/978-3-319-20273-0_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-20273-0_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-20273-0_7%26sid%3Dliteratum%253Aachs%26atitle%3DAdenosine%252BA2A%252BReceptor%252BAntagonists%252Bas%252BDrugs%252Bfor%252BSymptomatic%252BControl%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%252Bin%252BPreclinical%252BStudies%26aulast%3DPinna%26aufirst%3DAnnalisa%26date%3D2015%26date%3D2015%26spage%3D127%26epage%3D148%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BAdenosinergic%252BSystem%26aulast%3DMorelli%26aufirst%3DMicaela%26date%3D2015%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wojciech  Bobela</span>, <span class="hlFld-ContribAuthor ">Lu  Zheng</span>, <span class="hlFld-ContribAuthor ">Bernard L.  Schneider</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Mouse Models of Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Protocols in Mouse Biology</span><span> <strong>2014,</strong> <em>4 </em>
                                    (3)
                                     , 121-139. <a href="https://doi.org/10.1002/9780470942390.mo140092" title="DOI URL">https://doi.org/10.1002/9780470942390.mo140092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470942390.mo140092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470942390.mo140092%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Protocols%2520in%2520Mouse%2520Biology%26atitle%3DOverview%252Bof%252BMouse%252BModels%252Bof%252BParkinson%252527s%252BDisease%26aulast%3DBobela%26aufirst%3DWojciech%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D3%26spage%3D121%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Brunschweiger</span>, <span class="hlFld-ContribAuthor ">Pierre  Koch</span>, <span class="hlFld-ContribAuthor ">Miriam  Schlenk</span>, <span class="hlFld-ContribAuthor ">Felipe  Pineda</span>, <span class="hlFld-ContribAuthor ">Petra  Küppers</span>, <span class="hlFld-ContribAuthor ">Sonja  Hinz</span>, <span class="hlFld-ContribAuthor ">Meryem  Köse</span>, <span class="hlFld-ContribAuthor ">Stefan  Ullrich</span>, <span class="hlFld-ContribAuthor ">Jörg  Hockemeyer</span>, <span class="hlFld-ContribAuthor ">Michael  Wiese</span>, <span class="hlFld-ContribAuthor ">Jag  Heer</span>, <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">8-Benzyltetrahydropyrazino[2,1-
              f
              ]purinediones: Water-Soluble Tricyclic Xanthine Derivatives as Multitarget Drugs for Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>53 </em>, n/a-n/a. <a href="https://doi.org/10.1002/cmdc.201402082" title="DOI URL">https://doi.org/10.1002/cmdc.201402082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402082%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3D8-Benzyltetrahydropyrazino%25255B2%25252C1-%252Bf%252B%25255Dpurinediones%25253A%252BWater-Soluble%252BTricyclic%252BXanthine%252BDerivatives%252Bas%252BMultitarget%252BDrugs%252Bfor%252BNeurodegenerative%252BDiseases%26aulast%3DBrunschweiger%26aufirst%3DAndreas%26date%3D2014%26date%3D2014%26volume%3D53%26spage%3Dn%252Fa%26epage%3Dn%252Fa" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annalisa  Pinna</span>, <span class="hlFld-ContribAuthor ">Micaela  Morelli</span>. </span><span class="cited-content_cbyCitation_article-title">A Critical Evaluation of Behavioral Rodent Models of Motor Impairment Used for Screening of Antiparkinsonian Activity: The Case of Adenosine A2A Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Neurotoxicity Research</span><span> <strong>2014,</strong> <em>25 </em>
                                    (4)
                                     , 392-401. <a href="https://doi.org/10.1007/s12640-013-9446-8" title="DOI URL">https://doi.org/10.1007/s12640-013-9446-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12640-013-9446-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12640-013-9446-8%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurotoxicity%2520Research%26atitle%3DA%252BCritical%252BEvaluation%252Bof%252BBehavioral%252BRodent%252BModels%252Bof%252BMotor%252BImpairment%252BUsed%252Bfor%252BScreening%252Bof%252BAntiparkinsonian%252BActivity%25253A%252BThe%252BCase%252Bof%252BAdenosine%252BA2A%252BReceptor%252BAntagonists%26aulast%3DPinna%26aufirst%3DAnnalisa%26date%3D2014%26date%3D2013%26volume%3D25%26issue%3D4%26spage%3D392%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen P.  Andrews</span>, <span class="hlFld-ContribAuthor ">Giles A.  Brown</span>, <span class="hlFld-ContribAuthor ">John A.  Christopher</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based and Fragment-Based GPCR Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (2)
                                     , 256-275. <a href="https://doi.org/10.1002/cmdc.201300382" title="DOI URL">https://doi.org/10.1002/cmdc.201300382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300382%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructure-Based%252Band%252BFragment-Based%252BGPCR%252BDrug%252BDiscovery%26aulast%3DAndrews%26aufirst%3DStephen%2BP.%26date%3D2014%26date%3D2013%26volume%3D9%26issue%3D2%26spage%3D256%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian C.  Shook</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine A2A Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 1-42. <a href="https://doi.org/10.1007/7355_2014_67" title="DOI URL">https://doi.org/10.1007/7355_2014_67</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_67&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_67%26sid%3Dliteratum%253Aachs%26atitle%3DAdenosine%252BA2A%252BReceptor%252BAntagonists%26aulast%3DShook%26aufirst%3DBrian%2BC.%26date%3D2014%26date%3D2014%26spage%3D1%26epage%3D42%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNovel%252BTherapeutic%252BApproaches%252Bto%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DHopkins%26aufirst%3DCorey%2BR.%26date%3D2016%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nada  Marquise</span>, <span class="hlFld-ContribAuthor ">Vincent  Dorcet</span>, <span class="hlFld-ContribAuthor ">Floris  Chevallier</span>, <span class="hlFld-ContribAuthor ">Florence  Mongin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of substituted azafluorenones from dihalogeno diaryl ketones by palladium-catalyzed auto-tandem processes. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (41)
                                     , 8138-8141. <a href="https://doi.org/10.1039/C4OB01629G" title="DOI URL">https://doi.org/10.1039/C4OB01629G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB01629G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB01629G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DSynthesis%252Bof%252Bsubstituted%252Bazafluorenones%252Bfrom%252Bdihalogeno%252Bdiaryl%252Bketones%252Bby%252Bpalladium-catalyzed%252Bauto-tandem%252Bprocesses%26aulast%3DMarquise%26aufirst%3DNada%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D41%26spage%3D8138%26epage%3D8141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre  Koch</span>, <span class="hlFld-ContribAuthor ">Rhalid  Akkari</span>, <span class="hlFld-ContribAuthor ">Andreas  Brunschweiger</span>, <span class="hlFld-ContribAuthor ">Thomas  Borrmann</span>, <span class="hlFld-ContribAuthor ">Miriam  Schlenk</span>, <span class="hlFld-ContribAuthor ">Petra  Küppers</span>, <span class="hlFld-ContribAuthor ">Meryem  Köse</span>, <span class="hlFld-ContribAuthor ">Hamid  Radjainia</span>, <span class="hlFld-ContribAuthor ">Jörg  Hockemeyer</span>, <span class="hlFld-ContribAuthor ">Anna  Drabczyńska</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kieć-Kononowicz</span>, <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (23)
                                     , 7435-7452. <a href="https://doi.org/10.1016/j.bmc.2013.09.044" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.09.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.09.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D1%25252C3-Dialkyl-substituted%252Btetrahydropyrimido%25255B1%25252C2-f%25255Dpurine-2%25252C4-diones%252Bas%252Bmultiple%252Btarget%252Bdrugs%252Bfor%252Bthe%252Bpotential%252Btreatment%252Bof%252Bneurodegenerative%252Bdiseases%26aulast%3DKoch%26aufirst%3DPierre%26date%3D2013%26volume%3D21%26issue%3D23%26spage%3D7435%26epage%3D7452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nada  Marquise</span>, <span class="hlFld-ContribAuthor ">Philip J.  Harford</span>, <span class="hlFld-ContribAuthor ">Floris  Chevallier</span>, <span class="hlFld-ContribAuthor ">Thierry  Roisnel</span>, <span class="hlFld-ContribAuthor ">Vincent  Dorcet</span>, <span class="hlFld-ContribAuthor ">Anne-Laure  Gagez</span>, <span class="hlFld-ContribAuthor ">Sophie  Sablé</span>, <span class="hlFld-ContribAuthor ">Laurent  Picot</span>, <span class="hlFld-ContribAuthor ">Valérie  Thiéry</span>, <span class="hlFld-ContribAuthor ">Andrew E.H.  Wheatley</span>, <span class="hlFld-ContribAuthor ">Philippe C.  Gros</span>, <span class="hlFld-ContribAuthor ">Florence  Mongin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of azafluorenones and related compounds using deprotocupration–aroylation followed by intramolecular direct arylation. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (47)
                                     , 10123-10133. <a href="https://doi.org/10.1016/j.tet.2013.09.030" title="DOI URL">https://doi.org/10.1016/j.tet.2013.09.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.09.030%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bazafluorenones%252Band%252Brelated%252Bcompounds%252Busing%252Bdeprotocupration%2525E2%252580%252593aroylation%252Bfollowed%252Bby%252Bintramolecular%252Bdirect%252Barylation%26aulast%3DMarquise%26aufirst%3DNada%26date%3D2013%26volume%3D69%26issue%3D47%26spage%3D10123%26epage%3D10133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian C.  Shook</span>, <span class="hlFld-ContribAuthor ">Devraj  Chakravarty</span>, <span class="hlFld-ContribAuthor ">J. Kent  Barbay</span>, <span class="hlFld-ContribAuthor ">Aihua  Wang</span>, <span class="hlFld-ContribAuthor ">Kristi  Leonard</span>, <span class="hlFld-ContribAuthor ">Vernon  Alford</span>, <span class="hlFld-ContribAuthor ">Mark T.  Powell</span>, <span class="hlFld-ContribAuthor ">Stefanie  Rassnick</span>, <span class="hlFld-ContribAuthor ">Robert H.  Scannevin</span>, <span class="hlFld-ContribAuthor ">Karen  Carroll</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Wallace</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Crooke</span>, <span class="hlFld-ContribAuthor ">Mark  Ault</span>, <span class="hlFld-ContribAuthor ">Lisa  Lampron</span>, <span class="hlFld-ContribAuthor ">Lori  Westover</span>, <span class="hlFld-ContribAuthor ">Kenneth  Rhodes</span>, <span class="hlFld-ContribAuthor ">Paul F.  Jackson</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (9)
                                     , 2688-2691. <a href="https://doi.org/10.1016/j.bmcl.2013.02.078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.02.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.02.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.02.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSubstituted%252Bthieno%25255B2%25252C3-d%25255Dpyrimidines%252Bas%252Badenosine%252BA2A%252Breceptor%252Bantagonists%26aulast%3DShook%26aufirst%3DBrian%2BC.%26date%3D2013%26volume%3D23%26issue%3D9%26spage%3D2688%26epage%3D2691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles S.  Hesdorffer</span>, <span class="hlFld-ContribAuthor ">Enkhzol  Malchinkhuu</span>, <span class="hlFld-ContribAuthor ">Arya  Biragyn</span>, <span class="hlFld-ContribAuthor ">Omar S.  Mabrouk</span>, <span class="hlFld-ContribAuthor ">Robert T.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Karen  Madara</span>, <span class="hlFld-ContribAuthor ">Dennis D.  Taub</span>, <span class="hlFld-ContribAuthor ">Dan L.  Longo</span>, <span class="hlFld-ContribAuthor ">Janice B.  Schwartz</span>, <span class="hlFld-ContribAuthor ">Luigi  Ferrucci</span>, <span class="hlFld-ContribAuthor ">Edward J.  Goetzl</span>. </span><span class="cited-content_cbyCitation_article-title">Distinctive immunoregulatory effects of adenosine on T cells of older humans. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2012,</strong> <em>26 </em>
                                    (3)
                                     , 1301-1310. <a href="https://doi.org/10.1096/fj.11-197046" title="DOI URL">https://doi.org/10.1096/fj.11-197046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.11-197046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.11-197046%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DDistinctive%252Bimmunoregulatory%252Beffects%252Bof%252Badenosine%252Bon%252BT%252Bcells%252Bof%252Bolder%252Bhumans%26aulast%3DHesdorffer%26aufirst%3DCharles%2BS.%26date%3D2012%26date%3D2011%26volume%3D26%26issue%3D3%26spage%3D1301%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jae-Won  Huh</span>, <span class="hlFld-ContribAuthor ">Young-Hyun  Kim</span>, <span class="hlFld-ContribAuthor ">Sang-Je  Park</span>, <span class="hlFld-ContribAuthor ">Dae-Soo  Kim</span>, <span class="hlFld-ContribAuthor ">Sang-Rae  Lee</span>, <span class="hlFld-ContribAuthor ">Kyoung-Min  Kim</span>, <span class="hlFld-ContribAuthor ">Kang-Jin  Jeong</span>, <span class="hlFld-ContribAuthor ">Ji-Su  Kim</span>, <span class="hlFld-ContribAuthor ">Bong-Seok  Song</span>, <span class="hlFld-ContribAuthor ">Bo-Woong  Sim</span>, <span class="hlFld-ContribAuthor ">Sun-Uk  Kim</span>, <span class="hlFld-ContribAuthor ">Sang-Hyun  Kim</span>, <span class="hlFld-ContribAuthor ">Kyu-Tae  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Large-scale transcriptome sequencing and gene analyses in the crab-eating macaque (Macaca fascicularis) for biomedical research. </span><span class="cited-content_cbyCitation_journal-name">BMC Genomics</span><span> <strong>2012,</strong> <em>13 </em>
                                    (1)
                                     , 163. <a href="https://doi.org/10.1186/1471-2164-13-163" title="DOI URL">https://doi.org/10.1186/1471-2164-13-163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1471-2164-13-163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1471-2164-13-163%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Genomics%26atitle%3DLarge-scale%252Btranscriptome%252Bsequencing%252Band%252Bgene%252Banalyses%252Bin%252Bthe%252Bcrab-eating%252Bmacaque%252B%252528Macaca%252Bfascicularis%252529%252Bfor%252Bbiomedical%252Bresearch%26aulast%3DHuh%26aufirst%3DJae-Won%26date%3D2012%26volume%3D13%26issue%3D1%26spage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan  Duty</span>, <span class="hlFld-ContribAuthor ">Peter  Jenner</span>. </span><span class="cited-content_cbyCitation_article-title">Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2011,</strong> <em>164 </em>
                                    (4)
                                     , 1357-1391. <a href="https://doi.org/10.1111/j.1476-5381.2011.01426.x" title="DOI URL">https://doi.org/10.1111/j.1476-5381.2011.01426.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1476-5381.2011.01426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1476-5381.2011.01426.x%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DAnimal%252Bmodels%252Bof%252BParkinson%252527s%252Bdisease%25253A%252Ba%252Bsource%252Bof%252Bnovel%252Btreatments%252Band%252Bclues%252Bto%252Bthe%252Bcause%252Bof%252Bthe%252Bdisease%26aulast%3DDuty%26aufirst%3DSusan%26date%3D2011%26date%3D2012%26volume%3D164%26issue%3D4%26spage%3D1357%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian C.  Shook</span>, <span class="hlFld-ContribAuthor ">Devraj  Charavarty</span>, <span class="hlFld-ContribAuthor ">J. Kent  Barbay</span>, <span class="hlFld-ContribAuthor ">Aihua  Wang</span>, <span class="hlFld-ContribAuthor ">Kristi  Leonard</span>, <span class="hlFld-ContribAuthor ">Vernon  Alford</span>, <span class="hlFld-ContribAuthor ">Mark  Powell</span>, <span class="hlFld-ContribAuthor ">Derek A.  Beauchamp</span>, <span class="hlFld-ContribAuthor ">Stefanie  Rassnick</span>, <span class="hlFld-ContribAuthor ">Robert  Scannevin</span>, <span class="hlFld-ContribAuthor ">Karen  Carroll</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Wallace</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Crooke</span>, <span class="hlFld-ContribAuthor ">Mark  Ault</span>, <span class="hlFld-ContribAuthor ">Lisa  Lampron</span>, <span class="hlFld-ContribAuthor ">Lori  Westover</span>, <span class="hlFld-ContribAuthor ">Kenneth  Rhodes</span>, <span class="hlFld-ContribAuthor ">Paul F.  Jackson</span>. </span><span class="cited-content_cbyCitation_article-title">Aminomethyl substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2011,</strong> <em>2 </em>
                                    (10)
                                     , 950. <a href="https://doi.org/10.1039/c1md00082a" title="DOI URL">https://doi.org/10.1039/c1md00082a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c1md00082a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc1md00082a%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DAminomethyl%252Bsubstituted%252Bthieno%25255B2%25252C3-d%25255Dpyrimidines%252Bas%252Badenosine%252BA2A%252Breceptor%252Bantagonists%26aulast%3DShook%26aufirst%3DBrian%2BC.%26date%3D2011%26volume%3D2%26issue%3D10%26spage%3D950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Costa</span>, <span class="hlFld-ContribAuthor ">Filipe  Areias</span>, <span class="hlFld-ContribAuthor ">Marian  Castro</span>, <span class="hlFld-ContribAuthor ">Jose  Brea</span>, <span class="hlFld-ContribAuthor ">María I.  Loza</span>, <span class="hlFld-ContribAuthor ">Fernanda  Proença</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel chromene scaffolds for adenosine receptors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2011,</strong> <em>9 </em>
                                    (11)
                                     , 4242. <a href="https://doi.org/10.1039/c1ob05305a" title="DOI URL">https://doi.org/10.1039/c1ob05305a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c1ob05305a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc1ob05305a%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnovel%252Bchromene%252Bscaffolds%252Bfor%252Badenosine%252Breceptors%26aulast%3DCosta%26aufirst%3DMarta%26date%3D2011%26volume%3D9%26issue%3D11%26spage%3D4242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Discovery Synthesis of <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Optimized Large Scale Synthesis of <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reversal of neuroleptic-induced catalepsy in mice by compounds <b>1</b> and <b>2</b>. Left: Catalepsy was measured in haloperidol (1 mg/kg, sc) treated mice after oral administration of <b>1</b> (0.01, 0.10, 1.0, or 10.0 mg/kg, po). L-DOPA, the dopamine precursor and gold standard for treating PD, was used as the positive control for this model at 300 mg/kg, po. Right: Catalepsy was measured in haloperidol (1 mg/kg, sc) treated mice after oral administration of <b>2</b> (0.10, 1.0, 3.0, or 5.0 mg/kg, po). For both panels each value represents average (±SEM) time in cataleptic position of <i>n</i> = 9−11 mice per treatment group during a 60 s test session. Asterisks indicate significant differences compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Duration of action of <b>1</b> in the mouse model of neuroleptic-induced catalepsy. Catalepsy time was measured in haloperidol (1 mg/kg, sc) treated mice after oral administration of <b>1</b> (0, 1, or 3 mg/kg), vehicle, or <b>2</b> (5 mg/kg). Catalepsy was measured repeatedly 15 min, 1 h, 2 h, and 4 h after oral dosing of the respective treatment groups. Each value represents average (±SEM) time in cataleptic position of <i>n</i> = 12 mice per treatment group during a 60 s test session. Asterisks indicate significant differences as compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0007.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Reversal of neuroleptic-induced catalepsy in rats by compound <b>1</b>. Time to descend from the bar was measured in haloperidol (1 mg/kg, sc) treated Sprague−Dawley rats after oral administration of <b>1</b> (0.01, 0.10, 1.0, 10.0, or 30.0 mg/kg), L-DOPA coadministered with carbidopa (200:50 mg/kg), or vehicle. Each value represents average (±SEM) time in cataleptic position of <i>n</i> = 10−16 rats per treatment group during a 180 s test session. Asterisks indicate significant differences compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0008.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Duration of action of <b>1</b> in the rat model of neuroleptic-induced catalepsy. Time to descend from the bar was measured in haloperidol (1 mg/kg, sc) treated rats after oral administration of <b>1</b> (0, 1, or 10 mg/kg) or L-DOPA (200 mg/kg) coadministered with benserazide (50 mg/kg). Catalepsy was measured repeatedly 15 min, 1 h, 2 h, and 4 h after oral dosing of the respective treatment groups. Each value represents average (±SEM) time in cataleptic position of <i>n</i> = 10 rats per treatment group during a 180 s test session. Asterisks indicate significant differences compared with the haloperidol + vehicle control group (∗∗∗, <i>P</i> < 0.001, Dunnett’s test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0009.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Reversal of resepine-induced akinesia in mice by compound <b>1</b>. Efficacy was defined as reversal of reserpine-induced akinesia and was quantified as total distance traveled (cm). Locomotion was studied 60 min after oral administration of <b>1</b> (0.10, 1.0, 10.0, or 30.0 mg/kg) or vehicle in mice that were pretreated with reserpine (0.6 mg/kg, sc) 18 h earlier. Each value represents the mean (±SEM) of the total distance traveled of <i>n</i> = 10−12 mice per treatment group during the 30 min measurement period in the behavioral test session. Asterisks indicate significant differences compared with the reserpine + vehicle control group (∗∗, <i>P</i> < 0.01; ∗∗∗, <i>P</i> < 0.001; Hochberg test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0010.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>1</b> potentiates the effects of L-DOPA in the 6-OHDA-lesioned rat model of Parkinson’s disease. Six weeks after administration of 6-OHDA the behavioral test was started by dosing rats with L-DOPA (10 mg/kg, po coadministered with carbidopa (2.5 mg/k, sc)) alone or with each dose of <b>1</b> (0.1, 1.0, 3.0, and 10 mg/kg, po). The effects of <b>1</b> alone were also studied in this model. The rotational behavior was determined as each animal was tethered to a high-resolution optical sensor connected to an automated computerized system that quantifies circular motion. One rotation count was defined as one 360° turn. Each value represents the mean (±SEM) of total contralateral rotations of <i>n</i> = 16 rats per treatment group during the 2 h before and after L-DOPA administration. Asterisks indicate significant differences compared with the L-DOPA + vehicle control treatment group (∗, <i>P</i> < 0.05, Tukey’s test of multiple comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/medium/jm-2010-00971t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In the left panel the parkinsonian/motor disability was monitored and scored on MPTP-treated marmosets dosed with vehicle or L-DOPA (12 mg/kg, po) or with each dose of <b>1</b> (0.1, 1.0, 10, and 50 mg/kg, po) out to 6 h. In the right panel the dyskinesias were monitored and scored on MPTP-treated marmosets dosed with vehicle or L-DOPA (12 mg/kg, po) or with each dose of <b>1</b> (0.1, 1.0, 10, and 50 mg/kg, po) out to 4 h. A total of eight animals were used for each treatment group. Data derived from nonparametric data were analyzed with a nonparametric one-way repeated measures ANOVA (Friedman test) followed by Dunn’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm100971t/production/images/large/jm-2010-00971t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100971t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lozano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostrovsky, J. O.</span><span> </span><span class="NLM_article-title">New developments in understanding the etiology of Parkinson’s disease and in its treatment</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=783-790&author=A.+M.+Lozanoauthor=A.+E.+Langauthor=W.+D.+Hutchisonauthor=J.+O.+Dostrovsky&title=New+developments+in+understanding+the+etiology+of+Parkinson%E2%80%99s+disease+and+in+its+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLozano%26aufirst%3DA.%2BM.%26aulast%3DLang%26aufirst%3DA.%2BE.%26aulast%3DHutchison%26aufirst%3DW.%2BD.%26aulast%3DDostrovsky%26aufirst%3DJ.%2BO.%26atitle%3DNew%2520developments%2520in%2520understanding%2520the%2520etiology%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520in%2520its%2520treatment%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D1998%26volume%3D8%26spage%3D783%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Fink, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivkees, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterfreund, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reppert, S. M.</span><span> </span><span class="NLM_article-title">Molecular cloning of the rat A<sub>2</sub> adenosine receptor: selective co-expression with D<sub>2</sub> dopamine receptors in rat striatum</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2F0169-328X%2892%2990173-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=1279342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVelt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1992&pages=186-195&author=J.+S.+Finkauthor=D.+R.+Weaverauthor=S.+A.+Rivkeesauthor=R.+A.+Peterfreundauthor=A.+E.+Pollackauthor=E.+M.+Adlerauthor=S.+M.+Reppert&title=Molecular+cloning+of+the+rat+A2+adenosine+receptor%3A+selective+co-expression+with+D2+dopamine+receptors+in+rat+striatum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum</span></div><div class="casAuthors">Fink, J. Stephen; Weaver, David R.; Rivkees, Scott A.; Peterfreund, Robert A.; Pollack, Alexia E.; Adler, Elizabeth M.; Reppert, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-95</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    </div><div class="casAbstract">A cDNA fragment homologous to other G protein-coupled receptors was isolated from rat brain using the PCR method and demonstrated to be abundantly expressed in striatum.  Using this fragment as a probe, a 2.1 kb full-length cDNA was isolated from a rat striatal cDNA library.  This cDNA encodes a protein of 410 amino acids and is highly homologous to previously isolated adenosine receptor cDNA.  Expression of this cDNA in COS cells revealed high affinity (Kd = 38.6 nM) and saturable binding of the A2 adenosine receptor-selective ligand [3H]CGS 21680.  Agonist displacement profile of [3H]CGS 21680 binding was consistent with an adenosine receptor of the A2 subtype (NECA > (R)-PIA > CPA > (S)-PIA).  In situ hybridization demonstrated that rat A2 adenosine receptor mRNA was co-expressed in the same striatal neurons as D2 dopamine receptor mRNA, and never co-expressed with striatal D1 dopamine receptor mRNA.  Several lines of evidence have previously suggested that dopamine-induced changes in motor behavior can be modulated by adenosine analogs acting at the A2 subtype of adenosine receptor in the forebrain.  The co-expression of D2 dopamine and A2 adenosine receptors in a subset of striatal cells provides an anatomical basis for dopaminergic-adenosinergic interactions on motor behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Daq1pagx8bVg90H21EOLACvtfcHk0lg05GxWthGkRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVelt7o%253D&md5=c625968121ce9599d80d0d7cad3e1b56</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0169-328X%2892%2990173-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-328X%252892%252990173-9%26sid%3Dliteratum%253Aachs%26aulast%3DFink%26aufirst%3DJ.%2BS.%26aulast%3DWeaver%26aufirst%3DD.%2BR.%26aulast%3DRivkees%26aufirst%3DS.%2BA.%26aulast%3DPeterfreund%26aufirst%3DR.%2BA.%26aulast%3DPollack%26aufirst%3DA.%2BE.%26aulast%3DAdler%26aufirst%3DE.%2BM.%26aulast%3DReppert%26aufirst%3DS.%2BM.%26atitle%3DMolecular%2520cloning%2520of%2520the%2520rat%2520A2%2520adenosine%2520receptor%253A%2520selective%2520co-expression%2520with%2520D2%2520dopamine%2520receptors%2520in%2520rat%2520striatum%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D1992%26volume%3D14%26spage%3D186%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Schiffmann, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderhaeghen, J. J.</span><span> </span><span class="NLM_article-title">Distribution of adenosine A<sub>2</sub>receptor mRNA in the human brain</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=1991&pages=177-181&author=S.+N.+Schiffmannauthor=F.+Lipertauthor=G.+Vassartauthor=J.+J.+Vanderhaeghen&title=Distribution+of+adenosine+A2receptor+mRNA+in+the+human+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchiffmann%26aufirst%3DS.%2BN.%26aulast%3DLipert%26aufirst%3DF.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DVanderhaeghen%26aufirst%3DJ.%2BJ.%26atitle%3DDistribution%2520of%2520adenosine%2520A2receptor%2520mRNA%2520in%2520the%2520human%2520brain%26jtitle%3DNeurosci.%2520Lett.%26date%3D1991%26volume%3D130%26spage%3D177%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">MAO-B inhibitors in Parkinson’s disease</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=8420207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK3sXktF2lurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1993&pages=666-671&author=C.+W.+Olanow&title=MAO-B+inhibitors+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">MAO-B inhibitors in Parkinson's disease</span></div><div class="casAuthors">Olanow, C. Warren</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Parkinson's Disease</span>),
    <span class="NLM_cas:pages">666-71</span>CODEN:
                <span class="NLM_cas:coden">ADNRA3</span>;
        ISSN:<span class="NLM_cas:issn">0091-3952</span>.
    </div><div class="casAbstract">A review with 46 ref.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQFDRpN_SkdrVg90H21EOLACvtfcHk0liyD9hGhsDXjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktF2lurw%253D&md5=e90fcc306d9c58991fe71c94a48e5fba</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DMAO-B%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAdv.%2520Neurol.%26date%3D1993%26volume%3D60%26spage%3D666%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title">Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson’s disease</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">IV/37</span><span class="NLM_x">–</span> <span class="NLM_lpage">IV/48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2007&pages=IV%2F37-IV%2F48&author=A.+Gordinauthor=D.+J.+Brooks&title=Clinical+pharmacology+and+therapeutic+use+of+COMT+inhibition+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3DClinical%2520pharmacology%2520and%2520therapeutic%2520use%2520of%2520COMT%2520inhibition%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%26date%3D2007%26volume%3D254%26spage%3DIV%252F37%26epage%3DIV%252F48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocchi, F.</span><span> </span><span class="NLM_article-title">COMT inhibitors in Parkinson’s disease. Can they prevent and/or reverse levodopa-induced motor complications?</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">S72</span><span class="NLM_x">–</span> <span class="NLM_lpage">S81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2004&pages=S72-S81&author=C.+W.+Olanowauthor=F.+Stocchi&title=COMT+inhibitors+in+Parkinson%E2%80%99s+disease.+Can+they+prevent+and%2For+reverse+levodopa-induced+motor+complications%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DStocchi%26aufirst%3DF.%26atitle%3DCOMT%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease.%2520Can%2520they%2520prevent%2520and%252For%2520reverse%2520levodopa-induced%2520motor%2520complications%253F%26jtitle%3DNeurology%26date%3D2004%26volume%3D62%26spage%3DS72%26epage%3DS81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Antonini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clilia, R.</span><span> </span><span class="NLM_article-title">Behavioural adverse effects of dopaminergic treatments in Parkinson’s disease: incidence, neurobiological basis, management and prevention</span> <span class="citation_source-journal">Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=475-488&author=A.+Antoniniauthor=R.+Clilia&title=Behavioural+adverse+effects+of+dopaminergic+treatments+in+Parkinson%E2%80%99s+disease%3A+incidence%2C+neurobiological+basis%2C+management+and+prevention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAntonini%26aufirst%3DA.%26aulast%3DClilia%26aufirst%3DR.%26atitle%3DBehavioural%2520adverse%2520effects%2520of%2520dopaminergic%2520treatments%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520incidence%252C%2520neurobiological%2520basis%252C%2520management%2520and%2520prevention%26jtitle%3DDrug%2520Safety%26date%3D2009%26volume%3D32%26spage%3D475%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hansard, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetham, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1124%2Fjpet.102.039743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=12438514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD38Xptlamt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=952-958&author=M.+J.+Hansardauthor=L.+A.+Smithauthor=M.+J.+Jacksonauthor=S.+C.+Cheethamauthor=P.+Jenner&title=Dopamine%2C+but+not+norepinephrine+or+serotonin%2C+reuptake+inhibition+reverses+motor+deficits+in+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine-treated+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates</span></div><div class="casAuthors">Hansard, Matthew J.; Smith, Lance A.; Jackson, Michael J.; Cheetham, Sharon C.; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">952-958</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Monoamine reuptake inhibitors that do not discriminate between the transporters for dopamine (DA), norepinephrine (NE), or 5-hydroxytryptamine (5-HT, serotonin) can reverse locomotor deficits and motor disability in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosets.  DA reuptake inhibition is presumed to be primarily responsible, but the role played by inhibition of NE and 5-HT reuptake is unknown.  This work evaluated the efficacy of a range of monoamine reuptake inhibitors either alone or in combination in MPTP-treated common marmosets to det. the actions required for effective antiparkinsonian activity.  Monoamine reuptake inhibitors not discriminating between the DA, NE, and 5-HT transporters [1-[1-(3,4-dichlororphenyl)cyclobutyl]-2-(3-diaminethylaminopropylthio)ethanone monocitrate (BTS 74 398) and nomifensine] reversed locomotor deficits and motor disability in MPTP-treated marmosets but bupropion was without effect.  The selective DA reuptake inhibitor 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride (GBR 12909) also reversed these motor deficits.  The relative efficacy of the compds. (BTS 74 398 > GBR 12909 > nomifensine » bupropion) paralleled their previously detd. potency in inhibiting DA uptake in vitro and in vivo.  In contrast, the selective NE reuptake inhibitor nisoxetine and the 5-HT reuptake inhibitor sertraline administered alone failed to improve motor function and tended to worsen the deficits.  Coadministration of nisoxetine attenuated the improvement in motor deficits produced by GBR 12909.  Coadministration of sertraline also abolished the reversal of motor deficits produced by GBR 12909.  Coadministration of both sertraline and nisoxetine similarly abolished the improvement of motor deficits produced by GBR 12909.  Mols. possessing potent DA reuptake inhibitory activity may be useful in the treatment of the motor symptoms of Parkinson's disease.  In contrast, there seems to be no role for NE or 5-HT reuptake inhibitors, and they may impair antiparkinsonian activity mediated through dopaminergic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprkAiG5hgKS7Vg90H21EOLACvtfcHk0liyD9hGhsDXjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xptlamt7g%253D&md5=f5b88eadd0c931fe318d49b4701b8760</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039743%26sid%3Dliteratum%253Aachs%26aulast%3DHansard%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DCheetham%26aufirst%3DS.%2BC.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DDopamine%252C%2520but%2520not%2520norepinephrine%2520or%2520serotonin%252C%2520reuptake%2520inhibition%2520reverses%2520motor%2520deficits%2520in%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine-treated%2520primates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D952%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Antonini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolosa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poewe, W. H.</span><span> </span><span class="NLM_article-title">A reassessment of risks and benefits of dopamine agonists in Parkinson’s disease</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2FS1474-4422%2809%2970225-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=19709931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Kitr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=929-937&author=A.+Antoniniauthor=E.+Tolosaauthor=Y.+Mizunoauthor=M.+Yamamotoauthor=W.+H.+Poewe&title=A+reassessment+of+risks+and+benefits+of+dopamine+agonists+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">A reassessment of risks and benefits of dopamine agonists in Parkinson's disease</span></div><div class="casAuthors">Antonini, Angelo; Tolosa, Eduardo; Mizuno, Yoshikuni; Yamamoto, Mitsutoshi; Poewe, Werner H.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">929-937</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurologists have several choices of drugs that have been shown to be effective for the treatment of the symptoms of Parkinson's disease.  Among the first options are the dopamine agonists, which are commonly used both as an early monotherapy and as an adjunct therapy to levodopa.  However, before starting any treatment, the overall benefit-to-risk ratio to individual patients must be considered.  For the dopamine agonists, the available evidence on their symptomatic efficacy, effect on long-term levodopa-related motor complications, putative effect on progression of disease, and adverse event profile must be taken into account.  Recently, the occurrence of adverse events such as leg edema, daytime somnolence, impulse control disorders, and fibrosis have increasingly been recognized.  The risks of these potentially serious adverse events must therefore be taken into account and treatment decisions should be based on considerations of risks vs. benefits for individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Rc8SOX7hMrVg90H21EOLACvtfcHk0liyD9hGhsDXjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Kitr7I&md5=3126e343054967641c318000aab5d2fe</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970225-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970225-X%26sid%3Dliteratum%253Aachs%26aulast%3DAntonini%26aufirst%3DA.%26aulast%3DTolosa%26aufirst%3DE.%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DPoewe%26aufirst%3DW.%2BH.%26atitle%3DA%2520reassessment%2520of%2520risks%2520and%2520benefits%2520of%2520dopamine%2520agonists%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%2520Neurol.%26date%3D2009%26volume%3D8%26spage%3D929%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Dopamine agonists in Parkinson’s disease</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1586%2F14737175.8.4.671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=18416667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFSht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=671-677&author=M.+Yamamotoauthor=A.+H.+V.+Schapira&title=Dopamine+agonists+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine agonists in Parkinson's disease</span></div><div class="casAuthors">Yamamoto, Mitsutoshi; Schapira, Anthony H. V.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">671-677</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Dopamine agonists are established as effective drugs for the symptomatic treatment of Parkinson's disease (PD) throughout its course.  As monotherapy, they produce effective control of motor symptoms and combine this with a low risk for motor complications.  As an adjunct to levodopa, they improve motor control and limit the need for levodopa in those patients in whom this may be considered relevant.  The non-ergot dopamine agonists in particular have a good safety profile, although as with other agonists, sedation, and cognitive and behavioral problems may be limiting in some patients.  Pramipexole has shown benefit in improving depressive symptoms in PD.  Ropinirole and pramipexole have both demonstrated a redn. in the rate of loss of nigrostriatal innervation as detd. by imaging in PD patients, when compared with levodopa.  Thus, dopamine agonists contribute to several dimensions of the management of PD and have become an integral part of the disease treatment algorithm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxVM_IekUXprVg90H21EOLACvtfcHk0ljZAOTQurvhqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFSht70%253D&md5=9a145ab9c49de374322fb02fe543d4ad</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1586%2F14737175.8.4.671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.8.4.671%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DDopamine%2520agonists%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2008%26volume%3D8%26spage%3D671%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredduzzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span> </span><span class="NLM_article-title">Potent and selective adenosine A<sub>2A</sub> antagonists 1,2,4-triazolo[1,5-<i>c</i>]pyrimidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=967-971&author=B.+R.+Neustadtauthor=H.+Liuauthor=J.+Haoauthor=W.+J.+Greenleeauthor=A.+W.+Stamfordauthor=C.+Fosterauthor=L.+Arikauthor=J.+Lachowiczauthor=H.+Zhangauthor=R.+Bertorelliauthor=S.+Fredduzziauthor=G.+Vartyauthor=M.+Cohen-Williamsauthor=K.+Ng&title=Potent+and+selective+adenosine+A2A+antagonists+1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DLachowicz%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DFredduzzi%26aufirst%3DS.%26aulast%3DVarty%26aufirst%3DG.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DNg%26aufirst%3DK.%26atitle%3DPotent%2520and%2520selective%2520adenosine%2520A2A%2520antagonists%25201%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D967%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">Identification of novel, water soluble, 2-amino-<i>N</i>-pyrimin-4-ylacetamides as A<sub>2A</sub> receptor antagonists with in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070623o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=400-406&author=D.+H.+Sleeauthor=X.+Zhangauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+K.+rueterauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=T.+Joswigauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+P.+Williamsauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.+L.+Diazauthor=J.+Wenauthor=Z.+O%E2%80%99Brienauthor=J.+Saunders&title=Identification+of+novel%2C+water+soluble%2C+2-amino-N-pyrimin-4-ylacetamides+as+A2A+receptor+antagonists+with+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm070623o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070623o%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3Drueter%26aufirst%3DJ.%2BK.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520novel%252C%2520water%2520soluble%252C%25202-amino-N-pyrimin-4-ylacetamides%2520as%2520A2A%2520receptor%2520antagonists%2520with%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D400%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Shao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brescia, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokosz, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuinness, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1399-1402&author=Y.+Shaoauthor=A.+G.+Coleauthor=M.+R.+Bresciaauthor=L.+Y.+Qinauthor=J.+Duoauthor=T.+M.+Staufferauthor=L.+L.+Rokoszauthor=B.+F.+McGuinnessauthor=I.+Henderson&title=Synthesis+and+SAR+studies+of+trisubstituted+purinones+as+potent+and+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DY.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DBrescia%26aufirst%3DM.%2BR.%26aulast%3DQin%26aufirst%3DL.%2BY.%26aulast%3DDuo%26aufirst%3DJ.%26aulast%3DStauffer%26aufirst%3DT.%2BM.%26aulast%3DRokosz%26aufirst%3DL.%2BL.%26aulast%3DMcGuinness%26aufirst%3DB.%2BF.%26aulast%3DHenderson%26aufirst%3DI.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520trisubstituted%2520purinones%2520as%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1399%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smits, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phadke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span> </span><span class="NLM_article-title">Piperazine derivatives of 1,2,4-triazolo[1,5-<i>a</i>][1,3,5]triazine as potent and selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4291</span><span class="NLM_x">–</span> <span class="NLM_lpage">4299</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0498405" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4291-4299&author=C.+B.+Vuauthor=B.+Pengauthor=G.+Kumaravelauthor=G.+Smitsauthor=X.+Jinauthor=D.+Phadkeauthor=T.+Engberauthor=C.+Huangauthor=J.+Reillyauthor=S.+Tamauthor=D.+Grantauthor=G.+Hetuauthor=L.+Chenauthor=J.+Zhangauthor=R.+C.+Petter&title=Piperazine+derivatives+of+1%2C2%2C4-triazolo%5B1%2C5-a%5D%5B1%2C3%2C5%5Dtriazine+as+potent+and+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1021%2Fjm0498405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0498405%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DSmits%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DPhadke%26aufirst%3DD.%26aulast%3DEngber%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DGrant%26aufirst%3DD.%26aulast%3DHetu%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26atitle%3DPiperazine%2520derivatives%2520of%25201%252C2%252C4-triazolo%255B1%252C5-a%255D%255B1%252C3%252C5%255Dtriazine%2520as%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4291%26epage%3D4299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span> </span><span class="NLM_article-title">Adenosine in the central nervous system: release mechanisms and extracellular concentrations</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1046%2Fj.1471-4159.2001.00607.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=11701750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlSht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2001&pages=463-484&author=S.+Latiniauthor=F.+Pedata&title=Adenosine+in+the+central+nervous+system%3A+release+mechanisms+and+extracellular+concentrations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine in the central nervous system: release mechanisms and extracellular concentrations</span></div><div class="casAuthors">Latini, Serena; Pedata, Felicita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">463-484</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Adenosine has several functions within the CNS that involve an inhibitory tone of neurotransmission and neuroprotective actions in pathol. conditions.  The understanding of adenosine prodn. and release in the brain is therefore of fundamental importance and has been extensively studied.  Conflicting results are often obtained regarding the cellular source of adenosine, the stimulus that induces release and the mechanism for release, in relation to different exptl. approaches used to study adenosine prodn. and release.  A neuronal origin of adenosine has been demonstrated through electrophysiol. approaches showing that neurons can release significant quantities of adenosine, sufficient to activate adenosine receptors and to modulate synaptic functions.  Specific actions of adenosine are mediated by different receptor subtypes (A1, A2A, A2B and A3), which are activated by various ranges of adenosine concns.  Another important issue is the measurement of adenosine concns. in the extracellular fluid under different conditions in order to know the degree of receptor stimulation and understand adenosine central actions.  For this purpose, several exptl. approaches have been used both in vivo and in vitro, which provide an estn. of basal adenosine levels in the range of 50-200 nM.  The purpose of this review is to describe pathways of adenosine prodn. and metab., and to summarize characteristics of adenosine release in the brain in response to different stimuli.  Finally, studies performed to evaluate adenosine concns. under physiol. and hypoxic/ischemic conditions will be described to evaluate the degree of adenosine receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD81oBeM405rVg90H21EOLACvtfcHk0liNV8koCJUACg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlSht7Y%253D&md5=c9636f206b3dbf0e3e2aa1c9ac9bb9fc</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2001.00607.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2001.00607.x%26sid%3Dliteratum%253Aachs%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DPedata%26aufirst%3DF.%26atitle%3DAdenosine%2520in%2520the%2520central%2520nervous%2520system%253A%2520release%2520mechanisms%2520and%2520extracellular%2520concentrations%26jtitle%3DJ.%2520Neurochem.%26date%3D2001%26volume%3D79%26spage%3D463%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dunwiddie, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masino, S. A.</span><span> </span><span class="NLM_article-title">The role and regulation of adenosine in the central nervous system</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1146%2Fannurev.neuro.24.1.31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=11283304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Siu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=31-55&author=T.+V.+Dunwiddieauthor=S.+A.+Masino&title=The+role+and+regulation+of+adenosine+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">The role and regulation of adenosine in the central nervous system</span></div><div class="casAuthors">Dunwiddie, Thomas V.; Masino, Susan A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-55</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 166 refs.  Adenosine is a modulator that has a pervasive and generally inhibitory effect on neuronal activity.  Tonic activation of adenosine receptors by adenosine that is normally present in the extracellular space in brain tissue leads to inhibitory effects that appear to be mediated by both adenosine A1 and A2A receptors.  Relief from this tonic inhibition by receptor antagonists such as caffeine accounts for the excitatory actions of these agents.  Characterization of the effects of adenosine receptor agonists and antagonists has led to numerous hypotheses concerning the role of this nucleoside.  Previous work has established a role for adenosine in a diverse array of neural phenomena, which include regulation of sleep and the level of arousal, neuroprotection, regulation of seizure susceptibility, locomotor effects, analgesia, mediation of the effects of ethanol, and chronic drug use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0o-Qitx0a6LVg90H21EOLACvtfcHk0liNV8koCJUACg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Siu7c%253D&md5=b9e0a3a4bc0c6cc23cc0ab9728d4b410</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.24.1.31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.24.1.31%26sid%3Dliteratum%253Aachs%26aulast%3DDunwiddie%26aufirst%3DT.%2BV.%26aulast%3DMasino%26aufirst%3DS.%2BA.%26atitle%3DThe%2520role%2520and%2520regulation%2520of%2520adenosine%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D24%26spage%3D31%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Stiles, G. L.</span><span> </span><span class="NLM_article-title">Adenosine receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">6451</span><span class="NLM_x">–</span> <span class="NLM_lpage">6454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=6451-6454&author=G.+L.+Stiles&title=Adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStiles%26aufirst%3DG.%2BL.%26atitle%3DAdenosine%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D6451%26epage%3D6454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rosin, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robeva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyenet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">Immunohistochemical localization of adenosine A<sub>2A</sub> receptors in rat central nervous system</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1002%2F%28SICI%291096-9861%2819981116%29401%3A2%3C163%3A%3AAID-CNE2%3E3.0.CO%3B2-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=9822147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK1cXntlanu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1998&pages=163-186&author=D.+L.+Rosinauthor=A.+Robevaauthor=R.+L.+Woodardauthor=P.+G.+Guyenetauthor=J.+Linden&title=Immunohistochemical+localization+of+adenosine+A2A+receptors+in+rat+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system</span></div><div class="casAuthors">Rosin, Diane L.; Robeva, Anna; Woodard, Robin L.; Guyenet, Patrice G.; Linden, Joel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-186</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The A2A adenosine receptor (A2A-AR) transcript and radioligand binding sites have a distinct distribution in rat brain, restricted primarily to the striatum, nucleus accumbens, and olfactory tubercles.  The authors describe here the use of purified recombinant human A2A-ARs to generate a monoclonal antibody that has been used to better resolve the distribution of A2A-ARs in rat brain.  The antibody can detect 1 ng of purified recombinant receptor by Western blotting and is potent (EC50 = 0.62 μg/mL) and highly selective for the A12A-AR subtype.  By Western blotting, the apparent mol. mass of recombinant and rat striatal receptors shifts upon deglycosylation from 43-48 to 42 kilodaltons.  Analyses of chimeric A1/A2A-ARs and synthesis of a blocking peptide pinpointed the epitope (SQPLPGER) of the antibody to the center of the third intracellular loop of the receptor.  Incubation of rat striatal membranes with antibody reduces receptor coupling to G-proteins.  In rat brain, dense A2A-AR-like immunoreactivity that is eliminated by the blocking peptide was found in the neuropil of the striatum, nucleus accumbens (rostral pole, core, and shell), cell bridges of the striatum, olfactory tubercles, and areas of extended amygdala with somewhat lighter labeling in the globus pallidus and nucleus of the solitary tract.  Light perikaryal labeling was found in other areas of the brain, including the cortex, hippocampus, thalamus, cerebellum, and portions of the hindbrain.  The obsd. distribution of A2A-AR immunoreactivity throughout the neuraxis is consistent with the receptors' role in modulating dopaminergic neurotransmission and central control of cardiovascular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNFUvkZHeam7Vg90H21EOLACvtfcHk0liNV8koCJUACg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntlanu7Y%253D&md5=297b00a8d21c3430128983539209aa65</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-9861%2819981116%29401%3A2%3C163%3A%3AAID-CNE2%3E3.0.CO%3B2-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-9861%252819981116%2529401%253A2%253C163%253A%253AAID-CNE2%253E3.0.CO%253B2-D%26sid%3Dliteratum%253Aachs%26aulast%3DRosin%26aufirst%3DD.%2BL.%26aulast%3DRobeva%26aufirst%3DA.%26aulast%3DWoodard%26aufirst%3DR.%2BL.%26aulast%3DGuyenet%26aufirst%3DP.%2BG.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DImmunohistochemical%2520localization%2520of%2520adenosine%2520A2A%2520receptors%2520in%2520rat%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D1998%26volume%3D401%26spage%3D163%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenningsson, P.</span><span> </span><span class="NLM_article-title">Striatal adenosine A<sub>2A</sub> receptors-where are they? What do they do? Comments</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=46-47&author=B.+B.+Fredholmauthor=P.+Svenningsson&title=Striatal+adenosine+A2A+receptors-where+are+they%3F+What+do+they+do%3F+Comments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DSvenningsson%26aufirst%3DP.%26atitle%3DStriatal%2520adenosine%2520A2A%2520receptors-where%2520are%2520they%253F%2520What%2520do%2520they%2520do%253F%2520Comments%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26spage%3D46%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K.</span><span> </span><span class="NLM_article-title">First visualization of adenosine A<sub>2A</sub> receptors in the human brain by positron emission tomography with [<sup>11</sup>C]TMSX</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=133-136&author=K.+Ishiwataauthor=M.+Mishinaauthor=Y.+Kimuraauthor=K.+Odaauthor=T.+Sasakiauthor=K.+Ishii&title=First+visualization+of+adenosine+A2A+receptors+in+the+human+brain+by+positron+emission+tomography+with+%5B11C%5DTMSX"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DMishina%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DOda%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DK.%26atitle%3DFirst%2520visualization%2520of%2520adenosine%2520A2A%2520receptors%2520in%2520the%2520human%2520brain%2520by%2520positron%2520emission%2520tomography%2520with%2520%255B11C%255DTMSX%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D133%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Svenningsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedvall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1997&pages=322-335&author=P.+Svenningssonauthor=H.+Hallauthor=G.+Sedvallauthor=B.+B.+Fredholm&title=Distribution+of+adenosine+receptors+in+the+postmortem+human+brain%3A+an+extended+autoradiographic+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DHall%26aufirst%3DH.%26aulast%3DSedvall%26aufirst%3DG.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DDistribution%2520of%2520adenosine%2520receptors%2520in%2520the%2520postmortem%2520human%2520brain%253A%2520an%2520extended%2520autoradiographic%2520study%26jtitle%3DSynapse%26date%3D1997%26volume%3D27%26spage%3D322%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Pollack, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, J. S.</span><span> </span><span class="NLM_article-title">Adenosine antagonists potentiate D2 dopamine dependent activation of Fos in the striatopallidal pathway</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1995&pages=721-728&author=A.+E.+Pollackauthor=J.+S.+Fink&title=Adenosine+antagonists+potentiate+D2+dopamine+dependent+activation+of+Fos+in+the+striatopallidal+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPollack%26aufirst%3DA.%2BE.%26aulast%3DFink%26aufirst%3DJ.%2BS.%26atitle%3DAdenosine%2520antagonists%2520potentiate%2520D2%2520dopamine%2520dependent%2520activation%2520of%2520Fos%2520in%2520the%2520striatopallidal%2520pathway%26jtitle%3DNeuroscience%26date%3D1995%26volume%3D68%26spage%3D721%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonsalla, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzchild, M. A.</span><span> </span><span class="NLM_article-title">Neuroprotection by caffeine and A<sub>2A</sub> adenosine receptor inactivation in a model of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">RC143/1</span><span class="NLM_x">–</span> <span class="NLM_lpage">RC143/6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=RC143%2F1-RC143%2F6&author=J.+F.+Chenauthor=K.+Xuauthor=J.+P.+Petzerauthor=R.+Staalauthor=Y.+H.+Xuauthor=M.+Beilsteinauthor=P.+K.+Sonsallaauthor=K.+Castagnoliauthor=N.+Castagnoliauthor=M.+A.+Schwarzchild&title=Neuroprotection+by+caffeine+and+A2A+adenosine+receptor+inactivation+in+a+model+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DStaal%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DY.%2BH.%26aulast%3DBeilstein%26aufirst%3DM.%26aulast%3DSonsalla%26aufirst%3DP.%2BK.%26aulast%3DCastagnoli%26aufirst%3DK.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DSchwarzchild%26aufirst%3DM.%2BA.%26atitle%3DNeuroprotection%2520by%2520caffeine%2520and%2520A2A%2520adenosine%2520receptor%2520inactivation%2520in%2520a%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3DRC143%252F1%26epage%3DRC143%252F6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grondin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahar, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregoire, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span> </span><span class="NLM_article-title">Antiparkinsonian effect of a new adenosine A<sub>2A</sub> receptor antagonist in MPTP-treated monkeys</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=1673-1677&author=R.+Grondinauthor=P.+J.+Bedardauthor=A.+J.+Taharauthor=L.+Gregoireauthor=A.+Moriauthor=H.+Kase&title=Antiparkinsonian+effect+of+a+new+adenosine+A2A+receptor+antagonist+in+MPTP-treated+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrondin%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DP.%2BJ.%26aulast%3DTahar%26aufirst%3DA.%2BJ.%26aulast%3DGregoire%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DKase%26aufirst%3DH.%26atitle%3DAntiparkinsonian%2520effect%2520of%2520a%2520new%2520adenosine%2520A2A%2520receptor%2520antagonist%2520in%2520MPTP-treated%2520monkeys%26jtitle%3DNeurology%26date%3D1999%26volume%3D52%26spage%3D1673%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Impagnatiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredduzzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzchild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span> </span><span class="NLM_article-title">Dual actions of A<sub>2A</sub> adenosine receptor antagonists on motor dysfunction and neurodegenerative processes</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2001&pages=379-386&author=E.+Onginiauthor=A.+Monopoliauthor=F.+Impagnatielloauthor=S.+Fredduzziauthor=M.+Schwarzchildauthor=J.+F.+Chen&title=Dual+actions+of+A2A+adenosine+receptor+antagonists+on+motor+dysfunction+and+neurodegenerative+processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DImpagnatiello%26aufirst%3DF.%26aulast%3DFredduzzi%26aufirst%3DS.%26aulast%3DSchwarzchild%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26atitle%3DDual%2520actions%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%2520on%2520motor%2520dysfunction%2520and%2520neurodegenerative%2520processes%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2001%26volume%3D52%26spage%3D379%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span> </span><span class="NLM_article-title">Neuroprotection by adenosine A<sub>2A</sub> receptor blockade in experimental models of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1046%2Fj.0022-3042.2001.00694.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=11902116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD38XptV2jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=262-270&author=K.+Ikedaauthor=M.+Kurokawaauthor=S.+Aoyamaauthor=Y.+Kuwana&title=Neuroprotection+by+adenosine+A2A+receptor+blockade+in+experimental+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease</span></div><div class="casAuthors">Ikeda, Ken; Kurokawa, Masako; Aoyama, Shiro; Kuwana, Yoshihisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-270</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Adenosine A2A receptors are abundant in the caudate-putamen and involved in the motor control in several species.  In MPTP-treated monkeys, A2A receptor-blockade with an antagonist alleviates parkinsonian symptoms without provoking dyskinesia, suggesting this receptor may offer a new target for the antisymptomatic therapy of Parkinson's disease.  In the present study, a significant neuroprotective effect of A2A receptor antagonists is shown in exptl. models of Parkinson's disease.  Oral administration of A2A receptor antagonists protected against the loss of nigral dopaminergic neuronal cells induced by 6-hydroxydopamine in rats.  A2A antagonists also prevented the functional loss of dopaminergic nerve terminals in the striatum and the ensuing gliosis caused by MPTP in mice.  The neuroprotective property of A2A receptor antagonists may be exerted by altering the packaging of these neurotoxins into vesicles, thus reducing their effective intracellular concn.  We therefore conclude that the adenosine A2A receptor may provide a novel target for the long-term medication of Parkinson's disease, because blockade of this receptor exerts both acutely antisymptomatic and chronically neuroprotective activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb8toXJpqCzLVg90H21EOLACvtfcHk0lgm5sgyuGXfRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptV2jsQ%253D%253D&md5=68ddb10b0be184393df31567d2acc7ca</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1046%2Fj.0022-3042.2001.00694.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0022-3042.2001.00694.x%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKurokawa%26aufirst%3DM.%26aulast%3DAoyama%26aufirst%3DS.%26aulast%3DKuwana%26aufirst%3DY.%26atitle%3DNeuroprotection%2520by%2520adenosine%2520A2A%2520receptor%2520blockade%2520in%2520experimental%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D80%26spage%3D262%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, R. K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1002%2Fana.410430415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=9546333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK1cXisFyisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=507-513&author=T.+Kandaauthor=M.+J.+Jacksonauthor=L.+A.+Smithauthor=R.+K.+B.+Pearceauthor=J.+Nakamuraauthor=H.+Kaseauthor=Y.+Kuwanaauthor=P.+Jenner&title=Adenosine+A2A+antagonist%3A+a+novel+antiparkinsonian+agent+that+does+not+provoke+dyskinesia+in+parkinsonian+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys</span></div><div class="casAuthors">Kanda, Tomoyuki; Jackson, Michael J.; Smith, Lance A.; Pearce, Ronald K. B.; Nakamura, Joji; Kase, Hiroshi; Kuwana, Yoshihisa; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">507-513</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">Treatment of Parkinson's disease with L-DOPA therapy leads to long-term complications, including loss of drug efficacy and the onset of dyskinesia.  Adenosine A2A receptors in the striatum are selectively localized to GABAergic output neurons of the striato-pallidal pathway and may avoid such problems.  The novel adenosine A2A receptor antagonist KW-6002 was examd. for antiparkinsonian activity in MPTP-treated primates.  Oral administration of KW-6002 reversed motor disability in MPTP-treated common marmosets in a dose-dependent manner.  However, KW-6002 only modestly increased overall locomotor activity and did not cause abnormal movement, such as stereotypy.  The ability of KW-6002 to reverse motor disability was maintained on repeated daily administration for 21 days, and no tolerance was obsd.  KW-6002 induced little or no dyskinesia in MPTP-treated primates previously primed to exhibit dyskinesia by prior exposure to L-DOPA.  Thus, selective adenosine A2A receptor antagonists represent a new class of antiparkinsonian agents that do not produce hyperactivity or induce dyskinesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouQ20y4EvPvLVg90H21EOLACvtfcHk0lhO4hKpBmxdFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFyisbw%253D&md5=36af21fdde02b63c588e3ca03785dafe</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1002%2Fana.410430415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410430415%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DPearce%26aufirst%3DR.%2BK.%2BB.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DKase%26aufirst%3DH.%26aulast%3DKuwana%26aufirst%3DY.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DAdenosine%2520A2A%2520antagonist%253A%2520a%2520novel%2520antiparkinsonian%2520agent%2520that%2520does%2520not%2520provoke%2520dyskinesia%2520in%2520parkinsonian%2520monkeys%26jtitle%3DAnn.%2520Neurol.%26date%3D1998%26volume%3D43%26spage%3D507%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2FS0014-2999%2800%2900745-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=11090641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1ygsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=249-255&author=K.+Kogaauthor=M.+Kurokawaauthor=M.+Ochiauthor=J.+Nakamuraauthor=Y.+Kuwana&title=Adenosine+A2A+receptor+antagonists+KF17837+and+KW-6002+potentiate+rotation+induced+by+dopaminergic+drugs+in+hemi-Parkinsonian+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats</span></div><div class="casAuthors">Koga, K.; Kurokawa, M.; Ochi, M.; Nakamura, J.; Kuwana, Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-255</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The effects of novel adenosine A2A receptor antagonists KF17837 ((E)-1,3-dipropyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dihydro-1H-purine-2,6-dione) and KW-6002 ((E)-1,3-diethyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dihydro-1H-purine-2,6-dione), on rotational behavior induced by apomorphine or L-DOPA (l-3,4-dihydroxyphenylalanine) were investigated in rats with unilateral 6-hydroxydopamine lesions.  Both KF17837 and KW-6002 slightly induced rotational behavior per se.  However, KF17837 and KW-6002 significantly increased the total counts of turning induced by apomorphine at doses of 3 mg/kg, p.o. and 10 mg/kg, p.o., and at doses of 1 mg/kg, p.o. and higher, resp.  KF17837 and KW-6002 also potentiated the rotational behavior induced by L-DOPA at a dose of 3 mg/kg, p.o.  Furthermore, i.c.v. injection (10 μg/20 μl) of a selective adenosine A2 receptor agonist CGS 21680 {2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine} partially prevented the rotational behavior induced by apomorphine and this inhibition was reversed by KW-6002 (1 mg/kg, p.o.).  The increase in total counts of apomorphine-induced turning by the adenosine A2A receptor antagonists seems to be mainly attributable to prolongation of turning duration rather than enhancement of intensity.  These results suggest that these adenosine A2A receptor antagonists may be useful to ameliorate shortening in the duration of dopaminergic drug response in patients with advanced Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZbOArDCv31rVg90H21EOLACvtfcHk0lhO4hKpBmxdFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1ygsb0%253D&md5=1763bbd6e38fbfc8bf3f9ab1b3f12374</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900745-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900745-7%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DK.%26aulast%3DKurokawa%26aufirst%3DM.%26aulast%3DOchi%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DKuwana%26aufirst%3DY.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonists%2520KF17837%2520and%2520KW-6002%2520potentiate%2520rotation%2520induced%2520by%2520dopaminergic%2520drugs%2520in%2520hemi-Parkinsonian%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D408%26spage%3D249%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Combined use of the adenosine A<sub>2A</sub> antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1006%2Fexnr.2000.7350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=10739638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVWqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2000&pages=321-327&author=T.+Kandaauthor=M.+J.+Jacksonauthor=L.+A.+Smithauthor=R.+K.+Pearceauthor=J.+Nakamuraauthor=H.+Kaseauthor=Y.+Kuwanaauthor=P.+Jenner&title=Combined+use+of+the+adenosine+A2A+antagonist+KW-6002+with+L-DOPA+or+with+selective+D1+or+D2+dopamine+agonists+increases+antiparkinsonian+activity+but+not+dyskinesia+in+MPTP-treated+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Combined Use of the Adenosine A2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys</span></div><div class="casAuthors">Kanda, Tomoyuki; Jackson, Michael J.; Smith, Lance A.; Pearce, Ronald K. B.; Nakamura, Joji; Kase, Hiroshi; Kuwana, Yoshihisa; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-327</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The novel selective adenosine A2A receptor antagonist KW-6002 improves motor disability in MPTP-treated parkinsonian marmosets without provoking dyskinesia.  In this study we have investigated whether KW-6002 in combination with l-DOPA or selective D1 or D2 dopamine receptor agonists enhances antiparkinsonian activity in MPTP-treated common marmosets.  Combination of KW-6002 with the selective dopamine D2 receptor agonist quinpirole or the D1 receptor agonist SKF80723 produced an additive improvement in motor disability.  Coadministration of KW-6002 with a low dose of l-DOPA also produced an additive improvement in motor disability, and increased locomotor activity.  The ability of KW-6002 to enhance antiparkinsonian activity was more marked with l-DOPA and quinpirole than with the D1 agonist.  However, despite producing an enhanced antiparkinsonian response KW-6002 did not exacerbate l-DOPA-induced dyskinesia in MPTP-treated common marmosets previously primed to exhibit dyskinesia by prior exposure to l-DOPA.  Selective adenosine A2A receptor antagonists, such as KW-6002, may be one means of reducing the dosage of l-DOPA used in treating Parkinson's disease and are potentially a novel approach to treating the illness both as monotherapy and in combination with dopaminergic drugs.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsA7cu-aJS8rVg90H21EOLACvtfcHk0lhO4hKpBmxdFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVWqsLY%253D&md5=28db343f66ae2a8179d7113246f39ae7</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1006%2Fexnr.2000.7350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexnr.2000.7350%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DPearce%26aufirst%3DR.%2BK.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DKase%26aufirst%3DH.%26aulast%3DKuwana%26aufirst%3DY.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DCombined%2520use%2520of%2520the%2520adenosine%2520A2A%2520antagonist%2520KW-6002%2520with%2520L-DOPA%2520or%2520with%2520selective%2520D1%2520or%2520D2%2520dopamine%2520agonists%2520increases%2520antiparkinsonian%2520activity%2520but%2520not%2520dyskinesia%2520in%2520MPTP-treated%2520monkeys%26jtitle%3DExp.%2520Neurol.%26date%3D2000%26volume%3D162%26spage%3D321%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hauser, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubble, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, D. D.</span><span> </span><span class="NLM_article-title">Randomized trial of adenosine A<sub>2A</sub> receptor antagonist istradefylline in advanced PD</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=297-303&author=R.+A.+Hauserauthor=J.+P.+Hubbleauthor=D.+D.+Truong&title=Randomized+trial+of+adenosine+A2A+receptor+antagonist+istradefylline+in+advanced+PD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DHubble%26aufirst%3DJ.%2BP.%26aulast%3DTruong%26aufirst%3DD.%2BD.%26atitle%3DRandomized%2520trial%2520of%2520adenosine%2520A2A%2520receptor%2520antagonist%2520istradefylline%2520in%2520advanced%2520PD%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D297%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bara-Jimenez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherzai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouradian, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonist treatment of Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=293-296&author=W.+Bara-Jimenezauthor=A.+Sherzaiauthor=T.+Dimitrovaauthor=A.+Favitauthor=F.+Bibbianiauthor=M.+Gillespieauthor=M.+J.+Morrisauthor=M.+M.+Mouradianauthor=T.+N.+Chase&title=Adenosine+A2A+receptor+antagonist+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBara-Jimenez%26aufirst%3DW.%26aulast%3DSherzai%26aufirst%3DA.%26aulast%3DDimitrova%26aufirst%3DT.%26aulast%3DFavit%26aufirst%3DA.%26aulast%3DBibbiani%26aufirst%3DF.%26aulast%3DGillespie%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonist%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D293%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ballarin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiriz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahy, N.</span><span> </span><span class="NLM_article-title">Effect of locally infused 2-cholroadenosine, an A<sub>1</sub> receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1995&pages=29-32&author=M.+Ballarinauthor=J.+Reirizauthor=S.+Ambrosioauthor=N.+Mahy&title=Effect+of+locally+infused+2-cholroadenosine%2C+an+A1+receptor+agonist%2C+on+spontaneous+and+evoked+dopamine+release+in+rat+neostriatum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallarin%26aufirst%3DM.%26aulast%3DReiriz%26aufirst%3DJ.%26aulast%3DAmbrosio%26aufirst%3DS.%26aulast%3DMahy%26aufirst%3DN.%26atitle%3DEffect%2520of%2520locally%2520infused%25202-cholroadenosine%252C%2520an%2520A1%2520receptor%2520agonist%252C%2520on%2520spontaneous%2520and%2520evoked%2520dopamine%2520release%2520in%2520rat%2520neostriatum%26jtitle%3DNeurosci.%2520Lett.%26date%3D1995%26volume%3D185%26spage%3D29%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moore, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, D.</span><span> </span><span class="NLM_article-title">Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses</span> <span class="citation_source-journal">Proc. Nat. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">14397</span><span class="NLM_x">–</span> <span class="NLM_lpage">14402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1073%2Fpnas.1835831100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=14608033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFGhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=14397-14402&author=K.+A.+Mooreauthor=R.+A.+Nicollauthor=D.+Schmitz&title=Adenosine+gates+synaptic+plasticity+at+hippocampal+mossy+fiber+synapses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses</span></div><div class="casAuthors">Moore, Kimberly A.; Nicoll, Roger A.; Schmitz, Dietmar</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">14397-14402</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The release properties of synapses in the central nervous system vary greatly, not only across anatomically distinct types of synapses but also among the same class of synapse.  This variation manifests itself in large part by differences in the probability of transmitter release, which affects such activity-dependent presynaptic forms of plasticity as paired-pulse facilitation and frequency facilitation.  This heterogeneity in presynaptic function reflects differences in the intrinsic properties of the synaptic terminal and the activation of presynaptic neurotransmitter receptors.  The unique presynaptic properties of the hippocampal mossy fiber synapse are largely imparted onto the synapse by the continuous local action of extracellular adenosine at presynaptic A1 adenosine receptors, which maintains a low basal probability of transmitter release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7O6W_5jGVTLVg90H21EOLACvtfcHk0liSkVsG-lmMPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFGhs7w%253D&md5=4f873eae58d0090114a4e1c8854384b9</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1835831100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1835831100%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DK.%2BA.%26aulast%3DNicoll%26aufirst%3DR.%2BA.%26aulast%3DSchmitz%26aufirst%3DD.%26atitle%3DAdenosine%2520gates%2520synaptic%2520plasticity%2520at%2520hippocampal%2520mossy%2520fiber%2520synapses%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D14397%26epage%3D14402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rebola, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinheiro, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malva, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, R. A.</span><span> </span><span class="NLM_article-title">Subcellular localization of adenosine A<sub>1</sub> receptors in nerve terminal and synapses of the rat hippocampus</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">987</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2FS0006-8993%2803%2903247-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=14499945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1aqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=987&publication_year=2003&pages=49-58&author=N.+Rebolaauthor=P.+C.+Pinheiroauthor=C.+R.+Oliveiraauthor=J.+O.+Malvaauthor=R.+A.+Cunha&title=Subcellular+localization+of+adenosine+A1+receptors+in+nerve+terminal+and+synapses+of+the+rat+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Subcellular localization of adenosine A1 receptors in nerve terminals and synapses of the rat hippocampus</span></div><div class="casAuthors">Rebola, Nelson; Pinheiro, Paulo C.; Oliveira, Catarina R.; Malva, Joao O.; Cunha, Rodrigo A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">987</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-58</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Adenosine is a neuromodulator in the CNS that mainly acts through pre- and postsynaptic A1 receptors to inhibit the release of excitatory neurotransmitters and NMDA receptor function.  This might result from a highly localized distribution of A1 receptors in the active zone and postsynaptic d. of CNS synapses that we now investigated in the rat hippocampus.  The binding d. of the selective A1 receptor antagonist, [3H]1,3-dipropyl-8-cyclopentylxanthine ([3H]DPCPX), was enriched in membranes from Percoll-purified nerve terminals (Bmax=1839±52 fmol/mg protein) compared to total membranes from the hippocampus (Bmax=984±31 fmol/mg protein), the same occurring with A1 receptor immunoreactivity.  [3H]DPCPX binding occurred mainly to the plasma membrane rather than to intracellular sites, since the binding of the membrane permeable A1 receptor ligand [3H]DPCPX to intact hippocampal nerve terminals (Bmax=1901±192 fmol/mg protein) was markedly reduced (Bmax=321±30 fmol/mg protein) by the membrane impermeable adenosine receptor antagonist, 8-sulfophenyltheophilline (25 μM).  Further subcellular fractionation of hippocampal nerve terminals revealed that A1 receptor immunoreactivity was strategically located in the active zone of presynaptic nerve terminals, as expected to understand the efficiency of A1 receptors to depress neurotransmitter release.  A1 Receptors were also present in nerve terminals outside the active zone in accordance with the existence of a presynaptic A1 receptor reserve.  Finally, A1 receptor immunoreactivity was evident in the postsynaptic d. together with NMDA receptor subunits 1, 2A and 2B and with N-and P/Q-type calcium channel immunoreactivity, emphasizing the importance of A1 receptors in the control of dendritic integration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXNS9YJIv75rVg90H21EOLACvtfcHk0liSkVsG-lmMPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1aqsr8%253D&md5=3400357993c99c6aa97d2def8af5b8ca</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2803%2903247-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252803%252903247-5%26sid%3Dliteratum%253Aachs%26aulast%3DRebola%26aufirst%3DN.%26aulast%3DPinheiro%26aufirst%3DP.%2BC.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26aulast%3DMalva%26aufirst%3DJ.%2BO.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26atitle%3DSubcellular%2520localization%2520of%2520adenosine%2520A1%2520receptors%2520in%2520nerve%2520terminal%2520and%2520synapses%2520of%2520the%2520rat%2520hippocampus%26jtitle%3DBrain%2520Res.%26date%3D2003%26volume%3D987%26spage%3D49%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Maemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noriko, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyoharu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoru, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsushi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinori, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitaro, M.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of FR194921, a new potent, selective, orally active antagonist for central adenosine A<sub>1</sub> receptors</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1254%2Fjphs.FP0040359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=15351792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFyjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=42-52&author=T.+Maemotoauthor=T.+Mihoauthor=M.+Takumaauthor=U.+Norikoauthor=M.+Hideakiauthor=H.+Katsuyaauthor=Y.+Takayukiauthor=S.+Kiyoharuauthor=K.+Satoruauthor=A.+Atsushiauthor=I.+Akinoriauthor=M.+Nobuyaauthor=M.+Seitaro&title=Pharmacological+characterization+of+FR194921%2C+a+new+potent%2C+selective%2C+orally+active+antagonist+for+central+adenosine+A1+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A1 receptors</span></div><div class="casAuthors">Maemoto, Takuya; Tada, Miho; Mihara, Takuma; Ueyama, Noriko; Matsuoka, Hideaki; Harada, Katsuya; Yamaji, Takayuki; Shirakawa, Kiyoharu; Kuroda, Satoru; Akahane, Atsushi; Iwashita, Akinori; Matsuoka, Nobuya; Mutoh, Seitaro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-52</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Adenosine A1 receptors in the brain are believed to play an important role in brain functioning.  We have discovered a novel adenosine A1 receptor antagonist, FR194921 (2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-3(2H)-pyridazinone), and characterized the pharmacol. activity in the present study.  FR194921 showed potent and selective affinity for the adenosine A1 receptor without affinity for A2A and A3 receptors and did not show any species differences in binding affinity profile among human, rat, and mouse.  Pharmacokinetic study in rats revealed that FR194921 was orally active and highly brain penetrable.  Oral administration of FR194921 dose-dependently ameliorated the hypolocomotion induced by the A1 receptor agonist N6-cyclopentyladenosine in rats, indicating this compd. exerts A1-antagonistic action in vivo.  In the passive avoidance test, scopolamine (1 mg/kg)-induced memory deficits were significantly ameliorated by FR194921 (0.32, 1 mg/kg).  In two animal models of anxiety, the social interaction test and elevated plus maze, FR194921 showed specific anxiolytic activity without significantly influencing general behavior.  In contrast, FR194921 did not show antidepressant activity even at a dose of 32 mg/kg in the rat forced swimming test.  These results indicate that the novel, potent, and selective adenosine A1 receptor antagonist FR194921 exerts both cognitive-enhancing and anxiolytic activity, suggesting the therapeutic potential of this compd. for dementia and anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpor8cuLg5xVrVg90H21EOLACvtfcHk0livRJo3fjWg6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFyjs78%253D&md5=1828b4e7afe4c25a61aa0fa094f64c38</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FP0040359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FP0040359%26sid%3Dliteratum%253Aachs%26aulast%3DMaemoto%26aufirst%3DT.%26aulast%3DMiho%26aufirst%3DT.%26aulast%3DTakuma%26aufirst%3DM.%26aulast%3DNoriko%26aufirst%3DU.%26aulast%3DHideaki%26aufirst%3DM.%26aulast%3DKatsuya%26aufirst%3DH.%26aulast%3DTakayuki%26aufirst%3DY.%26aulast%3DKiyoharu%26aufirst%3DS.%26aulast%3DSatoru%26aufirst%3DK.%26aulast%3DAtsushi%26aufirst%3DA.%26aulast%3DAkinori%26aufirst%3DI.%26aulast%3DNobuya%26aufirst%3DM.%26aulast%3DSeitaro%26aufirst%3DM.%26atitle%3DPharmacological%2520characterization%2520of%2520FR194921%252C%2520a%2520new%2520potent%252C%2520selective%252C%2520orally%2520active%2520antagonist%2520for%2520central%2520adenosine%2520A1%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D96%26spage%3D42%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintzelman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullington, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osbourne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Methylene amine substituted arylindenopyrimidines as potent adenosine A<sub>2A</sub>/A<sub>1</sub> antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2864</span><span class="NLM_x">–</span> <span class="NLM_lpage">2867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2864-2867&author=B.+C.+Shookauthor=S.+Rassnickauthor=D.+Hallauthor=K.+C.+Rupertauthor=G.+R.+Heintzelmanauthor=K.+Hansenauthor=D.+Chakravartyauthor=J.+L.+Bullingtonauthor=R.+Scannevinauthor=B.+Magliaroauthor=L.+Westoverauthor=K.+Carrollauthor=L.+Lampronauthor=R.+Russellauthor=S.+Branumauthor=K.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=X.+Liauthor=M.+Osbourneauthor=K.+Demarestauthor=Y.+Tangauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Methylene+amine+substituted+arylindenopyrimidines+as+potent+adenosine+A2A%2FA1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHeintzelman%26aufirst%3DG.%2BR.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DBullington%26aufirst%3DJ.%2BL.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DMagliaro%26aufirst%3DB.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DOsbourne%26aufirst%3DM.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DMethylene%2520amine%2520substituted%2520arylindenopyrimidines%2520as%2520potent%2520adenosine%2520A2A%252FA1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2864%26epage%3D2867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbay, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alford, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintzelman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullington, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Optimization of arylindenopyrimidines as potent adenosine A<sub>2A</sub>/A<sub>1</sub> antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2868</span><span class="NLM_x">–</span> <span class="NLM_lpage">2871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2868-2871&author=B.+C.+Shookauthor=S.+Rassnickauthor=D.+Chakravartyauthor=N.+Wallaceauthor=M.+Aultauthor=J.+Crookeauthor=J.+K.+Barbayauthor=A.+Wangauthor=K.+Leonardauthor=M.+T.+Powellauthor=V.+Alfordauthor=D.+Hallauthor=K.+C.+Rupertauthor=G.+R.+Heintzelmanauthor=K.+Hansenauthor=J.+L.+Bullingtonauthor=R.+Scannevinauthor=K.+Carrollauthor=L.+Lampronauthor=L.+Westoverauthor=R.+Russellauthor=S.+Branumauthor=K.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=D.+Beauchampauthor=X.+Liauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Optimization+of+arylindenopyrimidines+as+potent+adenosine+A2A%2FA1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DWallace%26aufirst%3DN.%26aulast%3DAult%26aufirst%3DM.%26aulast%3DCrooke%26aufirst%3DJ.%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DPowell%26aufirst%3DM.%2BT.%26aulast%3DAlford%26aufirst%3DV.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHeintzelman%26aufirst%3DG.%2BR.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DBullington%26aufirst%3DJ.%2BL.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DBeauchamp%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DOptimization%2520of%2520arylindenopyrimidines%2520as%2520potent%2520adenosine%2520A2A%252FA1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2868%26epage%3D2871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Zarrindast, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modabber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabetkasai, M.</span><span> </span><span class="NLM_article-title">Influence on different adenosine receptor subtypes on catalepsy in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1993&pages=257-261&author=M.+R.+Zarrindastauthor=M.+Modabberauthor=M.+Sabetkasai&title=Influence+on+different+adenosine+receptor+subtypes+on+catalepsy+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZarrindast%26aufirst%3DM.%2BR.%26aulast%3DModabber%26aufirst%3DM.%26aulast%3DSabetkasai%26aufirst%3DM.%26atitle%3DInfluence%2520on%2520different%2520adenosine%2520receptor%2520subtypes%2520on%2520catalepsy%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D1993%26volume%3D113%26spage%3D257%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Mandhane, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopde, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2</sub> receptors modulate haloperidol-induced catalepsy in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x"> (</span><span class="NLM_issue">2/3</span><span class="NLM_x">) </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2FS0014-2999%2897%2983039-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=9218695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK2sXjsVKgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=1997&pages=135-141&issue=2%2F3&author=S.+N.+Mandhaneauthor=C.+T.+Chopdeauthor=A.+K.+Ghosh&title=Adenosine+A2+receptors+modulate+haloperidol-induced+catalepsy+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats</span></div><div class="casAuthors">Mandhane, Sanjay N.; Chopde, Chandrabhan T.; Ghosh, Anuradha K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">135-141</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effect of adenosine A1 and A2 receptor agonists and antagonists was investigated on haloperidol-induced catalepsy in rats.  Pretreatment (i.p.) with the non-selective adenosine receptor antagonist, theophylline, or the selective adenosine A2 receptor antagonist, 3,7-dimethyl-1-propargylxanthine (DMPX), significantly reversed haloperidol-induced catalepsy, whereas the selective adenosine A1 receptor antagonists, 8-phenyltheophylline and 8-cyclopentyl-1,3-dipropylxanthine produced no effect.  Similar administration of the adenosine A2 receptor agonists, 5'-(N-cyclopropyl)carboxamidoadenosine and 5'-N-ethylcarboxamidoadenosine (NECA), and the mixed agonists with predominantly A1 site of action, N6-(2-phenylisopropyl)adenosine or 2-chloroadenosine, potentiated haloperidol-induced catalepsy.  Higher doses of the adenosine agonists produced catalepsy when given alone.  However, N6-cyclopentyladenosine, a highly selective adenosine A1 receptor agonist, was ineffective in these respects.  The per se cataleptic effect of adenosine agonists was blocked by DMPX and the centrally acting anticholinergic agent, scopolamine.  Scopolamine also attenuated the potentiation of haloperidol-induced catalepsy by adenosine agonists.  Further, i.c.v. administration of NECA and DMPX produced a similar effect as that produced after their systemic administration.  These findings demonstrate the differential influence of adenosine A1 and A2 receptors on haloperidol-induced catalepsy and support the hypothesis that the functional interaction between adenosine and dopamine mechanisms might occur through adenosine A2 receptors at the level of cholinergic neurons.  The results suggest that adenosine A2, but not A1, receptor antagonists may be of potential use in the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_yuXIH62xu7Vg90H21EOLACvtfcHk0li7ARr1XdWsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsVKgt70%253D&md5=369d9508f13df6a3a9e3ce41bf83fa13</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2983039-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252983039-7%26sid%3Dliteratum%253Aachs%26aulast%3DMandhane%26aufirst%3DS.%2BN.%26aulast%3DChopde%26aufirst%3DC.%2BT.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26atitle%3DAdenosine%2520A2%2520receptors%2520modulate%2520haloperidol-induced%2520catalepsy%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D328%26issue%3D2%252F3%26spage%3D135%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Cooper, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C. D.</span><span> </span><span class="NLM_article-title">L-Dopa esters as potential prodrugs: behavioral activity in experimental models of Parkinson’s disease</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1111%2Fj.2042-7158.1987.tb03441.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=2888854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaL2sXmtFWnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1987&pages=627-635&author=D.+R.+Cooperauthor=C.+Marrelauthor=H.+van+de+Waterbeemdauthor=B.+Testaauthor=P.+Jennerauthor=C.+D.+Marsden&title=L-Dopa+esters+as+potential+prodrugs%3A+behavioral+activity+in+experimental+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">L-Dopa esters as potential prodrugs:  behavioral activity in experimental models of Parkinson's disease</span></div><div class="casAuthors">Cooper, D. R.; Marrel, C.; Van de Waterbeemd, H.; Testa, B.; Jenner, P.; Marsden, C. D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-35</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">The behavioral activity of 13 ester prodrugs of L-dopa (I; R = Me, Et, Pr, CH2CH(OH)Me, CHMeCH2OMe, cyclohexyl, tetrahydropyranylmethyl, CH2Ph, substituted benzyl, phenylethyl, phenoxyethyl, substituted phenylethyl) was evaluated on 2 exptl. animal models of Parkinson's disease; reverse of reserpine-induced akinesia in mice and induction of circling behavior in rats with 6-hydroxydopamine lesion of the medial forebrain bundle.  In general, I did not have markedly greater activity or a more sustained effect than L-dopa itself and thus would be unlikely to offer major therapeutic advantages on intermittent oral dosage.  However, their various physiochem. properties may make them more suitable i.v. or s.c. infusions.  Structure-activity relations are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx_hPJDd522bVg90H21EOLACvtfcHk0li7ARr1XdWsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmtFWnt7k%253D&md5=06e8a60094d1a7d55c4017a2ff462cd3</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1987.tb03441.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1987.tb03441.x%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DD.%2BR.%26aulast%3DMarrel%26aufirst%3DC.%26aulast%3Dvan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DMarsden%26aufirst%3DC.%2BD.%26atitle%3DL-Dopa%2520esters%2520as%2520potential%2520prodrugs%253A%2520behavioral%2520activity%2520in%2520experimental%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1987%26volume%3D39%26spage%3D627%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ungerstedt, U.</span><span> </span><span class="NLM_article-title">6-Hydroxydopamine-induced generation of central monoamine neurons</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2F0014-2999%2868%2990164-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=5718510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaF1MXns1eisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1968&pages=107-110&author=U.+Ungerstedt&title=6-Hydroxydopamine-induced+generation+of+central+monoamine+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">6-Hydroxydopamine-induced degeneration of central monoamine neurons</span></div><div class="casAuthors">Ungerstedt, Urban</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-10</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">6-Hydroxydopamine (I) (2 or 8 μg.) injected into the nucleus caudatus putamen, the zona compacta of the substantia nigra, and the area dorsolateral to the nucleus interpedunclaris of rats caused degeneration of dopamine and noradrenaline cell bodies, axons, and terminals in the vicinity of the injection site.  The degeneration of the nigroneostriatal dopamine neuron system occurring after I injections into the substantia nigra produced marked motor disturbances.  Intracerebral administration of I may be used as a tool for anatomical and functional studies on central monoamine neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI9wsRougpvrVg90H21EOLACvtfcHk0li7ARr1XdWsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXns1eisw%253D%253D&md5=57298843164b07af35ca21b4624826c4</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2868%2990164-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252868%252990164-7%26sid%3Dliteratum%253Aachs%26aulast%3DUngerstedt%26aufirst%3DU.%26atitle%3D6-Hydroxydopamine-induced%2520generation%2520of%2520central%2520monoamine%2520neurons%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1968%26volume%3D5%26spage%3D107%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ungerstedt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbuthnott, G. W.</span><span> </span><span class="NLM_article-title">Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2F0006-8993%2870%2990187-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=5494536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A280%3ADyaE3M%252Fotl2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1970&pages=485-493&author=U.+Ungerstedtauthor=G.+W.+Arbuthnott&title=Quantitative+recording+of+rotational+behavior+in+rats+after+6-hydroxy-dopamine+lesions+of+the+nigrostriatal+dopamine+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system</span></div><div class="casAuthors">Ungerstedt U; Arbuthnott G W</div><div class="citationInfo"><span class="NLM_cas:title">Brain research</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">485-93</span>
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxWjpxbmSViUg6wdEZmT2rfW6udTcc2eY-LUID_xsNXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3M%252Fotl2msA%253D%253D&md5=e31a2eee4f4fff68329c0ab8a8a62788</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2870%2990187-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252870%252990187-3%26sid%3Dliteratum%253Aachs%26aulast%3DUngerstedt%26aufirst%3DU.%26aulast%3DArbuthnott%26aufirst%3DG.%2BW.%26atitle%3DQuantitative%2520recording%2520of%2520rotational%2520behavior%2520in%2520rats%2520after%25206-hydroxy-dopamine%2520lesions%2520of%2520the%2520nigrostriatal%2520dopamine%2520system%26jtitle%3DBrain%2520Res.%26date%3D1970%26volume%3D24%26spage%3D485%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Luthman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredriksson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstroem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, T.</span><span> </span><span class="NLM_article-title">Selective lesion of central dopamine or moradenaline neuron systems in the neonatal rat: motor behavior and monoamine alteration at adult stage</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1989&pages=267-277&author=J.+Luthmanauthor=A.+Fredrikssonauthor=E.+Sundstroemauthor=G.+Jonssonauthor=T.+Archer&title=Selective+lesion+of+central+dopamine+or+moradenaline+neuron+systems+in+the+neonatal+rat%3A+motor+behavior+and+monoamine+alteration+at+adult+stage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuthman%26aufirst%3DJ.%26aulast%3DFredriksson%26aufirst%3DA.%26aulast%3DSundstroem%26aufirst%3DE.%26aulast%3DJonsson%26aufirst%3DG.%26aulast%3DArcher%26aufirst%3DT.%26atitle%3DSelective%2520lesion%2520of%2520central%2520dopamine%2520or%2520moradenaline%2520neuron%2520systems%2520in%2520the%2520neonatal%2520rat%253A%2520motor%2520behavior%2520and%2520monoamine%2520alteration%2520at%2520adult%2520stage%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1989%26volume%3D33%26spage%3D267%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bankiewicz, K. S.</span><span> </span><span class="NLM_article-title">MPTP-induced parkinsonism in nonhuman primates</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2FB978-0-12-185263-4.50018-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaK38XisFejt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1991&pages=168-182&author=K.+S.+Bankiewicz&title=MPTP-induced+parkinsonism+in+nonhuman+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">MPTP-induced parkinsonism in nonhuman primates</span></div><div class="casAuthors">Bankiewicz, Krzysztof S.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">Lesions Transplant.</span>),
    <span class="NLM_cas:pages">168-82</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review with 45 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx3yh0hBeYerVg90H21EOLACvtfcHk0lg7JQYyC7dnWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XisFejt7s%253D&md5=d3848e6d09f0015f716ca9cdca6933ea</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-185263-4.50018-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-185263-4.50018-2%26sid%3Dliteratum%253Aachs%26aulast%3DBankiewicz%26aufirst%3DK.%2BS.%26atitle%3DMPTP-induced%2520parkinsonism%2520in%2520nonhuman%2520primates%26jtitle%3DMethods%2520Neurosci.%26date%3D1991%26volume%3D7%26spage%3D168%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jakowec, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzinger, G. M.</span><span> </span><span class="NLM_article-title">1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced lesion model of Parkinson’s disease, with emphasis on mice and nonhuman primates</span> <span class="citation_source-journal">Comp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=15575363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVejsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=497-513&author=M.+W.+Jakowecauthor=G.+M.+Petzinger&title=1-Methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine-induced+lesion+model+of+Parkinson%E2%80%99s+disease%2C+with+emphasis+on+mice+and+nonhuman+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of Parkinson's disease, with emphasis on mice and nonhuman primates</span></div><div class="casAuthors">Jakowec, Michael W.; Petzinger, Giselle M.</div><div class="citationInfo"><span class="NLM_cas:title">Comparative Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-513</span>CODEN:
                <span class="NLM_cas:coden">COMEFT</span>;
        ISSN:<span class="NLM_cas:issn">1532-0820</span>.
    
            (<span class="NLM_cas:orgname">American Association for Laboratory Animal Science</span>)
        </div><div class="casAbstract">A review.  Animal models play a crit. role in our understanding of the cause of human diseases and provide an opportunity to evaluate new therapeutic treatments.  The usefulness of an animal model is dependent, in part, on how closely it resembles neurochem., neuropathol., and behavioral features of the human condition.  Other considerations that may enhance the value of a model include expense, availability, reproducibility, animal morbidity and mortality, and investigator experience.  Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by slow movements, tremor, and walking impairment due to loss of midbrain nigrostriatal neurons and depletion of striatal dopamine.  In the PD research field, a no. of neurotoxic, pharmacol., and transgenic animal models are available for research studies.  We will focus on the advantages and disadvantages of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned mouse and nonhuman primate models of PD.  Our goal is to guide researchers in the appropriateness of the MPTP models in their studies by balancing understanding of the models, objectives of the study, and health and safety of the animals.  In addn., the tech. use and safe handling of MPTP are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1AbpYksctuLVg90H21EOLACvtfcHk0lg7JQYyC7dnWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVejsrrE&md5=268362f3d9a889531b0d888f0c86a96f</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakowec%26aufirst%3DM.%2BW.%26aulast%3DPetzinger%26aufirst%3DG.%2BM.%26atitle%3D1-Methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine-induced%2520lesion%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%252C%2520with%2520emphasis%2520on%2520mice%2520and%2520nonhuman%2520primates%26jtitle%3DComp.%2520Med.%26date%3D2004%26volume%3D54%26spage%3D497%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Campos-Romo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojeda-Flores, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Briseno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Ruiz, J.</span><span> </span><span class="NLM_article-title">Quantitative evaluation of MPTP-treated nonhuman parkinsonian primates in the hallway task</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2Fj.jneumeth.2008.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=19022292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2009&pages=361-368&author=A.+Campos-Romoauthor=R.+Ojeda-Floresauthor=P.+Moreno-Brisenoauthor=J.+Fernandez-Ruiz&title=Quantitative+evaluation+of+MPTP-treated+nonhuman+parkinsonian+primates+in+the+hallway+task"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative evaluation of MPTP-treated nonhuman parkinsonian primates in the HALLWAY task</span></div><div class="casAuthors">Campos-Romo, Aurelio; Ojeda-Flores, Rafael; Moreno-Briseno, Pablo; Fernandez-Ruiz, Juan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">361-368</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is a progressive neurodegenerative disorder.  An exptl. model of this disease is produced in nonhuman primates by the administration of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).  In this work, we put forward a new quant. evaluation method that uses video recordings to measure the displacement, gate, gross and fine motor performance of freely moving subjects.  Four Vervet monkeys (Cercopithecus aethiops) were trained in a behavioral observation hallway while being recorded with digital video cameras from four different angles.  After MPTP intoxication the animals were tested without any drug and after 30 and 90 min of Levodopa/Carbidopa administration.  Using a personal computer the following behaviors were measured and evaluated from the video recordings: displacement time across the hallway, reaching time towards rewards, ingestion time, no. of attempts to obtain rewards, no. of rewards obtained, and level of the highest shelf reached for rewards.  Our results show that there was an overall behavioral deterioration after MPTP administration and an overall improvement after Levodopa/Carbidopa treatment.  This demonstrates that the HALLWAY task is a sensitive and objective method that allows detailed behavioral evaluation of freely moving monkeys in the MPTP Parkinson's disease model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruYimo678roLVg90H21EOLACvtfcHk0lg7JQYyC7dnWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFeisQ%253D%253D&md5=e824a38d96e1e6d37bac316822174a89</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2008.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2008.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DCampos-Romo%26aufirst%3DA.%26aulast%3DOjeda-Flores%26aufirst%3DR.%26aulast%3DMoreno-Briseno%26aufirst%3DP.%26aulast%3DFernandez-Ruiz%26aufirst%3DJ.%26atitle%3DQuantitative%2520evaluation%2520of%2520MPTP-treated%2520nonhuman%2520parkinsonian%2520primates%2520in%2520the%2520hallway%2520task%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2009%26volume%3D177%26spage%3D361%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Kraus, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sy, J. O.</span><span> </span><span class="NLM_article-title">A synthetic approach to rocaglamide via reductive cyclization of δ-keto nitriles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00262a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=77-83&author=G.+A.+Krausauthor=J.+O.+Sy&title=A+synthetic+approach+to+rocaglamide+via+reductive+cyclization+of+%CE%B4-keto+nitriles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo00262a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00262a022%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DG.%2BA.%26aulast%3DSy%26aufirst%3DJ.%2BO.%26atitle%3DA%2520synthetic%2520approach%2520to%2520rocaglamide%2520via%2520reductive%2520cyclization%2520of%2520%25CE%25B4-keto%2520nitriles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1989%26volume%3D54%26spage%3D77%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Heintzelman, G. R.; Bullington, J. L.; Rupert, K. C.</span><span> </span><span class="NLM_article-title">Preparation of Arylindenopyridines and Arylindenopyrimidines and Their Use as Adenosine A<sub>2a</sub> Receptor Antagonists</span>. PCT Int. Appl. WO 2005042500,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=G.+R.+Heintzelman&author=J.+L.+Bullington&author=K.+C.+Rupert&title=Preparation+of+Arylindenopyridines+and+Arylindenopyrimidines+and+Their+Use+as+Adenosine+A2a+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHeintzelman%26aufirst%3DG.%2BR.%26atitle%3DPreparation%2520of%2520Arylindenopyridines%2520and%2520Arylindenopyrimidines%2520and%2520Their%2520Use%2520as%2520Adenosine%2520A2a%2520Receptor%2520Antagonists%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebeskind, L. S.</span><span> </span><span class="NLM_article-title">Copper-mediated, palladium-catalyzed coupling of thiol ester with aliphatic organoboron reagents</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3554</span><span class="NLM_x">–</span> <span class="NLM_lpage">3557</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo049964p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=3554-3557&author=Y.+Yuauthor=L.+S.+Liebeskind&title=Copper-mediated%2C+palladium-catalyzed+coupling+of+thiol+ester+with+aliphatic+organoboron+reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1021%2Fjo049964p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049964p%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DLiebeskind%26aufirst%3DL.%2BS.%26atitle%3DCopper-mediated%252C%2520palladium-catalyzed%2520coupling%2520of%2520thiol%2520ester%2520with%2520aliphatic%2520organoboron%2520reagents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D3554%26epage%3D3557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kusturin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebeskind, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sample, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srogl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, W. L.</span><span> </span><span class="NLM_article-title">Switchable catalysis: modular synthesis of functionalized pyrimidones via selective sulfide and halide cross-coupling chemistry</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4349</span><span class="NLM_x">–</span> <span class="NLM_lpage">4352</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol035649y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=4349-4352&author=C.+Kusturinauthor=L.+S.+Liebeskindauthor=H.+Rahmanauthor=K.+Sampleauthor=B.+Schweitzerauthor=J.+Sroglauthor=W.+L.+Neumann&title=Switchable+catalysis%3A+modular+synthesis+of+functionalized+pyrimidones+via+selective+sulfide+and+halide+cross-coupling+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1021%2Fol035649y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol035649y%26sid%3Dliteratum%253Aachs%26aulast%3DKusturin%26aufirst%3DC.%26aulast%3DLiebeskind%26aufirst%3DL.%2BS.%26aulast%3DRahman%26aufirst%3DH.%26aulast%3DSample%26aufirst%3DK.%26aulast%3DSchweitzer%26aufirst%3DB.%26aulast%3DSrogl%26aufirst%3DJ.%26aulast%3DNeumann%26aufirst%3DW.%2BL.%26atitle%3DSwitchable%2520catalysis%253A%2520modular%2520synthesis%2520of%2520functionalized%2520pyrimidones%2520via%2520selective%2520sulfide%2520and%2520halide%2520cross-coupling%2520chemistry%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D4349%26epage%3D4352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Liebeskind, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srogl, J.</span><span> </span><span class="NLM_article-title">Heteroaromatic thioether−boronic acid cross-coupling under neutral reaction conditions</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0200091" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=979-981&author=L.+S.+Liebeskindauthor=J.+Srogl&title=Heteroaromatic+thioether%E2%88%92boronic+acid+cross-coupling+under+neutral+reaction+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1021%2Fol0200091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0200091%26sid%3Dliteratum%253Aachs%26aulast%3DLiebeskind%26aufirst%3DL.%2BS.%26aulast%3DSrogl%26aufirst%3DJ.%26atitle%3DHeteroaromatic%2520thioether%25E2%2588%2592boronic%2520acid%2520cross-coupling%2520under%2520neutral%2520reaction%2520conditions%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D979%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Hyttel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span> </span><span class="NLM_article-title">Recptor-binding profiles of neuroleptics</span> <span class="citation_source-journal">Psychopharmacol. Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1007%2F978-3-642-70140-5_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=2860665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaL2MXlvVyrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1985&pages=9-18&author=J.+Hyttelauthor=J.+J.+Larsenauthor=A.+V.+Christensenauthor=J.+Arnt&title=Recptor-binding+profiles+of+neuroleptics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor-binding profiles of neuroleptics</span></div><div class="casAuthors">Hyttel, J.; Larsen, J. J.; Christensen, A. V.; Arnt, J.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology, Supplementum</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">Dyskinesia</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">PSSUE5</span>;
        ISSN:<span class="NLM_cas:issn">0179-8456</span>.
    </div><div class="casAbstract">A review with 33 refs. of the dopaminergic receptor binding blockade by neuroleptics in relation to antipsychotic activity and side-effects of neuroleptics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBA2EApKaKZ7Vg90H21EOLACvtfcHk0lhKmE5DWRkA6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlvVyrurk%253D&md5=fb425b1ed020812fdd72f602a9e398e4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-70140-5_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-70140-5_2%26sid%3Dliteratum%253Aachs%26aulast%3DHyttel%26aufirst%3DJ.%26aulast%3DLarsen%26aufirst%3DJ.%2BJ.%26aulast%3DChristensen%26aufirst%3DA.%2BV.%26aulast%3DArnt%26aufirst%3DJ.%26atitle%3DRecptor-binding%2520profiles%2520of%2520neuroleptics%26jtitle%3DPsychopharmacol.%2520Suppl.%26date%3D1985%26volume%3D2%26spage%3D9%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptors modify motor function in MPTP-treated common marmosets</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2857</span><span class="NLM_x">–</span> <span class="NLM_lpage">2860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=2857-2860&author=T.+Kandaauthor=T.+Tashiroauthor=Y.+Kuwanaauthor=P.+Jenner&title=Adenosine+A2A+receptors+modify+motor+function+in+MPTP-treated+common+marmosets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DT.%26aulast%3DTashiro%26aufirst%3DT.%26aulast%3DKuwana%26aufirst%3DY.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DAdenosine%2520A2A%2520receptors%2520modify%2520motor%2520function%2520in%2520MPTP-treated%2520common%2520marmosets%26jtitle%3DNeuroReport%26date%3D1998%26volume%3D9%26spage%3D2857%26epage%3D2860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grondin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadj, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregoire, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span> </span><span class="NLM_article-title">Antiparkinsonian effect of a new selective adenosine A<sub>2A</sub> receptor antagonist in MPTP-treated monkeys</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=1673-1677&author=R.+Grondinauthor=P.+J.+Bedardauthor=T.+A.+Hadjauthor=L.+Gregoireauthor=A.+Moriauthor=H.+Kase&title=Antiparkinsonian+effect+of+a+new+selective+adenosine+A2A+receptor+antagonist+in+MPTP-treated+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrondin%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DP.%2BJ.%26aulast%3DHadj%26aufirst%3DT.%2BA.%26aulast%3DGregoire%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DKase%26aufirst%3DH.%26atitle%3DAntiparkinsonian%2520effect%2520of%2520a%2520new%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonist%2520in%2520MPTP-treated%2520monkeys%26jtitle%3DNeurology%26date%3D1999%26volume%3D52%26spage%3D1673%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bara-Jimenez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherzai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouradian, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonist treatment of Parkinson’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=293-296&author=W.+Bara-Jimenezauthor=A.+Sherzaiauthor=T.+Dimitrovaauthor=A.+Favitauthor=F.+Bibbianiauthor=M.+Gillespieauthor=M.+J.+Morrisauthor=M.+M.+Mouradianauthor=T.+N.+Chase&title=Adenosine+A2A+receptor+antagonist+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBara-Jimenez%26aufirst%3DW.%26aulast%3DSherzai%26aufirst%3DA.%26aulast%3DDimitrova%26aufirst%3DT.%26aulast%3DFavit%26aufirst%3DA.%26aulast%3DBibbiani%26aufirst%3DF.%26aulast%3DGillespie%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonist%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D293%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hauser, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubble, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, D. D.</span><span> </span><span class="NLM_article-title">Randomized trial of the adenosine A<sub>2A</sub> receptor antagonist istradefylline in advanced PD</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=297-303&author=R.+A.+Hauserauthor=J.+P.+Hubbleauthor=D.+D.+Truong&title=Randomized+trial+of+the+adenosine+A2A+receptor+antagonist+istradefylline+in+advanced+PD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DR.%2BA.%26aulast%3DHubble%26aufirst%3DJ.%2BP.%26aulast%3DTruong%26aufirst%3DD.%2BD.%26atitle%3DRandomized%2520trial%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520antagonist%2520istradefylline%2520in%2520advanced%2520PD%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D297%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marsden, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolphin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvoisin, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarsy, D.</span><span> </span><span class="NLM_article-title">Role of noradrenaline in levodopa reversal of reserpine akinesia</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2F0006-8993%2874%2990643-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaE2MXlsVA%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1974&pages=521-525&author=C.+D.+Marsdenauthor=A.+Dolphinauthor=R.+C.+Duvoisinauthor=P.+Jennerauthor=D.+Tarsy&title=Role+of+noradrenaline+in+levodopa+reversal+of+reserpine+akinesia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of noradrenaline in levodopa reversal of reserpine akinesia</span></div><div class="casAuthors">Marsden, C. D.; Dolphin, A.; Duvoisin, R. C.; Jenner, P.; Tarsy, D.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">521-5</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Pretreatment of reserpinized rats with 25 mg FLA-63/kg, a dopamine β-hydroxylase inhibitor, or with 20 mg phenoxybenzamine/kg, a noradrenaline (I) [51-41-2] receptor blocker, decreased the levodopa [59-92-7] (500 mg/kg) reversal of akinesia induced by reserpine [50-55-5].  Some spontaneous activity did occur after levodopa administration in animals pretreated with FLA-63 or phenoxybenzamine but this activity was unlike that of reserpinized animals treated with levodopa alone.  Other compds. which blocked both central dopamine [51-61-6] and I receptors in the brain also decreased the levodopa effect, whereas pimozide, which primarily blocks only dopamine receptors, had no effect on the response to levodopa.  Thus, levodopa reversal of reserpine akinesia may require the formation of  I as well as dopamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQMLyHwjYI7rVg90H21EOLACvtfcHk0lhDcYBRc4xnbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXlsVA%253D&md5=68b938889d6e3945f83bbcaa2539642c</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2874%2990643-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252874%252990643-X%26sid%3Dliteratum%253Aachs%26aulast%3DMarsden%26aufirst%3DC.%2BD.%26aulast%3DDolphin%26aufirst%3DA.%26aulast%3DDuvoisin%26aufirst%3DR.%2BC.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DTarsy%26aufirst%3DD.%26atitle%3DRole%2520of%2520noradrenaline%2520in%2520levodopa%2520reversal%2520of%2520reserpine%2520akinesia%26jtitle%3DBrain%2520Res.%26date%3D1974%26volume%3D17%26spage%3D521%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Starr, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, B. S.</span><span> </span><span class="NLM_article-title">Comparison of the effects NMDA and AMPA antagonist on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1994&pages=495-504&author=M.+S.+Starrauthor=B.+S.+Starr&title=Comparison+of+the+effects+NMDA+and+AMPA+antagonist+on+the+locomotor+activity+induced+by+selective+D1+and+D2+dopamine+agonists+in+reserpine-treated+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStarr%26aufirst%3DM.%2BS.%26aulast%3DStarr%26aufirst%3DB.%2BS.%26atitle%3DComparison%2520of%2520the%2520effects%2520NMDA%2520and%2520AMPA%2520antagonist%2520on%2520the%2520locomotor%2520activity%2520induced%2520by%2520selective%2520D1%2520and%2520D2%2520dopamine%2520agonists%2520in%2520reserpine-treated%2520mice%26jtitle%3DPsychopharmacology%26date%3D1994%26volume%3D114%26spage%3D495%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Robinson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. B.</span><span> </span><span class="NLM_article-title">The rotational behavior model: asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm100971t&amp;key=10.1016%2F0006-8993%2883%2991129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm100971t&amp;key=6405975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm100971t&amp;key=1%3ACAS%3A528%3ADyaL3sXitV2rtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1983&pages=127-131&author=T.+E.+Robinsonauthor=J.+B.+Becker&title=The+rotational+behavior+model%3A+asymmetry+in+the+effects+of+unilateral+6-OHDA+lesions+of+the+substantia+nigra+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The rotational behavior model:  asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats</span></div><div class="casAuthors">Robinson, Terry E.; Becker, Jill B.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-31</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The d-amphetamine  [51-64-9]-induced rotational behavior of rats with dopamine  [51-61-6] depletion in the dominant striatum was in the opposite direction of that obsd. in rats with damage to the nondominant striatum.  Thus, when using the 6-hydroxydopamine (6-OHDA) lesion rotation model, the intrinsic asymmetry in the nigrostriatal dopaminergic system should be taken into consideration with respect to the side of lesion placement, since different results may be obtained depending on the side of the lesion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG7YxiJKMBTbVg90H21EOLACvtfcHk0lhDcYBRc4xnbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitV2rtbg%253D&md5=b90687387f1f528f0b5ed09e84084344</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2883%2991129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252883%252991129-0%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DT.%2BE.%26aulast%3DBecker%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520rotational%2520behavior%2520model%253A%2520asymmetry%2520in%2520the%2520effects%2520of%2520unilateral%25206-OHDA%2520lesions%2520of%2520the%2520substantia%2520nigra%2520in%2520rats%26jtitle%3DBrain%2520Res.%26date%3D1983%26volume%3D264%26spage%3D127%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Damier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graybiel, A. M.</span><span> </span><span class="NLM_article-title">The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1437</span><span class="NLM_x">–</span> <span class="NLM_lpage">1448</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1999&pages=1437-1448&author=P.+Damierauthor=E.+C.+Hirschauthor=Y.+Agidauthor=A.+M.+Graybiel&title=The+substantia+nigra+of+the+human+brain.+II.+Patterns+of+loss+of+dopamine-containing+neurons+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDamier%26aufirst%3DP.%26aulast%3DHirsch%26aufirst%3DE.%2BC.%26aulast%3DAgid%26aufirst%3DY.%26aulast%3DGraybiel%26aufirst%3DA.%2BM.%26atitle%3DThe%2520substantia%2520nigra%2520of%2520the%2520human%2520brain.%2520II.%2520Patterns%2520of%2520loss%2520of%2520dopamine-containing%2520neurons%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D1999%26volume%3D122%26spage%3D1437%26epage%3D1448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100971t&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-22%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm100971t%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100971t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679951bb7bb3192e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
